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Ac acetyl 
acac acetylacetonate  
Ar undefined aryl substituent 
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Bu butyl 
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calcd. calculated 
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1 Overview 
The FDA’s Center for Drug Evaluation and Research approved 45 new drugs in 2015 which marks a 
19-year high, exceeding even the previous recent record of 41 drugs in 2014.1 This number shows that 
the constantly increasing search for novel biologically active molecules for the pharmaceutical industry 
is still one of the major areas of chemical research. The majority of the new therapeutic drugs (33) are 
still categorized in the broad class of small organic molecules with a low molecular weight 
(< 900 g mol-1). Sonidegib (Odomzo®, Novartis, anticancer, 1), Palbociclib (Ibrance®, Pfizer, 
anticancer, 2), Flibanserin (Addyi®, Sprout Pharmaceuticals, hypoactive sexual desire disorder 
treatment, 3), and Panobinostat (Farydak®, Novartis, anticancer, 4) are four examples of such molecules 
(Figure 1). New drug candidates are nowadays identified as such with the use of chemical libraries of 
synthetic small molecules or natural products in a process known as classical pharmacology in which 
the synthetic organic chemist plays a fundamental role.2 
 
1 2 3 4 
Figure 1: Selected small molecules approved as therapeutic drugs in the U.S. by the FDA in 2015. 
In order to meet the high needs in quantity and complexity of the target molecules novel strategies 
allowing the efficient formation of new carbon–carbon bonds between functionalized moieties are 
required. Organometallic reagents provide a general entry into complex molecules and many 
applications in total synthesis have been described.3 To achieve an efficient and selective formation of 
a new C–C bond with an organometallic compound the origin of the reagent is crucial. Organolithium 
compounds display an exceptional reactivity toward a variety of electrophiles due to the high ionic 
nature of the carbon–lithium bond (Figure 2). However, due to the high reactivity of organolithium 
reagents low reaction temperatures are often necessary and only few functional groups are tolerated in 
the course of the reaction. By using magnesium and aluminum compounds some of these drawbacks 
can be overcome as the carbon–metal bond is less polarized and thus displays a somewhat lower 
reactivity. 
                                                     
1 A. Mullard, Nat. Rev. Drug Discovery 2016, 15, 73. 
2 J. A. Lee, M. T. Uhlik, C. M. Moxham, D. Tomandl, D. J. Sall, J. Med. Chem. 2012, 55, 4527.  
3 K. C. Nicolaou, J. S. Chen, in Classics in Total Synthesis III, Wiley-VCH Verlag GmbH, 2011. 
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Figure 2: Electronegativity difference of selected metals relative to carbon (Pauling electronegativity scale).4 
On the other hand, gallium, tin, and boron which form covalent bonds with carbon can tolerate a range 
of functional groups, but also show a very limited reactivity toward many electrophiles. The middle of 
the spectrum is occupied by zinc, which enables both, broad functional group tolerance as well as 
sufficient reactivity with a variety of reaction partners. 
2 Organozinc Compounds 
2.1 Overview 
The chemistry of organozinc compounds dates back into a long history of scientific breakthroughs. 
Diethyl- and dimethylzinc, the first organozinc compounds were already prepared in 1849 by 
Frankland.5 Since then, organozinc compounds have found numerous applications in organic synthesis. 
The Reformatsky reaction6 or the Simmons-Smith cylopropanation7 are only two examples. In addition, 
organozinc compounds have proved to easily undergo transmetalation reactions with various transition 
metals such as copper due to the presence of empty p-orbitals of appropriate energy which facilitates 
4-membered transition states leading to mixed zinc-copper species. The resulting reagents, although 
being thermodynamically more stable (more covalent carbon–copper bond) are more reactive due to the 
presence of nucleophilic, nonbonding d-electrons that interact in an oxidative process with the 
electrophile and mediate the formation of the new carbon-carbon bond.8 The facile transmetalation to 
palladium in the Negishi cross-coupling reaction made organozinc compounds again a powerful and 
indispensable tool in organic synthesis resulting in rewarding Ei-ichi Negishi among Richard F. Heck 
and Akira Suzuki with the Nobel Prize in Chemistry in 2010 for their work on this new type of C–C-
bond formation.9 Organozinc reagents could be regarded as the most advantageous reagents in cross-
coupling reactions due to their high functional group tolerance, whilst a good reactivity and non-toxic 
                                                     
4 A. Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. Chem. Int. Ed. 2009, 39, 4414. 
5 E. Frankland, Liebigs Ann. Chem. 1849, 71, 171. 
6 a) S. Reformatsky, Chem. Ber. 1887, 20, 1210; 1895, 28, 2842; b) R. Ocampo, Tetrahedron 2004, 60, 9325. 
7 a) H. E. Simmons, R. D. Smith, J. Am. Chem. Soc. 1958, 80, 5323; b) H. E. Simmons, R. D. Smith, J. Am. Chem. 
Soc. 1959, 81, 5323; c) H. Lebel, J.- F. Marcoux, C. Molinaro, A. B. Charette, Chem. Rev. 2003, 103, 977.  
8 P. Knochel, H. Leuser, L.-Z. Cong, S. Perrone, F. F. Kneisel, in Handbook of Functionalized Organometallics, 
Wiley-VCH Verlag GmbH, 2008, pp. 251. 
9 X.-F. Wu, P. Anbarasan, H. Neumann, M. Beller, Angew. Chem. Int. Ed. 2010, 49, 9047. 
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byproducts.10 A major drawback is their lability when exposed to air which is believed to be mainly 
attributed to the hydrolysis via air moisture. 
2.2 Preparation of Organozinc Compounds 
2.2.1 Oxidative Insertion 
Similarly to the preparation of organomagnesium compounds, the most common method for the direct 
synthesis of organozinc reagents is the insertion of zinc powder into organic halides. However, in many 
cases expensive organic iodides have to be used and elevated reaction temperatures are necessary. To 
avoid these drawbacks, Rieke et al. used highly active zinc (Zn*), prepared by reduction of ZnCl2 with 
lithium naphthalide to obtain functionalized organozinc reagents from less reactive arylbromides 
(Scheme 1).11 Thus, starting from ethyl 4-bromobutyrate (5) the organozinc bromide (6) was obtained 
using the Rieke zinc, which led after addition of benzoyl chloride in the presence of CuCN·2LiBr to the 
desired ethyl 5-oxo-5-phenylpentanoate (7) in 95% yield over two steps. 
 
5 6 7 
Scheme 1: Zinc insertion using Rieke zinc and subsequent acylation.11b 
Knochel and co-workers were able to show that also the use of commercial available zinc powder is 
suitable for the insertion into highly functionalized halides at mild conditions in the presence of LiCl 
(Scheme 2).12 This allowed for the preparation of aromatic, heteroaromatic, and benzylic zinc reagents 
in the presence of a variety of functional groups like esters, nitriles, and aldehydes. The role of LiCl has 
been investigated by means of experimental, computational, and analytical studies.13 An additional 
positive effect of LiCl is the increased solubility of the organometallic reagent in THF solution and thus 
in the insertion reaction a free metal surface is regenerated which allows a further reaction with the 
starting halide.12a,14 Thus, the heteroaromatic bromide 8 could be transformed into the corresponding 
                                                     
10 a) P. Knochel, J. Almena, P. Jones, Tetrahedron 1998, 54, 8275; b) A. Boudier, L. O. Bromm, M. Lotz, P. 
Knochel, Angew. Chem. 2000, 112, 4584; Angew. Chem. Int. Ed. 2000, 39, 4414; c) P. Knochel, N. Millot, A. L. 
Rodriguez, C. E. Tucker, Org. React. 2001, 58, 417; d) A. Lemire, A. Côté, M. K. Janes, A. B. Charette, 
Aldrichimica Acta 2009, 42, 71. 
11 a) R. D. Rieke, P. T.-J. Li, T. P. Burns, S. T. Uhm, J. Org. Chem. 1981, 46, 4322. b) L. Zhu, R. M. Wehmeyer, 
R. D. Rieke, J. Org. Chem. 1991, 56, 1445. 
12 a) A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 6040; Angew. 
Chem. 2006, 118, 6186; b) N. Boudet, S. Sase, P. Sinha, C.-Y. Liu, A. Krasovskiy, P. Knochel, J. Am. Chem. Soc. 
2007, 129, 12358; c) A. Metzger, M. A. Schade, P. Knochel, Org. Lett. 2008, 10, 1107. 
13 a) C.-Y. Liu, X. Wang, T. Furuyama, S. Yasuike, A. Muranaka, K. Morokuma, M. Uchiyama, Chem. Eur. J. 
2010, 16, 1780. a) K. Koszinowski, P. Böhrer, Organometallics 2009, 28, 771; b) J. E. Fleckenstein, K. 
Koszinowski, Organometallics 2011, 30, 5018.  
14 a) A. Krasovskiy, B. F. Straub, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 159; b) C. Feng, D. W. Cunningham, 
Q. T. Easter, S. A. Blum, J. Am. Chem. Soc. 2016, 138, 11156. 
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organozinc compound 9 under mild conditions and subsequently undergo a palladium catalyzed cross-
coupling to the arylated product 10. Furthermore the preparation and cross-coupling of the benzylic zinc 
reagent 11 with 1-iodo-6,7-dimethoxyisoquinoline (12) to furnish the opium alkaloid antispasmodic 
drug papaverine (13) was described.12a,b 
 
8 9  10 
 11 12 13 
Scheme 2: Preparation of functionalized organozinc reagents using zinc dust in the presence of LiCl.12a,b 
2.2.2 Iodine-Zinc Exchange 
Starting from organic iodides, the organozinc compound can alternatively be prepared by an exchange 
reaction using another organozinc reagent. The driving force in this reaction is the formation of the more 
stable organometallic reagent.15 Thus, for example the reaction of 3-iodo-4-methylbenzonitrile (14) with 
iPr2Zn in the presence of Li(acac) as promoter for an intermediate ate complex formation leads to the 
diaromatic zinc reagent 15 and can be transformed in a copper catalyzed acylation to 
3-acetyl-4-methylbenzonitrile (16) in 87% yield (Scheme 3).16,17 
 
14 15 16 
Scheme 3: Preparation of diorganozincs by an Li(acac)-mediated iodine-zinc exchange reaction.16 
2.2.3 Metalation 
A different approach toward functionalized organometallics is the direct metalation using metal bases. 
Traditionally, strong bases such as alkyllithium reagents and lithium amides (R2NLi; e.g., LDA) have 
been extensively used for this purpose. However, they often suffer under undesired side reactions due 
to their high reactivity, their strong nucleophilicity, and their low functional group tolerance. Another 
                                                     
15 D. Hauk, S. Lang, A. Murso, Org. Process Res. Dev. 2006, 10, 733.  
16 F. F. Kneisel, M. Dochnahl, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 1017. 
17 G. Dunet, P. Knochel, Synlett, 2007, 1383. 
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serious drawback is the low stability of organolithium reagents in THF at ambient temperature. Thus, 
low temperatures (–78 to –100 °C) are often necessary for these reactions. A major improvement in this 
respect was the development of the highly active mixed Mg/Li-bases of type R2NMgCl·LiCl by Knochel 
et al.18 TMPMgCl·LiCl (17) has been extensively used in the metalation of a variety of substrates.19 
However, the resulting magnesium reagents also suffer from high reactivity and therefore have a limited 
functional group tolerance. As a logical consequence, Knochel et al. developed the highly 
chemoselective TMP-derived bases (TMP)2Zn·2MgCl2·2LiCl (18) and TMPZnCl·LiCl (19) for the 
metalation of sensitive aromatics and heterocycles under mild conditions (Scheme 4).20,21 
 
17  
18 19 
Scheme 4: Knochel bases 18 and 19 for the regioselective metalation and functionalization of aromatic and 
heteroaromatic scaffolds.20a,21 
                                                     
18 a) A. Krasovskiy, V. Krasovskaya, P. Knochel, Angew. Chem. 2006, 118, 3024; Angew. Chem. Int. Ed. 2006, 
45, 2958; b) T. Kunz, P. Knochel, Angew. Chem. 2012, 124, 1994; Angew. Chem. Int. Ed. 2012, 51, 1958. 
19 For an overview see: B. Haag, M. Mosrin, H. Ila, V. Malakhov, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 
9794. S. M. Manolikakes, N. M. Barl, C. Sämann, P. Knochel, Z. Naturforsch., B: Chem. Sci. 2014, 68, 411; T. 
Klatt, J. T. Markiewicz, C. Sämann, P. Knochel, J. Org. Chem. 2014, 79, 4253. 
20 S. H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7685; S. H. Wunderlich, P. Knochel, Org. Lett. 
2008, 10, 4705; S. H. Wunderlich, C. J. Rohbogner, A. Unsinn, P. Knochel, Org. Process Res. Dev. 2010, 14, 339; 
21 M. Mosrin, P. Knochel, Org. Lett. 2009, 11, 1837; T. Bresser, G. Monzon, M. Mosrin, P. Knochel, Org. Process 
Res. Dev. 2010, 14, 1299. 
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2.2.4 Transmetalation 
The treatment of organomagnesium or organolithium compounds with ZnCl2 solution in THF leads to a 
transmetalation to the corresponding organozinc compounds. The driving force is the formation of the 
more covalent and hence more stable C–Zn bond. For example the magnesium insertion into methyl 
2-bromobenzoate (20) in the presence of ZnCl2 leads to an intermediate formation of the magnesium 
compound 21 but is trapped by the zinc salt before intramolecular side reactions can occur leading to 
the stable zinc compound 22.22 Acylation in the presence of CuCN·2LiCl furnishes the desired ketone 
23 in 77% overall yield. 
 
20 21 22 23 
Scheme 5: Magnesium insertion in the presence of ZnCl2.22 
The lithiation of arenes and heteroarenes is an important tool for the functionalization of complex 
aromatic scaffolds. However, the resulting lithium derivatives suffer from an exceptionally high 
reactivity and thus are limited in terms of functional group tolerance. Knochel et al. reported a procedure 
which allows for the concomitant use of TMPLi with various metal salts such as MgCl2, ZnCl2 or CuCN. 
Thus, the metalation of 2,4-dichlorobenzonitrile (24) using TMPLi in the presence of ZnCl2·2LiCl and 
subsequent addition of iodine leads to the kinetic iodinated product (25) whereas the use of 
TMPZnCl·LiCl (19) leads to a metalation in the most acidic position 3 furnishing 26.23 Furthermore, it 
was shown that the reaction of TMPLi with 24 is more than six times faster than the reaction of TMPLi 
with ZnCl2·2LiCl which allows for the high regioselectivity in this transformation.  
 
 
 24  
25  26 
Scheme 6: Regioselectivity switch in the metalation of 24 using TMPLi in the presence of ZnCl2·LiCl or 
TMPZnCl·LiCl (19). [a] Calculated pKa values for H3, H5, and H6.23 
                                                     
22 F. M. Piller, A. Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 7192 
23 A. Frischmuth, M. Fernández, N. M. Barl, F. Achrainer, H. Zipse, G. Berionni, H. Mayr, K. Karaghiosoff, P. 
Knochel, Angew. Chem. Int. Ed. 2014, 53, 7928; Angew. Chem. 2014, 126, 8062. 
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3 Solid, Salt Stabilized Organozinc Reagents 
3.1 Overview 
As described in Chapter 2, organozinc reagents play a major role in organometallic chemistry due to 
their high compatibility with a broad variety of functional groups. Moreover, they are valuable reagents 
for transition metal mediated C–C bond formation reactions, such as Negishi cross-coupling,24 
allylation,25 or acylation26 reactions. However, their limited stability towards air and moisture represents 
a serious drawback for their practical use in the laboratory and for industrial applications. To overcome 
this problem, we recently developed a method for the preparation of aryl and heteroaryl zinc pivalates, 
which are easy-to-handle solids with exceptional stability when exposed to air.27 These zinc reagents 
can be prepared by magnesium insertion or halogen–magnesium exchange followed by transmetalation 
with Zn(OPiv)2·2LiCl (OPiv = pivalate) to give the corresponding aryl, heteroaryl, and benzylic zinc 
reagents described with the proposed formula RZnOPiv·Mg(OPiv)X·2LiCl (X = Cl, Br, I) (Scheme 7, 
A and B).27a A halogen–lithium exchange followed by transmetalation with Zn(OPiv)2 proved to be a 
feasible way to prepare 2-pyridylzinc reagents.27d Another possible route is directed metalation using 
the sterically hindered base TMPMgCl·LiCl (17)18,19 and subsequent addition of Zn(OPiv)2, giving 
organozinc reagents described as RZnOPiv·Mg(OPiv)Cl·LiCl (Scheme 7, C). The air-stability of such 
zinc organometallics was substantially superior to organozinc pivalates prepared by magnesium 
insertion (or exchange).27b In the presence of sensitive functionalities such as an aldehyde or a nitro 
group, the milder zinc amide base TMPZnOPiv·Mg(OPiv)Cl·LiCl27c (27) may be used for highly 
selective metalation reactions to give the desired organozinc reagents, which undergo a range of 
reactions with various electrophiles (Scheme 7, D). 
                                                     
24 a) E. Negishi, A. O. King, N. Okukado, J. Org. Chem. 1977, 42, 1821; b) E. Negishi, L. F. Valente, M. 
Kobayashi, J. Am. Chem. Soc. 1980, 102, 3298; c) G. Wang, N. Yin, E. Negishi, Chem. Eur. J. 2011, 17, 4118; d) 
E. Negishi, X. Zeng, Z. Tan, M. Qian,Q. Hu, Z. Huang in Metal-Catalyzed Cross-Coupling Reactions (Eds.: F. 
Diederich, A. de Meijere), 2nd ed., Wiley-VCH, Weinheim, 2004; e) A. A. Zemtsov, N. S. Kondratyev, V. V. 
Levin, M. I. Struchkova, A D. Dilman J. Org. Chem. 2014, 79, 818. 
25 a) F. Dübner, P. Knochel, Angew. Chem. 1999, 111, 391; Angew. Chem. Int. Ed. 1999, 38, 379; b) F. Dübner, 
P. Knochel, Tetrahedron, 2000, 41, 9233; c) H. Malda, A. W. van Zijl, L. A. Arnold, B. L. Feringa, Org. Lett. 
2001, 3, 1169; d) C. A. Falciola, A. Alexakis, Eur. J. Org. Chem. 2008, 3765; e) K. Geurts, S. P. Fletcher, A. W. 
van Zijl, A. J. Minnaard, B. L. Feringa, Pure Appl. Chem. 2008, 5, 1025; f) E. Erdik, M. Koçoğlu, J. Organomet. 
Chem. 2009, 694, 1890. 
26 a) E. Nakamura, I. Kuwajima, J. Am. Chem. Soc. 1982, 106, 3368; b) P. Knochel, M. Yeh, S. Berk, J. Talbert, 
J. Org. Chem. 1988, 53, 2390; c) P. Knochel, S. A. Rao, J. Am. Chem. Soc. 1990, 112, 6146. 
27 a) S. Bernhardt, G. Manolikakes, T. Kunz, P. Knochel, Angew. Chem. 2011, 123, 9372; Angew. Chem. Int. Ed. 
2011, 50, 9205; b) C. I. Stathakis, S. Bernhardt, V. Quint, P. Knochel, Angew. Chem. 2012, 124, 9563; Angew. 
Chem. Int. Ed. 2012, 51, 9428; c) C. I. Stathakis, S. M. Manolikakes, P. Knochel, Org. Lett. 2013, 15, 1302; d) J. 
R. Colombe, S. Bernhardt, C. Stathakis, S. L. Buchwald, P. Knochel, Org. Lett. 2013, 15, 5754; e) S. M. 
Manolikakes, M. Ellwart, C. I. Stathakis, P. Knochel, Chem. Eur. J. 2014, 20, 12289. 
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27 
Scheme 7: Different protocols for the preparation of (hetero-)aromatic organozinc pivalates.27a-c,e 
The structure of the resulting zinc reagents is complex due to the presence of various metal salts in the 
final reagents.27a Structural studies in solution and on the crystal performed by Mulvey and Hevia 
indicate that the addition of solid zinc pivalate leads to a complete transmetalation to the corresponding 
organozinc halide and Mg(OPiv)2, which then acts as an air and moisture scavenger and is hence 
responsible for the exceptional air-stability of the reagents.28 Therefore, a more accurate way to describe 
these trimetallic clusters would be the general formula: “RZnX·Mg(OPiv)2·nLiCl” (X = Br, I, Cl; n = 
1–2). For clarity, the abbreviation RZnOPiv was used in this thesis. 
3.2 Preparation of Organozinc Pivalates from (Hetero-)Aryl Halides 
As mentioned in Chapter 3.1 starting from (hetero-)aromatic or benzylic halides the magnesium 
insertion reaction in the presence of LiCl at ambient temperature followed by addition of solid Zn(OPiv)2 
led to the corresponding organozinc pivalates. Exchange reactions were performed by using 
iPrMgCl·LiCl (1.1 equiv) at low temperature and subsequent transmetalation with Zn(OPiv)2 gave the 
desired organozinc pivalates. In both cases, the solid organozinc pivalates were obtained after solvent 
evaporation in high vacuum (0.1 mmHg, 3–6 h). Thus, the addition of iPrMgCl·LiCl to ethyl 
4-iodobenzoate (28) and subsequent transmetalation with solid Zn(OPiv)2 led to the solid, air-stable zinc 
reagent 29 which underwent a PEPPSI-IPr catalyzed cross-coupling reaction with the indole 
derivative 30 producing the desired product 31 in 91% yield (Scheme 8). Starting from 
1-(chloromethyl)-3-methoxybenzene (32) the insertion of magnesium in the presence of the 
THF-soluble salt Zn(OPiv)2·2LiCl leads to the benzylic zinc reagent 33 which after addition of 2 mol% 
PEPPSI-IPr and aryl chloride 34 produces the cross-coupling product 35 in 80% yield. However, when 
no Pd-catalyst is added to a solution of the reagent in EtOAc the addition of 35 leads to the tertiary 
alcohol 36 in 93% yield. The solid reagent 33 shows an increased stability when exposed to air since 
24% of active species is still retained after 60 min (Scheme 8). 
                                                     
28 A. Hernán-Gómez, E. Herd, E. Hevia, A. R. Kennedy, P. Knochel, K. Koszinowski, S. M. Manolikakes, R. E. 
Mulvey, C. Schnegelsberg, Angew. Chem. Int. Ed. 2014, 53, 2706; Angew. Chem. 2014, 126, 2744. 
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28 29 30 31 
32 33 34 35 
   36 
Scheme 8: Preparation of solid, salt stabilized organozinc reagents and their application in Negishi cross-
coupling reactions and additions to carbonyls. [a] Complexed Mg(OPiv)X and LiCl are omitted for clarity. 
Furthermore we found recently, that these solid zinc reagents do not only show an excellent reactivity 
in Negishi cross-coupling reactions and have investigated the reactivity of organozinc pivalates in 
1,4-additions,29 carbocuprations30 as well as allylations, acylation reactions and their addition to 
aldehydes (Scheme 9).27e,31 
                                                     
29 Rh-catalysis: a) M. Sakai, H. Hayashi, N. Miyaura, Organometallics 1997, 16, 4229; b) T. Hayashi, K. 
Yamasaki, Chem. Rev. 2003, 103, 2829; c) T. Hayashi, Russ. Chem. Bull. Int. Ed. 2003, 52, 2595; d) J. Le Nôtre, 
D. van Mele, C. G. Frost, Adv. Synth. Catal. 2007, 349, 432; e) J. C. Allen, G. Kociok-Köhn, C. G. Frost, Org. 
Biomol. Chem. 2012, 10, 32; Cu-catalysis: f) E. Nakamura, S. Matsuzawa, Y. Horiguchi, I. Kuwajima, Tetrahedron 
Lett. 1986, 34, 4029; g) V. Wendisch, N. Sewald, Tetrahedron Asymmetry, 1997, 8, 1253; h) M. Kitamura, T. 
Miki, K. Nakano, R. Noyori, Bull. Chem. Soc. Jpn. 2000, 73, 999; i) A. Wilsily, E. Fillion, Org. Lett. 2008, 10, 
2801; j) A. Wilsily, T. Lou, E. Fillion, Synthesis 2009, 12, 2066; k) A. Quintarda, A. Alexakisa, Adv. Synth. Catal. 
2010, 352, 1856; l) M. Tissot, A. Pérez Hernández, D. Müller, M. Mauduit, A. Alexakis, Org. Lett. 2011, 13, 1524. 
30 a) H. Chechik-Lankin, I. Marek, Synthesis 2005, 19, 3311; b) A. Abramovitch, I. Marek, Eur. J. Org. Chem. 
2008, 4924; c) J. P. Das, H. Chechik, I. Marek, Nat. Chem. 2009, 1, 128; d) B. Dutta, N. Gilboa, I. Marek, J. Am. 
Chem. Soc. 2010, 132, 5588; e) C. Dunst, A. Metzger, E. A. Zaburdaeva, P. Knochel, Synthesis 2011, 3453; f) A. 
Frischmuth, P. Knochel, Angew. Chem. Int. Ed. 2013, 52, 10084; g) Y. Minko, M. Pasco, H. Chechik, I. Marek, 
Beilstein J. Org. Chem. 2013, 9, 526; h) W. Gati, F. Couty, T. Boubaker, M. M. Rammah, M. B. Rammah, G. 
Evano, Org. Lett. 2013, 15, 3122; For reviews on carbocupration reactions see also: i) J. F. Normant, A. Alexakis, 
Synthesis 1981, 841; j) N. Krause in Modern Organocopper Chemistry (Ed.: N. Krause), Wiley-VCH, Weinheim, 
2002; k) N. Chinkov, D. Tene, I. Marek in Metal-Catalyzed Cross-Coupling Reactions (Eds.: F. Diederich, A. de 
Meijere), 2nd ed. Wiley-VCH, Weinheim, 2004; l) A. Basheer, I. Marek, Beilstein J. Org. Chem. 2010, 6, 77. 
31 M. Ellwart, Master’s Thesis, Ludwig-Maximilians-Universität München, 2013. 
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Scheme 9: Selected examples for the extended applications of arylzinc pivalates. [a] Complexed Mg(OPiv)Br 
and LiCl are omitted for clarity.27e,31 
3.3 Preparation of Organozinc Pivalates by Metalation 
Although aryl and heteroaryl halides used for the preparation of solid organozinc pivalates are readily 
available, it was envisioned that these organometallics could be prepared by directed metalation, which 
would allow to expand the scope of our preparations to include various arenes and heteroarenes as 
convenient starting materials. The sterically hindered base TMPMgCl·LiCl (17) was used to deprotonate 
various carbo- and heterocycles and the resulting magnesium reagents were transmetalated by using 
Zn(OPiv)2 (Scheme 10).27b This procedure gives access to a range of new solid zinc reagents of type 37 
that show very high stability when exposed to air. As a general trend, the concentration of the new zinc 
reagents is almost entirely (>94%) preserved after 2 h of air exposure, while this percentage remains 
greater than 85% even after 4 h in air. 
 
37 
  
 
  
37a: 86% 
(−45 °C, 2h) 
37b: 83% 
(25 °C, 1 h) 
37c: 85% 
(−30 °C, 30 min) 
37d: 77% 
(−25 °C, 1 h) 
37e: 85% 
(25 °C, 1 h) 
Scheme 10: Selected examples for the metalation of heterocycles using TMPMgCl·LiCl (17) followed by a 
transmetalation with Zn(OPiv)2. [a] Complexed Mg(OPiv)X and LiCl are omitted for clarity. 
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In addition, these zinc reagents are stable for, at least, several months under argon or nitrogen in a closed 
vial. After redissolution of the solid zinc compound in dry THF (0.5 M), cross-coupling reactions as well 
as allylation or acylation reactions can be performed. Thus, pyrazole derivative 38 was readily metalated 
by using 17 (1.1 equiv., –30 °C, 0.5 h) and led, after transmetalation with Zn(OPiv)2 (1.2 equiv), to the 
formation of zinc reagent 39 in 83% yield (Scheme 11). Addition of 2% PEPPSI-IPr and subsequently 
5-bromo-2-chloropyridine (40, 0.84 equiv), led to the functionalized heterocyclic compound 41 in 87% 
yield after heating to 50 °C for 2 h. Interestingly, the use of technical-grade THF in an open flask led 
to 41 with only a minor yield decrement (81%). Furthermore, 2,6-dichloropurinylzinc pivalate 42 was 
used in a Negishi cross-coupling with 4-iodoanisole (43) and furnished the functionalized purine 
derivative in 81% yield, while the corresponding organozinc chloride 45 required 24 h for completion 
and afforded the coupling product 44 in significantly lower yield. 
 
38 39 40 41 
42 43 44  
45    
Scheme 11: Preparation and stability of zinc pivalate 39 and Negishi cross-coupling in different qualities of THF. 
Comparison of the reactivity of 2,6-dichloropurinylzinc pivalate 42 and the corresponding zinc chloride 45 in 
Negishi cross-coupling with 4-iodoanisole 43. [a] complexed Mg(OPiv)Cl and LiCl are omitted for clarity. 
However, none of the methods above can be applied efficiently when sensitive functionalities are 
present. To overcome this limitation, Knochel et al. described the milder zinc amide base, 
TMPZnOPiv·Mg(OPiv)Cl·LiCl (46) which is compatible with functionalities like nitro groups, 
aldehydes, or sensitive heteroaromatic rings. In addition, it was shown that the new base 46 provided 
fast and efficient access, after removal of the solvent, to solid zinc pivalates, which exhibit significant 
tolerance towards hydrolysis or oxidation after air-exposure. TMPZnOPiv·Mg(OPiv)Cl·LiCl (46) is 
prepared by addition of solid Zn(OPiv)2 (1.05 equiv., 0 °C) to a solution of TMPMgCl·LiCl (17, 1.23 M 
in THF) and subsequent dilution with dry THF until a clear solution is formed (final concentration: 
0.85–0.99 M, (Scheme 12). 
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  46   
47  48 49 50 
51 52 53   
Scheme 12: Preparation and reactivity of TMPZnOPiv·Mg(OPiv)Cl·LiCl (46) and selected examples for 
application and stability of the resulting organozinc pivalates. [a] complexed Mg(OPiv)Cl and LiCl are omitted 
for clarity. 
Thus, using the base 46 ethyl 5-nitrofuran-2-carboxylate (47) can be readily metalated and after solvent 
evaporation the solid zinc reagent 48 is obtained in 77% yield. The reaction of the zinc reagent thus 
formed (48) in Negishi cross-coupling with the aryl iodide 49 led to the furan 50 in 70% yield. The solid 
and air-stable zinc reagent undergoes a palladium catalyzed coupling reaction with the E-alkenyl 
iodide 52 to furnish the coupling product 53 in 95% yield and with complete retention of the double-
bond configuration (Scheme 12). 
4 Allylzinc Compounds 
In 1962, Gaudemar reported the direct insertion of zinc into various allylic bromides furnishing allylzinc 
bromides in moderate to good yields.32 Cinnamyl bromide (54) was reacted with zinc in THF at –15 ºC 
to –5 ºC leading to cinnamylzinc bromide (55) in 70% yield (Scheme 13). The low temperature was 
necessary to avoid the formation of Wurtz coupling products. 
 
 
54 55 
Scheme 13: Preparation of cinnamylzinc bromide by Gaudemar. 
                                                     
32 M. Gaudemar, Bull. Soc. Chim. Fr. 1962, 974. 
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An alternative approach included an insertion of zinc induced by a catalytic amount of AlCl3 (Scheme 
14) leading to the intermediate organozinc compounds, which were then trapped by various carbonyl 
compounds. However, the diastereoselectivity was very poor as the reaction of crotyl bromide (56) and 
unactivated zinc using a catalytic amount of AlCl3 to form crotylzinc bromide (57) and subsequent 
reaction with benzaldehyde led to both diastereomers with a combined yield of 90% and a d.r. of 55:45.33 
 
 
56 57 58 
Scheme 14: Preparation of crotylzinc bromide (57) from crotyl bromide (56) and unactivated zinc induced by a 
catalytic amount of AlCl3 and subsequent reaction with benzaldehyde.33 
The problem of Wurtz coupling and of poor diastereoselectivity were overcome by Knochel et al. who 
used masked allylic zinc reagents from a fragmentation reaction.34 Thus, starting from the sterically 
hindered tertiary alcohol 59 addition of BuLi and ZnCl2 led to the zinc alkoxide followed by a 
fragmentation to the corresponding allylic zinc reagent which in the presence of benzaldehyde reacts to 
the anti-diastereomer of benzylic alcohol 60 in 83% (d.r. = 94:6). 
 
 
59 60 
Scheme 15: Highly diastereoselective allylations using masked allylic zinc reagents.34b 
Later, it was found that the LiCl-mediated direct insertion of zinc powder to cyclic allylic chlorides leads 
to the corresponding allylic zinc reagents, forming only small amounts of Wurtz coupling products. 
These organometallics were found to add diastereoselectively to various carbonyl derivatives. Thus, the 
insertion of zinc dust into 3-chlorocyclohex-1-ene (61) in the presence of LiCl in THF leads after 36 h 
at 0 °C to the allylic zinc reagent 62 in 84% yield. 62 reacts with the aldehyde 63 even in the presence 
of a free -NH2 group and delivers diastereoselectively the product 64 in 94% yield. Even ketone 65 can 
be used in the reaction with 62 to produce the homoallylic alcohol 66 in 94% yield (d.r. = 99:1). A cyclic 
6-membered transition state 67 was proposed. 
                                                     
33 H. Maeda, K. Shono, H. Ohmori, Chem. Pharm. Bull. 1994, 42, 1808. 
34 a) P. Jones, N. Millot, P. Knochel, Chem. Commun. 1998, 2405; b) P. Jones, P. Knochel, Chem. Commun. 1998, 
2407. 
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61  62   
 63    
64   65 66 
    67 
Scheme 16: Highly diastereoselective preparation of homoallylic alcohols bearing adjacent quaternary centers 
using substituted allylic zinc reagents. 
In addition, this methodology was extended to silyl substituted crotylzinc reagents leading 
stereoselectively to syn-homoallylic alcohols.35 For instance, the readily available trimethylsilyl 
substituted allyl chloride 68 underwent a smooth insertion reaction and provided organozinc species 69 
in 78% yield as determined by iodometric titration (Scheme 17). Upon the addition of 69 to 
functionalized acetophenone 70 the allylation product 71 was obtained as a single diastereomer in 91% 
yield (d.r. > 98:2).  
 
68  69 70 71 
Scheme 17: Preparation of silyl substituted crotylzinc reagent 69 and subsequent reaction with acetophenone 70 
with an azide functional group.35 
Furthermore, it was shown that the addition of cinnamylzinc reagents to α-chiral carbonyl compounds 
leads to homoallylic alcohols bearing three adjacent stereocenters with high diastereoselectivity.36 The 
insertion of zinc into cinnamyl phosphate 72a or chloride 72b in the presence of LiCl led to the 
corresponding organozinc reagents 73a,b in 72 and 78% yield respectively (Scheme 18). A subsequent 
reaction with 2-allylcyclohexanone (74) furnished the homoallylic alcohol 75 in 83% yield and high 
diastereoselectivity. Subsequent metathesis with Grubbs II catalyst (5 mol%) led to the bicyclic alcohol 
76 in 93% yield. This diastereoselectivity was rationalized by considering a cyclic chair-like transition 
state 77, where the allylic zinc reagent approaches from the sterically less crowded side (opposite side 
of the allyl group, as depicted in Scheme 18). 
                                                     
35 M. D. Helm, P. Mayer, P. Knochel, Chem. Commun. 2008, 1916. 
36 G. Dunet, P. Mayer, P. Knochel, Org. Lett. 2008, 10, 117. 
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72  73 74 75 
  76   
77     
Scheme 18: Highly diastereoselective addition of cinnamylzinc derivatives to 2-allylcyclohexanone (74) and 
subsequent metathesis yielding bicyclic alcohol 76. Proposed cyclic chair-like transition state 77.36 
Recently, Knochel et al. reported a convenient synthesis of α-substituted β,γ-unsaturated ketones and 
esters by the addition of substituted allylic zinc reagents prepared by direct insertion. Thus, using 
cinnamyl chloride (72b) and only 2 equivalents of Zn and 1.1 equivalents of LiCl the corresponding 
organozinc chloride 78 was obtained in 86% yield and underwent a smooth acylation reaction with 
4-(tert-butyl)benzoyl chloride (79) to yield the corresponding ketone 80 in 90% yield.37 A 
diastereoselective addition of allylmagnesium chloride to 80 led to the diene precursor 81 which was 
used in a ring closing metathesis (RCM) reaction furnishing diastereoselectively the cyclopentene 
derivative 82 in 97% yield. 
 
 
s.o.   78 79 80 
   81  
 82    
Scheme 19: Synthesis of α-substituted β,γ-unsaturated ketone 80 via the addition of allylic zinc reagent 78 to 
acid chloride 79. Subsequent diastereoselective addition of allylmagnesium chloride and RCM. 
  
                                                     
37 C. Sämann, P. Knochel, Synthesis 2013, 1870. 
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5 Objectives 
Based on our results for the arylzinc pivalates and the recently reported versatile applications of allylzinc 
reagents we studied the preparation of the first solid allylic zinc compounds. Therefore, a novel protocol 
for the preparation of salt stabilized reagents starting from allylic bromides was investigated. As Mulvey 
and Hevia reported (Chapter 3.1), Mg(OPiv)2 is believed to play an important role in the increased 
stability of organozinc pivalates as an air- and moisture scavenger. Thus, it was envisioned that the 
addition of Mg(OPiv)2 during the zinc insertion might lead to stabilized allylic zinc pivalates (Scheme 
20).  
 
Scheme 20: Novel protocol for the preparation of allylic zinc pivalates. 
Moreover, the concept of Mg(OPiv)2 as an additive for stabilizing organozinc compounds was extended 
to the preparation of Reformatsky reagents. Particularly, morpholine amides were studied as substrates 
for a selective metalation using TMPZnCl and Mg(OPiv)2 (Scheme 21). 
 
 
Scheme 21: Preparation of solid zinc amide enolates using TMPZnCl and Mg(OPiv)2. 
Furthermore, due to the lack of a scalable protocol for the preparation of (hetero-)aryl pivalates a 
procedure was investigated to prepare these reagents in scales up to 70 mmol. A range of reagents should 
be prepared following this procedure in order to provide a set of reagents for high throughput screenings, 
e.g., in medicinal chemistry. 
 
Scheme 22: Development of a scalable protocol for the preparation of (hetero-)arylzinc pivalates and subsequent 
scale-up cross-coupling. 
Another subject dealt with the improvement of the selectivity of allyl-allyl cross-couplings toward the 
preparation of a single isomer out of four possible (Scheme 23). Allylic zinc compounds could be 
suitable reagents in this transformation due to their facile preparation and their tolerance of a variety of 
functional groups.  
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Scheme 23: Cross-coupling of allylic organometallics with allylic halides leading to four regioisomeric coupling 
products. 
Finally, to develop a novel preparation of benzylamines or biologically relevant phenethylamines a new 
protocol was investigated starting from N,N,N',N'-tetramethylmethanediamine (Scheme 24).38 After 
formation of Tieze’s salt a mixed aminal should be produced which could then be reacted with 
trifluoroacetic anhydride. The resulting iminium ion could be suitable for a reaction with a range of 
organometallic species. 
 
Scheme 24: One-pot reaction sequence for the preparation of benzylamines or phenethylamines. 
 
 
  
 
                                                     
38 This project was developed in cooperation with V. Werner and A. J. Wagner, see: V. Werner, Dissertation, LMU 
München 2015. 
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1 Preparation of Solid, Substituted Allylic Zinc Reagents and Their 
Reactions with Electrophiles 
1.1 Introduction 
Allylic organometallics are an important class of organometallic reagents owing to their enhanced 
reactivity compared to the corresponding alkyl, aryl, or even benzylic organometallics.39 For example, 
allylic magnesium halides are much more reactive than all other classes of Grignard reagents.40,41 This 
behavior can be explained by the higher ionic character of the allylic C–Mg bond. Although allylic 
derivatives of most main-group elements have been reported,42 allylic zinc reagents are by far the most 
useful reagents in synthetic organic chemistry43 since they display high reactivity and are at the same 
time compatible with a range of functional groups, including ester44 or cyano functions.45 Furthermore, 
allylic zinc reagents are conveniently prepared through insertion of zinc (in the form of commercially 
available zinc powder) into the corresponding allylic bromide.46 Recently, we reported the preparation 
of solid aryl-, heteroaryl-, and benzylzinc reagents that are air stable but still display high reactivity for 
forming new carbon–carbon bonds.47 
                                                     
39 a) G. Courtois, A. Al-Arnaout, L. Miginiac, Tetrahedron Lett. 1985, 26, 1027; b) M. Yasuda, K. Hirata, M. 
Nishino, A. Yamamoto, A. Baba, J. Am. Chem. Soc. 2002, 124, 13442; c) A. N. Thadani, R. A. Batey, Org. Lett. 
2002, 4, 3827; d) I. Marek, G. Sklute, Chem. Commun. 2007, 1683. 
40 a) Y. Yamamoto, N. Asao, Chem. Rev. 1993, 93, 2207; b) D. F. Taber, J. H. Green, J. M. Geremia, J. Org. 
Chem. 1997, 62, 9342. 
41 Related solid magnesium reagents have been reported: A. Boudin, G. Cerveau, C. Chutt, R. J.P. Corriu, C. Reye, 
Tetrahedron 1989, 45, 171. 
42 a) Y. Yamamoto, H. Yatagai, Y. Naruta, K. Maruyama, J. Am. Chem. Soc. 1980, 102, 7107; b) M. Schlosser, O. 
Desponds, R. Lehmann, E. Moret, G. Rauchschwalbe, Tetrahedron 1993, 49, 10175. 
43 a) P. Knochel , R. Singer, Chem. Rev. 1993, 93, 2117; b) Y. Tamaru, A. Tanaka, K. Yasui, S. Goto, S. Tanaka, 
Angew. Chem. Int. Ed. 1995, 34, 787; c) M. Uchiyama, M. Koike, M. Kameda, Y. Kondo, T. Sakamoto, J. Am. 
Chem. Soc. 1996, 118, 8733; d) M. Nakamura, A. Hirai, M. Sogi, E. Nakamura, J. Am. Chem. Soc. 1998, 120, 
5846; e) A. Côté, A. B. Charette, J. Am. Chem. Soc. 2008, 130, 2771; f) J. P. Das, H. Chechik, I. Marek, Nat. 
Chem. 2009, 1, 128; g) W. Shi , C. Liu, A. Lei, Chem. Soc. Rev. 2011, 40, 2761. 
44 a) J. Villieras, M. Rambaud, Synthesis 1982, 924; b) Y. A. Dembéléa, C. Belauda, P. Hitchcock, J. Villiéras, 
Tetrahedron: Asymmetry 1992, 3, 351; c) V. Nyzam, C. Belaud, F. Zammattio, J. Villieras, Tetrahedron: 
Asymmetry 1996, 7, 1835. 
45 a) H. Ren, G. Dunet, P. Mayer, P. Knochel, J. Am. Chem. Soc. 2007, 129, 5376; b) M. D. Helm, P. Mayer, P. 
Knochel, Chem. Commun. 2008, 1916; c) C. Sämann, P. Knochel, Synthesis 2013, 1870. 
46 a) G. Courtois, B. Mauze, L. Miginiac, J. Organomet. Chem. 1974, 72, 309; b) F. Dardoize, M. Gaudemar, Bull. 
Soc. Chim. Fr. 1976, 9, 1561; c) M. Bellassoued, Y. Frangin, M. Gaudemar, J. Organomet. Chem. 1979, 166, 1. 
47 a) S. Bernhardt, G. Manolikakes, T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9205; Angew. Chem. 
2011, 123, 9372; b) C. I. Stathakis, S. Bernhardt, V. Quint, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 9428; 
Angew. Chem. 2012, 124, 9563; c) C. I. Stathakis, S. M. Manolikakes, P. Knochel, Org. Lett. 2013, 15, 1302; d) 
J. R. Colombe, S. Bernhardt, C. Stathakis, S. L. Buchwald, P. Knochel, Org. Lett. 2013, 15, 5754; e) S. M. 
Manolikakes, M. Ellwart, C. I. Stathakis, P. Knochel, Chem. Eur. J. 2014, 20, 12289. 
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1.2 Preparation and Application of Solid, Substituted Allylic Zinc Reagents 
Consequently, we developed the synthesis of the first solid allylic zinc reagents of type 83 obtained by 
the insertion of zinc dust48 in the presence of LiCl49 and magnesium pivalate (Mg(OPiv)2; 
OPiv = OCOtBu) into various allylic bromides or chlorides of type 84. After evaporation of the solvent, 
solid allylic zinc derivatives are obtained as white or yellow powders. Iodometric titration50 indicated 
that these zinc compounds are obtained in 51–90% yield (Scheme 25). Important functional groups such 
as an ester or a nitrile are tolerated in these reagents (see 83e-h). Although these solids react rapidly 
with air and moisture, they are stable for an extended period of time. Thus, the allylic zinc reagents 83a-
d are thermally very stable (t1/2 > 2 years) at 25 °C as a solid under argon. The ester substituted zinc 
reagents (83e-f) have somewhat lower room temperature stability (t1/2 = 16–17 weeks). The stability of 
83f is increased to a half-life of 40 weeks when stored at −24 °C. The nitrile-substituted allylic zinc 
species 83g-h are more sensitive (t1/2 = 33–59 d) but again, storage at −24 °C increases their stability 
significantly (50–152 d). The presence of LiCl and Mg(OPiv)2 is essential for the success of the 
preparation of these allylic zinc reagents.51 The role of LiCl is to activate the zinc powder, whereas 
Mg(OPiv)2 was found to be essential for the long term stability of the solid allylic reagents.52 
 
 83 
84  
  
 
 
83a: 67% 83b: 74% 83c: 77% 83d: 78% 
t1/2 = 18 months t1/2 = 25 months t1/2 > 2 years t1/2 > 2 years 
    
83e: 51% 83f: 90% 83g: 81% 83h: 55% 
t1/2 = 17 weeks t1/2 = 16 (40) weeks t1/2 = 33 (50) days t1/2 = 59 (152) days 
Scheme 25: Preparation of solid functionalized allylzinc pivalates of type 83 from the corresponding allylic halides 
of type 84 by using Zn, Mg(OPiv)2 and LiCl. For the determination of the half-lives (t1/2) see the EXPERIMENTAL 
PART. Values given in brackets show the half-lives when the reagents were stored at −24 °C. [a] Complexed 
Mg(OPiv)X (X=Cl, Br) and LiCl are omitted for clarity. 
                                                     
48 Zinc dust was purchased from Sigma-Aldrich with a purity >98%, and was activated with 1,2-dibromoethane . 
49 A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 6040; Angew. Chem. 
2006, 118, 6186. 
50 See the EXPERIMENTAL PART. 
51 A. Hernán-Gómez, E. Herd, E. Hevia, A. R. Kennedy, P. Knochel, K. Koszinowski, S. M. Manolikakes, R. E. 
Mulvey, C. Schnegelsberg, Angew. Chem. Int. Ed. 2014, 53, 2706. 
52 NMR experiments show that there is no difference between the structure "before solvent evaporation" and after 
redissolution of the solid reagent. 
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1.3 Application of Solid Allylic Zinc Pivalates in Negishi Cross-Coupling Reactions 
We have first examined the reactivity of the new allylic zinc pivalates in Pd-catalyzed cross-couplings. 
Buchwald reported recently that prenylzinc bromide undergoes a smooth cross-coupling with various 
unsaturated bromides in the presence of a Pd-precatalyst and a sterically hindered phosphine ligand 
(CPhos).53 Consequently, we examined the cross-coupling of the allylic zinc reagents of type 83 with 
aryl bromides in the presence of various Pd-catalysts. In our hands, PEPPSI-IPent discovered by Organ54 
gave by far the best results. Thus, prenylzinc pivalate (83b) undergoes a cross-coupling with 
bromouracil derivative 85a in the presence of 2 mol% of PEPPSI-IPent. Interestingly, the corresponding 
prenylzinc bromide (87b) as a 0.3 M solution in THF led only to traces of the cross-coupling product 
(86a). This behavior was general and the functionalized allylic zinc reagent 83f reacts smoothly with 
2-bromotoluene (85b) in the presence of PEPPSI-IPent (2 mol%) producing the cross-coupling product 
(86b) in 79% yield. Again, the use of the corresponding allylic zinc chloride 87f led only to traces of 
the desired product showing the importance of Mg(OPiv)2 for such cross-couplings (Scheme 26). 
 
 85 86 
87   
Scheme 26: PEPPSI-IPent-catalyzed cross-coupling of allylic organozinc reagents (83b,f and 87b,f) in THF 
within 4 h at 50 °C. [a] Complexed Mg(OPiv)X (X=Cl, Br) and LiCl are omitted for clarity. 
The reaction scope of this Pd-catalyzed cross-coupling is quite broad and a range of unsaturated 
bromides provided the cross-coupling products (86c–g) in 69–79% yield (Table 1).55 Thus, the cross-
coupling of zinc pivalate 83a using electron poor 1-bromo-3-(trifluoromethyl)benzene (85c) and 
2 mol% of PEPPSI-IPent proceeds within 4 h at 50 °C and provides the cross-coupling product (86c) in 
69% yield (entry 1). Remarkably, the electron rich aryl bromides 85b and 85d also undergo the cross-
coupling reaction to afford the expected products 86d–e (70–71% yield, entries 2–3). Similarly, the 
myrtenylzinc species 83c reacts with 1-bromo-3-fluorobenzene (85e) providing after 4 h at 50 °C only 
the linear regioisomer (86f) in 77% yield (entry 4). Also heteroaromatic bromides such as 
                                                     
53 Y. Yang, T. J. L. Mustard, P. H.-Y. Cheong, S. L. Buchwald, Angew. Chem. Int. Ed. 2013, 52, 14098. 
54 C. J. O'Brien, E. A. B. Kantchev, C. Valente, N. Hadei, G. A. Chass A. Lough, A. C. Hopkinson, M. G. Organ, 
Chem. Eur. J. 2006, 12, 4743. 
55 Following the same procedure, the cross-coupling of allylzinc reagent 83b with β-bromostyrene led to the 
desired E-1,4-diene in 81% yield (>99% E). 
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3-bromopyridin (85f) was readily allylated with cinnamylzinc pivalate (83d) leading to the 
functionalized heteroaromatic product (86g) in 72% yield (entry 5). By following the same procedure, 
ester- and cyano-functionalized organozinc pivalates (83e–h) were converted into the corresponding 
polyfunctional cross-coupling products (86h–j) in 75–90% yield (entries 6–8).  
Table 1: PEPPSI-IPent-catalyzed cross-coupling of allylic organozinc pivalates of type 83 in THF within 4 h at 
50 °C 
Entry Zinc Reagent[a] Electrophile[b] Product[c] 
 
 
  
1 83a 85c 86c: 69% 
 
 
  
2 83b 85b 86d: 70% 
 
 
  
3 83b 85d 86e: 71% 
 
   
4 83c 85e 86f: 77% 
  
  
5 83d 85f 86g: 72% 
 
   
6 83e 85g 86h: 75% 
 
   
7 83g 85h 86i: 90% 
 
  
 
8 83h 85i 86j: 88% 
[a] Complexed Mg(OPiv)X (X=Cl, Br) and LiCl are omitted for clarity. [b] 0.80 equiv. of electrophile were used. 
[c] Yields refer to analytically pure products. 
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1.4 Diastereoselective Addition of Allylic Zinc Pivalates to Aldehydes and Ketones  
In addition, the solid allylic zinc reagents of type 83 react as previously reported allylic zinc halides56 
with electrophiles such as carbonyl derivatives or acid chlorides with complete regioselectivity 
(formation of the new carbon-carbon bond from the most substituted end of the allylic system) and very 
high diastereoselectivity as shown in Table 2 and Scheme 27. Thus, the cyclohex-2-en-1-ylzinc reagent 
83a (1.0 equiv) in THF adds to various methyl ketones45a (0.8 equiv) leading to the corresponding homo-
allylic alcohols (89a–b) in 89–92% yield and d.r. > 99:1 (Table 2, entries 1–2). The 2,3-disubstituted 
allylic zinc species 83c reacts with furfural (88c) with complete regio- and diastereoselectivity leading 
to the alcohol 89c in 89% yield (entry 3). Cinnamylzinc pivalate (83d) displays a similar behavior 
leading to the anti-alcohol (89d) in 86% yield and d.r. > 99:1. This zinc reagent allows the stereo control 
of three contiguous centers and its addition to 2-trimethylsilyloxy cyclohexanone (88e) provides the 
alcohol 89e in 80% yield (d.r. = 95:5; entry 5). The structure of alcohol 89e was confirmed by X-ray 
analysis.57 The solid functionalized zinc reagent 83e reacts smoothly with 3-bromobenzaldehyde (88f) 
furnishing the secondary alcohol 89f in 91% (d.r. = 97:3; entry 6). Finally, the functionalized zinc 
reagents (83f,g) bearing an ester or cyano function in position 2 react with the ferrocenyl methyl ketone 
(88g) and furfural (88c) furnishing the products 89g,h in 91–92% yield and d.r. > 99:1 (entries 7–8). In 
the case of the addition of the allylzinc pivalate 83f to 88g a spontaneous lactonization was observed 
leading to the bicyclic product 89g (entry 7).57 
Table 2: Diastereoselective preparation of homoallylic alcohols of type 89 using solid, functionalized allylzinc 
pivalates of type 83 
 88 89 
Entry Zinc Reagent[a] Electrophile Product[b] 
 
 
  
1 83a 88a 89a: 89% 
d.r. > 99:1 
 
   
2 83a 88b 89b: 92% 
d.r. = 94:6 
                                                     
56 a) S. E. Denmark, E. J. Weber, Helv. Chim. Acta. 1983, 66, 1655; b) Y. Yamamoto, Acc. Chem. Res. 1987, 20, 
243. 
57 CCDC 1061748 (89e) and 1061747 (89g) contain the supplementary crystallographic data for these compounds. 
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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3 83c 88c 89c: 89% 
d.r. > 99:1 
  
 
 
4 83d 88d 89d: 86% 
d.r. > 99:1 
  
  
5 83d 88e 89e: 80% 
d.r. = 95:5 
 
   
6 83e 88f 89f: 91% 
d.r. = 97:3 
 
 
 
 
7 83f 88g 89g: 92% 
d.r. > 99:1 
 
 
 
 
8 83g 88c 89h: 91% 
d.r. > 99:1 
Reaction conditions: 0.80 equiv. of electrophile, THF, −78 °C, 1 h. [a] Complexed Mg(OPiv)X (X=Cl, Br) and 
LiCl are omitted for clarity. [b] Yields refer to analytically pure products; The d.r. was determined by 
NMR- and/or GC analysis of the crude product. 
1.5 Acylation of Allylic Zinc Pivalates Using Acid Chlorides 
Furthermore, the method was also applicable to the synthesis of various β,γ-unsaturated ketones of type 
91 by addition of the solid functionalized allylzinc pivalates of type 83 to acid chlorides in the absence 
of any transition metal catalyst (Scheme 27). Thus, the allylic reagents 83a and 83b react in THF under 
very mild conditions (1 h, −78 °C) with 4-chlorobenzoyl chloride (90a) and 4-methoxybenzoyl chloride 
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(90b) to give the β,γ-unsaturated ketones 91a-c in 78–95% yield without any trace of the α,β-unsaturated 
isomers. Interestingly, the competitive formation of a mixed anhydride by the reaction of the pivalate 
anion (PivO−) with the acyl chloride was not observed.27e Thus, starting from 3-bromobenzoyl chloride 
(90c) or 4-(tert-butyl)benzoyl chloride (90d) the corresponding β,γ-unsaturated ketones 91d-e were 
obtained in 68–75% yield using the functionalized organozinc pivalate 83e. Furthermore, the addition 
of the solid cyano-functionalized zinc reagent 83f to thiophene-2-carbonyl chloride (90e) furnished 
selectively the corresponding ketone 91f in 77% yield. 
 
 
 90 91 
   
91a: 78% 
 
91b: 93% 
 
91c: 95%[d] 
 
   
91d: 68%[d] 91e: 75%[d] 91f: 77%[d] 
Scheme 27: Reaction of the solid functionalized allylzinc pivalates (83a-h) with acid chlorides (90a-e). [a] 
Complexed Mg(OPiv)X (X=Cl, Br) and LiCl are omitted for clarity. [b] 0.80 equiv. of electrophile were used. [c] 
Yields refer to analytically pure products. [d] The reaction mixture was warmed to r.t. overnight. 
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2 Preparation and Application of Solid, Salt Stabilized Amide Enolates 
2.1 Introduction 
Metal enolates are an important class of reagents for organic synthesis58 and in recent years derivatives 
of Li,59 Mg,60 B,61 and Si62 have found extensive applications in the stereoselective elaboration of aldol 
products. Furthermore, the arylation of enolates is an important transformation for which alkali metal- 
or Si- enolates have been used.63 In situ generated Zinc enolates known in the literature as Reformatsky 
reagents have also proved their utility in Pd-catalyzed arylations.64 However, in this respect Reformatsky 
reagents did not find extensive applications as their lower chemical and thermal stability compared to 
silyl enol ethers is a major drawback. As shown in Chapter 1 we have found that the presence of 
Mg(OPiv)2 strongly enhanced the air and moisture stability of solid allylic zinc reagents which have 
extended half-lives under argon up to 2 years. Hence, we envisioned a general method with Mg(OPiv)2 
as an additive for Reformatsky reagents allowing the preparation of solid zinc enolates of high thermal 
and moisture stability. 
2.2 Optimization of the Preparation of Solid Reformatsky Reagents 
First, we examined the stability of different organozinc enolates upon storage in a sealed flask under 
argon. Thus, the metalation of tert-butyl acetate and N,N-dimethylacetamide using TMPZnCl·LiCl (19) 
in the presence of Mg(OPiv)2 led to colorless solids, which showed a poor stability under argon (11% 
and 54% active species left after 2 weeks under argon) (Table 3, entries 1 and 2). An improved stability 
of the zinc enolate was found starting from 1-morpholinoethanone where the zinc enolate still showed 
97% of the initial activity after storage under argon for four weeks (entry 3). Furthermore, it was found 
that the morphonyl amide containing zinc enolate showed an improved stability when exposed to air as 
                                                     
58 a) T. Mukaiyama, Pure Appl. Chem. 1983, 55, 1749; b) R. Mahrwald, B. Schetter, Angew. Chem. Int. Ed. 2006, 
45, 7506. 
59 D. Seebach, Angew. Chem. Int. Ed. 1988, 27, 1624. 
60 E. R. Hurley, X. He, S. N. Brown, K. W. Henderson, J. Am. Chem. Soc. 2009, 131, 6056. 
61 a) S. Masamune, W. Choy, B. Imperiali, J. Am. Chem. Soc. 1981, 103, 1566; b) D. A. Evans, J. V. Nelson, E. 
Vogel, T. R. Taber, J. Am. Chem. Soc. 1981, 103, 3099; c) D. A. Evans, J. Bartroli, T. L. Shih, J. Am. Chem. Soc. 
1981, 103, 2127. 
62 a) G. Stork, P. F. Hudrlik, J. Am. Chem. Soc. 1968, 90, 4462; b) E. M. Carreira, R. A. Singer, W. Lee, J. Am. 
Chem. Soc. 1994, 116, 8837; c) Takahiko Akiyama, J. Itoh, K. Yokota, K. Fuchibe, Angew. Chem. Int. Ed. 2004, 
43, 1566. 
63 a) A. A. Millard, M. W. Rathke, J. Am. Chem. Soc. 1977, 99, 4833; b) I. Kuwajima, H. Urabe, J. Am. Chem. 
Soc. 1982, 104, 6831; c) B. C. Hamann, J. F. Hartwig, J. Am. Chem. Soc. 1997, 119, 12382; d) W. Cabri, I. 
Candiani, A. Bedeschi, S. Penco, R. Santi, J. Org. Chem. 1992, 57, 1481; e) T. Hamada, A. Chieffi, J. Åhman, S. 
L. Buchwald, J. Am. Chem. Soc. 2002, 124, 1261; f) D. A. Culkin, J. F. Hartwig, Acc. Chem. Res. 2003, 36, 234; 
g) C. C. C. Johansson, T. J. Colacot, Angew. Chem. Int. Ed. 2010, 49, 676. 
64 a) T. Hama, X. Liu, D. A. Culkin, J. F. Hartwig, J. Am. Chem. Soc. 2003, 125, 11176; b) E. Bentz, M. G. 
Moloney, S. M. Westaway, Tetrahedron Lett. 2004, 45, 7395; c) T. Hama, D. A. Culkin, J. F. Hartwig, J. Am. 
Chem. Soc. 2006, 128, 4976; d) F. Bellina, R. Rossi, Chem. Rev. 2010, 110, 1082. 
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85% are retained after 2 h in air (entry 4). The corresponding Mg-free organozinc halides prepared by 
metalation using TMPZnCl·LiCl (19) or by TMPLi followed by transmetalation with Zn(OPiv)2 retained 
after 2 h in air only 59% and 36% respectively (entries 5 and 6). When MgCl2 was added before the 
transmetalation with Zn(OPiv)2 the air stability was increased (79% after 2 h air exposure, entry 7). 
Table 3: Optimization of the preparation of acetyl enolates 
 
 
Entry Conditions R Treatment Activity [%] 
1 TMPZnCl·LiCl / Mg(OPiv)2 tBuO 
argon 
(2 weeks) 
11 
2 TMPZnCl·LiCl / Mg(OPiv)2 Me2N 
argon 
(2 weeks) 
54 
3 TMPZnCl·LiCl / Mg(OPiv)2 
 
argon 
(4 weeks) 
97 
4 TMPZnCl·LiCl / Mg(OPiv)2 
 
air (2 h) 85 
5 TMPZnCl·LiCl 
 
air (2 h) 59 
6 TMPLi / Zn(OPiv)2 
 
air (2 h) 36 
7 TMPLi / MgCl2, Zn(OPiv)2 
 
air (2 h) 79 
 
2.3 Preparation of Solid Amide Enolates and Their Application in Cross-Couplings, 
Allylations, and Carbonyl Additions 
With these optimized conditions in hand, the treatment of various morphonyl amides (92a-d) with 
TMPZnCl·LiCl (19) in the presence of Mg(OPiv)2 at 25 °C for 15 min to 1 h produced after solvent 
evaporation the solid zinc enolates 93a-d as easy-to-handle white or yellow powders (Scheme 28). These 
reagents show an exceptional stability and can be stored under argon at room temperature for several 
months without significant loss of activity. The use of morphonyl amides led to much more robust 
compounds, which preserved their activity even after contact with air. Thus, zinc enolate 93b preserved 
72% of its activity after 1 h on air. Importantly, the zinc compound can now be weighed in air (94% of 
the active zinc species 93b is titrated after 10 min in air). 
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92 93 
  
  
93a: 78% 93b: 86% 93c: 65% 93d: 83% 
Scheme 28: Preparation of solid zinc amide enolates of type 93 from the corresponding morphonyl amides of type 
92 by using TMPZnCl·LiCl (19) in the presence of Mg(OPiv)2. [a] X = Cl·Mg(OPiv)2·LiCl. 
Furthermore, these solid zinc enolates proved to be excellent nucleophiles in Negishi cross-couplings, 
allylations and aldehyde additions.65 Thus, zinc reagent 93a reacts with (4-
bromophenyl)(methyl)sulfane (85j) using 2 mol% Pd(OAc)2 and 4 mol% DavePhos66 after 18 h at 25 °C 
and with furfural (88c) without the need of an external catalyst to the desired products 94a and 95a in 
99% yield (Table 4, entries 1 and 2). Zinc enolate 93b was used in a range of palladium catalyzed cross-
coupling reactions with aryl bromides 85k-l to the corresponding α-arylated amides 94b-c in 97–99% 
yield (entries 3–4). Furthermore, the ±-naproxen derivative 94d was successfully prepared by the 
Pd(OAc)2/DavePhos catalyzed cross-coupling of zinc enolate 93b with 2-bromo-6-methoxynaphthalene 
(85m) in 99% yield (entry 5). Aryl iodide 96a also underwent a smooth coupling with amide enolate 
93b and furnished the α-arylated amide 94e in 90% yield (entry 6). The reaction of zinc enolate 93b 
with the allylic bromides 97a,b in the presence of 10 mol% CuCN·LiCl led to the allylation products 
98a,b in 99% and 97% yield (entries 7–8). 
  
                                                     
65 a) J. Cossy, A. de Filippis, D. G. Pardo, Org. Lett. 2003, 5, 3037; b) J. Cossy, A. de Filippis, D. G. Pardo, Synlett 
2003, 2171; c) T. Hama, X. Liu, D. A. Culkin, J. F. Hartwig, J. Am. Chem. Soc. 2003, 125, 11176; d) T. Hama, X. 
Liu, D. A. Culkin, J. F. Hartwig, J. Am. Chem. Soc. 2003, 125, 11177; e) A. de Filippis, D. G. Pardo, J. Cossy, 
Tetrahedron, 2004, 60, 9757; f) E. Bentz, M. G. Moloney, S. M. Westaway, Tetrahedron Lett. 2004, 45, 7395; g) 
T. Hama, D. A. Culkin, J. F. Hartwig, J. Am. Chem. Soc. 2006, 128, 4976; h) G. Satyanarayana, M. E. Maier, 
Tetrahedron 2008, 64, 356; i) S. L. McDonald, Q. Wang, Chem. Commun. 2014, 50, 2535; j) B. Wong, X. Linghu, 
J. J. Crawford, J. Drobnick, W. Lee, H. Zhang, Tetrahedron 2014, 70, 1508. 
66 a) R. Martin, S. L. Buchwald, Acc. Chem. Res. 2008, 41, 1461; b) D. S. Surry, S. L. Buchwald, Chem. Sci, 2011, 
2, 27. 
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Table 4: Application of solid pivaloxy zinc amide enolates of type 93 in cross-couplings, allylations and carbonyl 
additions 
  94 
  95 
 96  
 97 98 
Entry Zinc Reagent[a] Electrophile Product[b] 
 
   
1 93a 85j 94a: 99%[c] 
 
 
 
 
2 93a 88c 95a: 99% 
 
 
 
 
3 93b 85k 94b: 99%[c] 
 
 
 
 
4 93b 85l 94c: 97%[c] 
 
 
 
 
5 93b 85m 94d: 99%[c] 
 
 
 
 
6 93b 96a 94e: 90%[c] 
 
 
 
 
7 93b 97a 98a: 99%[d] 
 
 
 
 
8 93b 97b 98b: 97%[d] 
[a] Complexed Mg(OPiv)X (X=Cl, Br) and LiCl are omitted for clarity. [b] Yields refer to analytically pure 
products. [c] 2 mol% Pd(OAc)2 and 4 mol% DavePhos were used as the catalytic system. [d] 10 mol% 
CuCN·LiCl were used as a catalyst. 
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Another advantage of the morpholineamide moiety is the facile substitution to the corresponding 
ketones.67 Thus, the α-arylated amide 94f which was prepared by cross-coupling of organozinc pivalate 
93b and 3-bromothiophene (85h) was reacted with PhMgCl·LiCl in the presence of stoichiometric 
amounts of LaCl3·2LiCl68 to form ketone 99 after 4.5 h at 0 °C in 96% yield (Scheme 29). 
 
 
x93b  x85h  x94f 99 
Scheme 29: Preparation of α-arylated amide 94f and subsequent substitution of the morpholineamide using 
PhMgCl·LiCl and LaCl3·2LiCl.  
                                                     
67 a) M. Kurosu, Y. Kishi, Tetrahedron Lett. 1998, 39, 4793; b) C. Douat, A. Heitz, J. Martinez, J.-A. Fehrentz, 
Tetrahedron Lett. 2000, 41, 37; c) M. Badioli, R. Ballini, M. Bartolacci, G. Bosica, E. Torregiani, E. Marcantoni, 
J. Org. Chem. 2002, 67, 8938; d) A. R. Jeon, M. E. Kim, J. K. Park, W. K. Shin, D. K. An, Tetrahedron, 2014, 70, 
4420. 
68 A. Krasovskiy, F. Kopp, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 497. 
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3 Scalable Preparation of Functionalized (Hetero-)Arylzinc Pivalates 
3.1 Introduction 
For many years, aromatic and heterocyclic boron and zinc organometallics have been the most important 
reagents for sp2-sp2 cross-coupling reactions due to their high compatibility with a broad variety of 
functional groups.69 However, the limited stability towards air and moisture represents a serious 
drawback of organozinc reagents for their practical use in the laboratory and for industrial applications. 
On the other hand, the lower reactivity and transmetalation ability of boronic derivatives as well as 
toxicity issues makes the availability of bench-stable organozinc reagents highly desirable. To overcome 
this problem, we recently developed a method for the preparation of aryl and heteroaryl zinc pivalates, 
which are easy-to-handle solids with exceptional stability when exposed to air (see INTRODUCTION 3). 
These reagents can be weighed out on the benchtop and have the potential for extended shelf life. Thus, 
they could represent highly efficient reagents for the functionalization of various complex molecules, 
and hence represent valuable building blocks to be used by both synthetic and medicinal chemists. In 
order to examine the performance of the organozinc pivalates in high throughput screenings a feasible 
preparation in gram-scale was developed. 
3.2 Scalable Protocol for the Preparation of Functionalized Organozinc Pivalates 
The preparation of zinc pivalate (100) was performed on a 53 mmol scale from pivalic acid (101) and 
diethylzinc (Scheme 30). After stirring in THF for 2 h at room temperature zinc pivalate was obtained 
as a puffy amorphous white solid in quantitative yield. The resulting salt was added to the subsequent 
reaction of 3-bromopyridine (102) with iPrMgCl·LiCl after 3 h at 25 °C in THF. After solvent 
evaporation pyridin-3-ylzinc pivalate (103) was produced in 89% yield. Cross-coupling of the reagent 
103 with ethyl 4-bromobenzoate (104) using PEPPSI-IPr (THF, 25 °C, 2 h) furnished ethyl 4-(pyridin-
3-yl)benzoate (105) in 92% yield (5.52 g) on a 26 mmol scale.70 
                                                     
69 Organozinc compounds see: a) P. Knochel, J. Almena, P. Jones, Tetrahedron 1998, 54, 8275; b) A. Boudier, L. 
O. Bromm, M. Lotz, P. Knochel, Angew. Chem. 2000, 112, 4584; Angew. Chem. Int. Ed. 2000, 39, 4414; c) P. 
Knochel, N. Millot, A. L. Rodriguez, C. E. Tucker, Org. React. 2001, 58, 417; d) P. Knochel, H. Leuser, L.-Z. 
Cong, S. Perrone, F. F. Kneisel in Handbook of Functionalized Organometallics (Ed.: P. Knochel), Wiley-VCH, 
Weinheim, 2005, pp. 251; e) A. Lemire, A. Côté, M. K. Janes, A. B. Charette, Aldrichimica Acta 2009, 42, 71; 
Boron organometallics see: f) S. J. Lee, K. C. Gray, J. S. Paek, M. D. Burke, J. Am. Chem. Soc. 2008, 130, 466; 
g) D. M. Knapp, E. P. Gillis, M. D. Burke, J. Am. Chem. Soc. 2009, 131, 6961; h) H. Noguchi, K. Hojo, M. 
Suginome, J. Am. Chem. Soc. 2007, 129, 758; i) N. Miyaura, K. Yamada, H. Suginome, A. Suzuki, J. Am. Chem. 
Soc. 1985, 107, 972; j) A. Suzuki, Pure & Appl. Chem. 1985, 57, 1749; k) N. Miyaura, A. Suzuki, Chem. Rev. 
1995, 95, 2457; l) G. A. Molander, B. Biolatto, J. Org. Chem. 2003, 68, 4302; m) G. A. Molander, B. Canturk, 
Angew. Chem. Int. Ed. 2009, 48, 9240. 
70 The detailed procedure for these transformations can be found in the EXPERIMENTAL PART. 
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  100  
101    
102   103  
 104  105  
Scheme 30: Scale-up preparation of zinc pivalate (100) and pyridin-3-ylzinc pivalate (103). Subsequent cross-
coupling with 4-bromobenzoate (104) using PEPPSI-IPr to ethyl 4-(pyridin-3-yl)benzoate (105). [a] Complexed 
Mg(OPiv)Br and LiCl are omitted for clarity. 
3.3 Preparation of a Set of 17 Polyfunctional Aryl, Benzyl, and Heteroarylzinc Pivalates 
With this optimized preparation protocol in hands, various polyfunctional benzylic, aryl-, and 
heteroarylzinc pivalates 106–122 were prepared on a 7.0 mmol scale and stored in sealed/inerted 
ampules containing approximately 0.125 mmol of each reagent (Figure 3). The protocol was slightly 
changed for compounds 109, 110, 114, 115, 116, 118 which were prepared by magnesium insertion 
followed by transmetalation with Zn(OPiv)2 (see EXPERIMENTAL PART). Furthermore, compound 119 
was prepared via metalation using TMPMgCl·LiCl (17) followed by the addition of solid Zn(OPiv)2 
whereas reagents 107, 112, 120, 122 were prepared using directly the base TMPZnOPiv (27). The 
preparation of compound 106 on a 70 mmol scale led to the desired product in a slightly increased yield 
(77% and 71% on 7.0 mmol scale). However, performing the reaction on a 70 mmol scale led in other 
cases to significantly lower yields. For instance, the preparation of reagent 109 was achieved in 27% 
yield on 70 mmol and in 83% on 7.0 mmol scale. 
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106: 71% (77%)[a] 107: 86% (74%)[d] 108: 92% (62%)[a] 109: 83% (27%)[b] 110: 69%[b] 
 
  
 
111: 84% (63%)[a] 112: 71%[d] 113: 90% (83%)[a] 114: 61% (29%)[b] 
 
   
115: 77% (38%)[b] 116: 70%[b] 117: 87%[a] 118: 76% (43%)[b] 
    
119: 94% (65%)[c] 120: 94% (82%)[d] 121: 75%[d] 122: 88% (69%)[d] 
106  107  108  109  110  
111  112  113  114   
115  116  117  118   
119  120  121  122   
Figure 3: Set of 17 polyfunctional aryl, benzyl, and heteroarylzinc pivalates prepared on a 7.0 mmol scale (values 
in parentheses represent the yield on a 70 mmol scale). Complexed Mg(OPiv)X (X=Cl, Br, I) and LiCl are omitted 
for clarity. [a] Prepared via halogen-magnesium exchange using iPrMgCl·LiCl followed by transmetalation with 
Zn(OPiv)2. [b] Prepared via magnesium insertion using magnesium turnings and LiCl followed by transmetalation 
with Zn(OPiv)2. [c] Prepared via metalation using TMPMgCl·LiCl (17) followed by transmetalation with 
Zn(OPiv)2. [d] Prepared via metalation using TMPZnOPiv (27).  
This set of reagents could be used for high throughput screenings in medicinal chemistry, e.g., in a late 
stage functionalization of drugs via palladium catalyzed Negishi cross-couplings. The feasible handling 
of the air-stable powders and the tolerance of technical solvents as well as the excellent shelf-life of 
these compounds could make the organozinc pivalates a valuable tool in synthetic chemistry. 
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4 Regioselective Transition-Metal-Free Allyl–Allyl Cross-Couplings 
4.1 Introduction 
Transition-metal-catalyzed cross-couplings represent a major tool for forming new carbon–carbon 
bonds.71 Although Pd-72 and Ni-73 catalyzed cross-couplings have found numerous applications, the 
search for alternative transition metal catalysts such as Fe and Co salts74 have become increasingly 
important owing to economical and toxicity issues. Alternatively, the performance of cross-couplings 
without transition metals as reported by Hayashi,75 Uchiyama,76 and others77 opens new perspectives for 
sustainable C−C bond formations. In this respect, allylic organometallics represent a promising class of 
organometallic reagents since the carbon–metal bond in these compounds is typically highly polarized 
and therefore highly reactive. Thus, the cross-coupling between 3-substituted allylic organometallics of 
type 123 with 3-substituted allylic halides of type 124 may provide up to four regioisomeric coupling 
products of type 125 (Scheme 31). 
 
123  124  125  
Scheme 31: Cross-coupling of allylic organometallic 123 with allylic halide 124 leading to four regioisomeric 
coupling products of type 125. 
In pioneering work, Y. Yamamoto and co-workers achieved a regioselective head-to-tail (γ,α′) cross-
coupling using allylic boronate complexes and allylic halides.78 More recently, several transition-metal-
                                                     
71 a) Metal-Catalyzed Cross-Coupling Reactions (Eds.: F. Diederich, A. de Meijere), 2nd ed. Wiley-VCH, 
Weinheim, 2004; b) Organotransition Metal Chemistry (Ed.: J. F. Hartwig), University Science Books, Sausalito, 
2010. 
72 Palladium Reagents and Catalysts: New Perspectives for the 21st Century (Ed.: J. Tsuji), Wiley, Weinheim, 
2004. 
73 R. Jana, T. P. Pathak, M. S. Sigman, Chem. Rev. 2011, 111, 1417. 
74 a) T. Tsuji, H. Yorimitsu, K. Oshima, Angew. Chem. Int. Ed. 2002, 41, 4137; b) T. Nagano, T. Hayashi, Org. 
Lett. 2004, 6, 1297; c) R. Martin, A. Fürstner, Angew. Chem. Int. Ed. 2004, 43, 3955. 
75 E. Shirakawa, Y. Hayashi, K. Itoh, R. Watabe, N. Uchiyama, W. Konagaya, S. Masui, T. Hayashi, Angew. 
Chem. Int. Ed. 2012, 51, 218; Angew. Chem. 2012, 124, 222. 
76 a) H. Minami, X. Wang, C. Wang, M. Uchiyama, Eur. J. Org. Chem. 2013, 7891; b) H. Minami, T. Saito, 
C. Wang, M. Uchiyama, Angew. Chem. Int. Ed. 2015, 54, 4665; Angew. Chem. 2015, 127, 4748. 
77 a) F. Ding, R. William, F. Wang, X.-W. Liu, Chem. Commun. 2012, 48, 8709; b) N. Uchiyama, E. Shirakawa, 
T. Hayashi, Chem. Commun. 2013, 49, 364; c) Q. Chen, X. Mollat du Jourdin, P. Knochel, J. Am. Chem. Soc. 
2013, 135, 4958; d) Q. Chen, T. León, P. Knochel, Angew. Chem. Int. Ed. 2014, 53, 8746; Angew. Chem. 2014, 
126, 8891; e) P. Quinio, D. Sustac Roman, T. León, S. William, K. Karaghiosoff, P. Knochel, Org. Lett. 2015, 17, 
4396. 
78 Y. Yamamoto, K. Maruyama, J. Am. Chem. Soc. 1978, 100, 6282. 
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catalyzed allyl–allyl cross-couplings have been reported by the groups of Morken79 and others.80 H. 
Yamamoto and co-workers have shown that both α- and γ-selective allyl–allyl cross-couplings can be 
accomplished using either allylic barium halides81 or allylic magnesium halides.82 
Recently, we have described convenient mild preparations of functionalized allylic zinc reagents and 
demonstrated their utility in synthesis.83 In contrast to most reactive allylic organometallics, these allylic 
zinc reagents tolerate various functional groups. Therefore, we envisioned that the allyl–allyl cross-
coupling between such functionalized allylic zinc reagents and substituted allylic halides may provide 
access to a broad range of functionalized 1,5-dienes of type 125. 
4.2 Preparation of Allylzinc Halides and Reaction with Allylic Halides 
In preliminary experiments, we examined the cross-coupling of prenylzinc bromide (123a), which was 
generated by the insertion of zinc dust in the presence of LiCl in THF (1 h, 25 °C, 72% yield), with 
(E)-1-bromonon-2-ene (124a), at various temperatures and in several solvent mixtures (Table 5). Thus, 
the addition of the zinc species 123a to the allylic bromide 124a in THF at room temperature led to a 
mixture of all four regioisomers (α,α′/α,γ′/γ,α′/γ,γ′=33:25:35:7; entry 1). Selectivity in favor of the 
α,α′-isomer was obtained by lowering the reaction temperature to −10 °C and −40 °C (57% and 88% of 
the α,α′-isomer were obtained, respectively; entries 2 and 3). This α,α′-regioselectivity was not further 
improved as we found that the addition of various cosolvents leads to a shift to the regioisomer γ,α′-125a.  
                                                     
79 a) L. A. Brozek, M. J. Ardolino, J. P. Morken, J. Am. Chem. Soc. 2011, 133, 16778; b) H. Le, A. Batten, J. P. 
Morken, Org. Lett. 2014, 16, 2096; c) M. J. Ardolino, J. P. Morken, J. Am. Chem. Soc. 2014, 136, 7092; d) M. J. 
Ardolino, J. P. Morken, Tetrahedron 2015, 71, 6409. 
80 For transition metal catalyzed allyl-allyl cross-couplings, see a) K. Sekiya, E. Nakamura, Tetrahedron Lett. 
1988, 29, 5155; b) E. F. Flegeau, U. Schneider, S. Kobayashi, Chem. Eur. J. 2009, 15, 12247; c) V. Hornillos, M. 
Pérez, M. Fañanás-Mastral, B. L. Feringa, J. Am. Chem. Soc. 2013, 135, 2140; d) Q. Yuan, K. Yao, D. Liu, W. 
Zhang, Chem. Commun, 2015, 51, 11834; e) K. Semba, N. Bessho, T. Fujihara, J. Terao, Y. Tsuji, Angew. Chem. 
Int. Ed. 2014, 53, 9007; Angew. Chem. 2014, 126, 9153.  
For transition metal free allyl-allyl cross-couplings, see f) C. Prévost, P. Miginiac, L. Miginiac-Groizeleau, Bull. 
Soc. Chim. Fr. 1964, 2485; g) Y. Yamamoto, H. Yatagai, K. Maruyama, J. Chem. Soc. Chem. Commun. 1979, 
157; h) Y. Yamamoto, H. Yatagai, K. Maruyama, J. Am. Chem. Soc. 1981, 103, 1969; i) A. Hosomi, T. Imai, M. 
Endo, H. Sakurai, J. Organomet. Chem. 1985, 285, 95; j) V. Calo, L. Lopez, G. Pesce, J. Chem. Soc. Perkin Trans. 
1 1988, 1301; k) S. Araki, T. Shimizu, S.-J. Jin, Y. Butsugan, J. Chem. Soc. Chem. Commun. 1991, 824; l) S. 
Araki, S.-J. Jin, Y. Butsugan, J. Chem. Soc. Perkin Trans. 1 1995, 549. 
81 a) A. Yanagisawa, H. Hibino, S. Habaue, Y. Hisada, K. Yasue, H. Yamamoto, Bull. Chem. Soc. Jpn. 1995, 68, 
1263; b) A. Yanagisawa, K. Yasue, H. Yamamoto, Synlett 1996, 842. 
82 A. Yanagisawa, H. Hibino, N. Nomura, H. Yamamoto, J. Am. Chem. Soc. 1993, 115, 5879. 
83 a) H. Ren, G. Dunet, P. Mayer, P. Knochel, J. Am. Chem. Soc. 2007, 129, 5376; b) M. D. Helm, P. Mayer, P. 
Knochel, Chem. Commun. 2008, 1916; c) C. Sämann, P. Knochel, Synthesis 2013, 1870. 
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Table 5: Optimization of the conditions for the allyl-allyl cross-coupling 
 
Entry Temp. 
[°C] 
Cosolvent[b] α,α' α,γ' γ,α' γ,γ' Yield[c] [%] 
1 25 none 33 25 35 7 75 
2 –10 none 57 27 10 6 65 
3 –40 none 88 8 4 0 61 
4 25 toluene 4 5 89 2 94 
5 25 n-hexane 16 2 82 0 82 
6 25 1,4-dioxane 5 10 81 4 92 
7 25 DMSO 0 5 91 4 100 
8 25 NMP 0 5 95 0 100 
9 25 DMPU 0 0 100 0 100 (91)[d] 
10 25 DMPU[e] 10 15 71 4 100 
[a] LiCl is omitted for clarity. [b] A 1:1 mixture with THF was used. [c] Determined by GC-analysis using 
undecane as an internal standard. [d] Yield of isolated product. [e] DMPU was just used as an additive (3.0 equiv. 
in respect to the organozinc reagent). 
Thus, the use of a 1:1 mixture of THF and unpolar solvents such as toluene (entry 4) and n-hexane (entry 
5) furnished selectively the cross-coupling product (γ,α′-125a) in 89% and 82% selectivity, respectively. 
Switching the solvent to a 1:1 mixture of 1,4-dioxane and THF led to a similar result (81% of γ,α-125a) 
with an overall yield of 92% (entry 6). Interestingly, significant regioselectivity improvements were 
achieved by using DMSO, NMP, and DMPU as cosolvents (up to 100% γ,α′-selectivity; entries 7–9), 
allowing us to isolate the pure coupling product (γ,α′-125a) in 91% yield (entry 9 and Scheme 32). 
Lowering the amount of DMPU to just 3 equivalents led only to a decrease in selectivity (entry 10). 
4.3 Tuneable Reactivity in the Allyl-Allyl Cross-Coupling Reaction 
Furthermore, by inverting the polarity of the reagents, we were also able to prepare selectively the 
α,γ′-regioisomer (α,γ′-125a). Thus, instead of using prenylzinc bromide (123a), we have used directly 
prenyl bromide (124b) and have replaced the allylic bromide (124a) with the corresponding zinc reagent 
(123b). Now, the cross-coupling between 124b and 123b produced only the regioisomer α,γ′-125a with 
97% selectivity and 78% yield (Scheme 32). 
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Scheme 32: Transition-metal-free allyl-allyl cross-coupling leading to the γ,α’-products of type 125 after 3 h at 
room temperature in very high selectivity (values in parentheses represent the γ,α’/α,α'/α,γ’/γ,γ’ ratio). [a] LiCl is 
omitted for clarity. Yield determined by titration with I2. 
4.4 Preparation of Functionalized 1,5-Dienes  
This γ,α′-selectivity was general and the sterically hindered prenylzinc bromide (123a) reacts smoothly 
with the allylic bromides 124c and 124d producing the coupling products 125b and 125c in 82–91% 
yield (Table 6, entries 1 and 2).84 (E)-Non-2-en-1-ylzinc bromide (123b) and cinnamylzinc chloride 
(123c) display a similar behavior leading to 125d,e in 92–96% yield after 3 h (entries 3 and 4). 
Interestingly, when cinnamylzinc pivalate (83d) was used in this cross-coupling the corresponding 
product was obtained with the same yield (96%; entry 4). In addition, geranylzinc bromide (123d) and 
nerylzinc bromide (123e) react with the functionalized allylic bromides 124e and 124c furnishing the 
branched isomers 125f and 125g in 90–92% yield (entries 5 and 6). Remarkably, the substituted allylzinc 
compounds 123f85 and 123g86 react smoothly with the allylic bromide 124f and prenyl bromide (124b) 
leading to the polyfunctionalized products (125h,i) in 83–90% yield (entries 7 and 8). Similarly, the 
allylic zinc reagents 123a and 123d were converted into the corresponding products (γ,α′-125j and 
γ,α′-125k) in 79–83% yield (entries 9 and 10). Finally, the allylzinc reagent 123h reacts twice with 
(E)-1,4-dibromobut-2-ene (124h) furnishing the symmetrical product (E)-125l as the only isomer 
(E/Z>99:1) in 90% yield after 3 h (entry 11). 
Table 6: Allyl-allyl cross-couplings in a 1:1 mixture of THF and DMPU within 1-3 h at 25 °C 
Entry Zinc Reagent[a] Electrophile[b] Product[c] 
 
  
 
1 123a 124c 125b: 82% 
 
   
2 123a 124d 125c: 91% 
                                                     
84 The use of allylic chlorides led in several cases to significantly lower yields. 
85 J. van der Louw, J. L. van der Baan, F. Bickelhaupt, G. W. Klumpp, Tetrahedron Lett. 1987, 28, 2889. 
86 N. El Alami, C. Belaud, J. Villiéras, J. Organomet. Chem. 1988, 348, 1. 
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3 123b (25, 2 h, 77) 124c 125d: 92% 
  
 
 
4 
X = Cl: 123c (25, 2 h, 86) 
X = OPiv: 83d 
124c 
 
125e, X = Cl: 96% 
X = OPiv: 96% 
 
 
 
 
5 123d (25, 1 h, 83) 124e 125f: 92% 
 
 
 
 
6 123e (25, 1 h, 58) 124c 125g: 90% 
 
 
  
7 123f (50, 8 h, 41) 124f 125h: 90% 
 
 
 
 
8 123g (25, 1 h, 60) 124b 125i: 83% 
 
 
  
9 123a 124g 125j: 79% 
 
 
 
 
10 123d 124b 125k: 83%[d] 
 
 
 
 
11 123h[e] (25, 1 h, 66) 124h 125l: 90% 
[a] LiCl is omitted for clarity. In parentheses: temperature, time, yield [%] for the insertion. Yields determined by 
titration with I2. [b] 0.8 equiv. of electrophile were used. [c] Yields refer to analytically pure products. [d] 6% of 
the α,α’-isomer was formed. [e] 2.4 equiv. of organozinc were used. 
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4.5 Preparation of Functionalized 1,5-Dienes with Retention of the Double Bond Configuration 
Remarkably, these cross-couplings proceed with retention of the double bond configuration of the allylic 
bromide indicating an SN2-type substitution. Thus, the zinc reagents 123i and 123b react with geranyl 
bromide (124i) selectively to give the corresponding (E)-1,5,9-trienes (125m,n) in 74–84% yield 
(Scheme 33). In a control experiment, prenylzinc bromide (123a) was treated with the (E)- and (Z)-
allylic bromides 124j,k providing stereoselectively the expected γ,α′-regioisomers (E)-γ,α′-125o and 
(Z)-γ,α′-125o in 76–77% yield and >99% retention of the double bond configuration (Scheme 33). 
 
Scheme 33: Allyl-allyl cross-couplings leading to the γ,α’-products of type 125 with full retention of the double 
bond configuration. [a] LiCl is omitted for clarity. 
4.6 Extension of the Cross-Coupling to Benzylic and Propargylic Halides 
This cross-coupling was also applicable to benzylic and propargylic halides. Thus, the reaction of 
prenylzinc bromide (123a) and (E)-non-2-en-1-ylzinc bromide (123b) with propargylic halides of type 
126 produces 1,5-enynes of type 127 (Scheme 34). Accordingly, the cross-coupling of 123b with the 
propargylic chloride 126a provides only the 1,5-enyne 127a in 88% yield. 
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 126     
127    128  129  
   
127a: 88%[d] 127b: 79% 127c: 85%[e] 
  
129a: 63% 129b: 72% 
Scheme 34: Cross-coupling of allylic zinc reagents of type 123 with propargylic and benzylic halides leading to 
the γ,α’-products of type 127 and 129. [a] LiCl is omitted for clarity. [b] 0.80 equiv. of electrophile were used. [c] 
Yields refer to analytically pure products. [d] The propargylic chloride was used instead of the bromide. [e] 
0.40 equiv. of electrophile were used. 
The reaction of prenylzinc bromide (123a) with ethyl 7-bromohept-5-ynoate (126b) furnishes the 
corresponding functionalized 1,5-enyne 127b in 79% yield. Furthermore, the coupling of zinc reagent 
123a with 1,4-dibromobut-2-yne (126c) selectively affords the symmetrical product 127c in 85% yield. 
Interestingly, benzyl bromides (128a,b) reacted under our standard reaction conditions furnishing the 
substitution products 129a and 129b in 63–72% yield. However, prenylzinc bromide did not react with 
1-bromononane. In addition, in a control experiment, prenylzinc bromide (123a) was added to a 1:1 
mixture of 1-bromononane and (E)-1-bromonon-2-ene (124a) which led to the allyl–allyl cross-coupling 
product γ,α′-125a exclusively. 
4.7 Theoretical Investigations on the Reaction Mechanism 
In order to support the experimental outcome of this selective transformation the reaction pathway was 
investigated using double hybrid density functional theory (DFT).87,88 The addition of LiCl is currently 
believed to accelerate reactions of organometallic reagents through increased formation of monomeric 
species or ate-like complexes.89 In line with this rationalization we find that hetero dimers of type 130 
                                                     
87 These calculations were performed by Florian Achrainer and are given here for the sake of completeness. 
88 Geometries of the corresponding organozinc intermediates have been obtained at B3LYP/631SVP level, 
followed by single-point calculations at B2PLYP-D3(FC)/def2-TZVPP level. Solvent effects have been included 
using Truhlar’s solvent model density (SMD) in combination with B3LYP/6-31G(d) calculations and THF or 
DMF as respective solvents. 
89 a) K. Koszinowski, P. Böhrer, Organometallics 2009, 28, 771; b) G. T. Achonduh, N. Hadei, C. Valente, S. 
Avola, C. J. O’Brien, M. G. Organ, Chem. Commun. 2010, 46, 4109; c) E. Hevia, R. E. Mulvey, Angew. Chem. 
Int. Ed. 2011, 50, 6448; d) B. Lecachey, H. Oulyadi, P. Lameiras, A. Harrison-Marchand, H. Gérard, J. Maddaluno, 
J. Org. Chem. 2010, 75, 5976; e) D. Stern, N. Finkelmeier, D. Stalke, Chem. Comm. 2011, 47, 2113; f) A. C. 
Hoepker, L. Gupta, M. F. Faggin, D. B. Collum, J. Am. Chem. Soc. 2011, 133, 7135; g) J. E. Fleckenstein, K. 
Koszinowski, Organometallics 2011, 30, 5018. 
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represent the most stable structures in solution; this is indicated by the significant exergonicity of the 
exchange reaction of (LiCl)2(sol)4 with (RZnBr)2(sol)2 (ΔGsol(THF) = −14.4 kJ mol−1, 
ΔGsol(DMPU) = −27.1 kJ mol−1) at the B2PLYP-D3(FC)/def2-TZVPP level90 including implicit 
SMD/B3LYP/6-31G(d) solvation.91 Indeed, 1H and 13C NMR shifts in THF obtained during the LiCl-
mediated oxidative addition of zinc to the carbon–bromine bond of prenyl bromide (124b) correlate 
quite well with theoretically calculated chemical shifts of lithium zinc dimer 130-THF at the 
mPW1K/IGLO-III level of theory92 (see the Supporting Information). Substituted allylic 
organometallics often show high diastereoselectivity in reactions with electrophiles due to their rather 
ordered cyclic or acyclic transition states.93 How LiCl facilitates the construction of highly ordered but 
unstrained transition states in substitution reactions with prenyl zinc nucleophiles is shown in an 
exemplary fashion in Figure 4 for the formation of γ,α′-cross-coupling products of type 125. Starting 
from mixed aggregate 130-THF, the reaction is here assumed to involve initial exchange of THF by 
DMPU. Due to the better donor ability of DMPU, as quantified by the Gutmann donor numbers,94 this 
ligand exchange is exergonic by ΔGexch = −40.9 kJ mol−1. Subsequent exchange of one of the DMPU 
ligands by the substrate leads to reactant complex PRC-I and is endergonic by ΔG298 = 26.0 kJ mol−1. 
In the absence of LiCl this step is significantly more costly, and formation of product complex PRC-II 
is endergonic by ΔG298 = 54.5 kJ mol−1. Subsequent reaction barriers are much lower for LiCl-
containing transition state TS-I as compared to its LiCl-free analogue TS-II, the difference amounting 
to ΔΔG≠ (TS-I/TS-II) = 48.7 kJ mol−1.95 
                                                     
90 a) L. Goerigk, S. Grimme, J. Chem. Theory Comput. 2011, 7, 291; b) F. Weigend, R. Ahlrichs, Phys. Chem. 
Chem. Phys. 2005, 7, 3297; c) F. Weigend, Phys. Chem. Chem. Phys. 2006, 8, 1057. 
91 A. V. Marenich, C. J. Cramer, D. G. Truhlar, J. Phys. Chem. B 2009, 113, 6378. ΔGsol (THF) includes implicit 
solvation in THF, ΔGsol (DMPU) in a DMF continuum. 
92 P. Quinio, C. François, A. E. Escribano Cuesta, A. K. Steib, F. Achrainer, H. Zipse, K. Karaghiosoff, P. Knochel, 
Org. Lett. 2015, 17, 1010. 
93 M. Yus, J. C. González-Gómez, F. Foubelo, Chem. Rev. 2013, 113, 5595. 
94 DN (THF) = 20 kcal mol-1, DN (NMP) = 27.3 kcal mol-1, DN (N,N-dimethylacetamide) = 27.8 kcal mol-1 taken 
from V. Gutmann, Coord. Chem. Rev. 1976, 18, 225. 
95 The selectivity increase observed by the use of non-polar solvents (entries 4 and 5 of Table 1) can be tentatively 
explained by the higher Lewis-acidity of the zinc cation in these solvents favoring the TS-I. 
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130 
Figure 4: Reaction pathway of the γ,α’-cross-coupling in THF solution (B2PLYP-D3(FC)/def2-TZVPP + 
ΔGsolv(SMD/B3LYP/6-31G(d)), in kJ mol-1) and graphical representation of the B3LYP/631SVP optimized 
transition states TS-I and TS-II (bond lengths in pm).96 
The main structural difference between these transition states concerns the trajectory angle of the 
backside attack: while the ideal angle of 180° is nearly reached in TS-I with a value of 163°, compared 
to TS-II with 134°. This indicates that geometrical factors as well as electronic interactions play an 
important role in decreasing the kinetic barrier. Replacement of the allylic bromide by n-butyl bromide 
leads to barriers significantly higher in energy (ΔΔG‡ (TS-I) = 29.1 kJ mol-1, 
ΔΔG‡ (TS-II) = 23.9 kJ mol-1), which is in agreement with the competition experiment of 
1-bromononane and (E)-1-bromonon-2-ene (124a). This behavior can be rationalized by inspection of 
the HOMO and LUMO levels which shows a larger energy difference for the respective aliphatic 
bromide and an increased substrate deformation energy in the respective transition state.[25] In 
conclusion, the presence of LiCl seems essential for fast and selective cross-couplings. In fact, complex 
mixtures of products are obtained in the absence of LiCl. 
  
                                                     
96 These calculations were performed by Florian Achrainer and are given here for the sake of completeness. 
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5 Preparation of Tertiary Amines by the Reaction of Iminium Ions 
Derived from Unsymmetrical Aminals with Zinc and Magnesium 
Organometallics 
5.1 Introduction 
The preparation of functionalized unsaturated amines is an important task in organic chemistry since 
many polyfunctional amino compounds are of interest due to their biological activity. A wide range of 
preparation methods have been reported,97 including the reaction of organometallic compounds with 
iminium ions.98 One suitable electrophile is the salt N,N-dimethyl(methylene)iminium trifluoroacetate 
(131) which was first prepared by Potier from trimethylamine oxide (Scheme 35, A).99 An improved 
synthesis was reported by Tietze, who used N,N,N′,N′-tetramethylmethanediamine (TMDAM) and 
trifluoroacetic anhydride (TFAA) (Scheme 35, B).100 
 
131  
Scheme 35: Preparation of N,N-dimethyl(methylene)iminium trifluoroacetate (131) starting from trimethylamine 
oxide (A) or from the symmetrical aminal N,N,N’,N’-tetramethylmethanediamine (TMDAM) (B). 
Thus, Knochel et al. reported the reaction of aromatic, benzylic and alkyl-magnesium and -zinc reagents 
with iminium ions derived from symmetric aminals and (CF3CO)2O according to Tietze’s protocol 
(Scheme 36, A).101 Furthermore, it was shown that polyfunctional unsaturated amines can be prepared 
by the reaction of unsaturated iminium ions with Grignard reagents (Scheme 36, B).102 
                                                     
97 For selected reviews, see: a) S. Kobayashi, H. Ishitani, Chem. Rev. 1999, 99, 1069; b) B. H. Yang, S. L. 
Buchwald, J. Organomet. Chem. 1999, 574, 125; c) B. List, Tetrahedron 2002, 58, 5573; d) R. I. Storer, D. E. 
Carrera, Y. Ni, D. W. MacMillan, J. Am. Chem. Soc. 2006, 128, 84; e) M. Kienle, S. R. Dubbaka, K. Brade, P. 
Knochel, Eur. J. Org. Chem. 2007, 4166; f) J. L. Klinkenberg, J. F. Hartwig, Angew. Chem. Int. Ed. 2011, 50, 86; 
g) C. Liu, H. Zhang, W. Shi, A. Lei, Chem. Rev. 2011, 111, 1780. 
98 a) N. L. Holy, Synth. Commun. 1976, 6, 539; b) N. L. Holy, Y. F. Wang, J. Am. Chem. Soc. 1977, 99, 944; c) J. 
L. Roberts, S. Borromeo, C. D. Poulter, Tetrahedron Lett. 1977, 15, 1299; d) N. Holy, R. Fowler, E. Burnett, R. 
Lorenz, Tetrahedron 1979, 35, 613; e) T. A. Bryson, G. H. Bonitz, C. J. Reichel, R. E. Dardis, J. Org. Chem. 1980, 
45, 534. 
99 A. Ahound, A. Cavé, C. Kan-Fan, H.-P. Husson, J. de Rostolan, P. Potier, J. Am. Chem. Soc. 1968, 90, 5622. 
100 G. Kinast, L.-F. Tietze, Angew. Chem. Int. Ed. 1976, 15, 239. 
101 N. Millot, C. Piazza, S. Avolio, P. Knochel, Synthesis 2000, 941. 
102 N. Gommermann, C. Konradin, P. Knochel, Synthesis 2002, 2143. 
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Scheme 36: A) Preparation of tertiary amines by the reaction of organozinc reagents with iminium ions;101 B) 
Addition of functionalized organomagnesium reagents to unsaturated iminium ions.102 
As a logical consequence, we envisioned the preparation of new unsymmetrical aminals by the reaction 
of 131 with metallic amides 132 (R1R2NMet; M = Li, MgX). The amides 132 were prepared by 
deprotonation of the corresponding amine R1R2NH (133) with CH3Met (M = Li, MgX). The addition of 
TFAA to the aminals of type 134 will provide a route to complex iminium ions of type 135. It is expected 
that the acylation of aminals with TFAA occurs selectively on the least sterically hindered side of the 
aminal. The resulting iminium salt 135 could show a similar behavior and lead after reaction with 
organometallics of type 123 and 136–138 (R3-Met) to polyfunctional tertiary amines of type 139 
(Scheme 37). 
 
x131   132  133  134  135    
   M: xallyl  136  137  138  
      139   
Scheme 37: Preparation of tertiary amines by cleavage of mixed aminals 134 to mixed iminium ions 135 and 
subsequent reaction with organometallic reagents. 
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5.2 One-Pot Procedure for the Reaction of Organometallic Reagents with Unsymmetrical 
Iminium Ions 
This one-pot procedure proved to be general and a range of functionalized amines of type 133 as well 
as a variety of organometallic reagents (123 and 136–138) were used, leading to various tertiary amines 
(139a-f) in 61–84% overall yield (Table 7, entries 1-6). Thus, the allylic reagents 123g,i furnished the 
functionalized homoallylic amines 139a,b in 76–84% yield. The sterically hindered amine 133a 
furthermore reacted with benzylzinc reagent 136a furnishing phenethylamine 139c in 72% yield. In 
addition, this reaction was successfully performed on gram-scale (72% yield on a 1 mmol scale 
compared to 68% yield on a 10 mmol scale). Phenethylamines are common targets in medicinal 
chemistry and have found many applications in neuropsychopharmacology.103 Other classes of zinc 
reagents104 were successfully used in this homologative synthesis of tertiary amines. Thus, the 
aminomethylation of the arylzinc iodide (137a) with indoline (133c) provided the benzylamine 139d in 
66% yield. Furthermore, aryl and heteroaryl Grignard reagents 138a,b were used in this one-pot 
homologative amination, furnishing highly functionalized benzylamines. Thus, phenoxazine (133d) and 
N-tert-butylisopropylamine (133a) were converted to the corresponding benzylamines 139e and 139f in 
61−77% yield, using the Grignard reagents 138a and 138b. 
Table 7: Tertiary amines of type 139 obtained by the one-pot reaction of amines of type 133 with various 
organometallic reagents 
Entry Amine Zinc Reagent[a] Product[b],[c] 
 
  
 
1 133a 123g 139a: 84% 
 
  
 
2 133b 123i 139b: 76% 
 
  
 
3 133a 136a 139c: 72% (68%)[d] 
                                                     
103 a) G. K. Aghajanian, G. J. Marek, Brain Res. Rev. 2000, 31, 302; b) S. L. Hill, S. H. L. Thomas, Clin. Toxicol. 
2011, 49, 705. 
104 a) Organozinc Reagents; P. Knochel, P. Jones, Eds.; Oxford University Press: New York, 1999; b) P. Knochel, 
N. Millot, A. L. Rodriguez, C. E. Tucker, Org. React. 2001, 58, 417; c) B. Haag, M. Mosrin, I. Hiriyakkanavar, 
V. Malakhov, P. Knochel, Angew. Chem. 2011, 123, 9968; Angew. Chem. Int. Ed. 2011, 50, 9794. 
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4 133c 137a 139d: 66% 
 
  
 
5 133d 138a 139e: 77% 
 
 
 
 
6 133a 138b 139f: 61% 
[a] The concentration of the zinc reagent was determined by iodometric titration. [b] Isolated yield of analytically 
pure product. [c] The reaction was performed on a 1 mmol scale. [d] The reaction was performed on a 10 mmol 
scale.  
5.3 Preparation of Functionalized Precursors Suitable for Cyclization Reactions 
The high functional group tolerance of this procedure enabled the synthesis of functionalized precursors 
suitable for cyclization reactions. This was demonstrated in the homologation of the amine 133e, which 
led to an intermediate iminium ion that reacted regioselectively with cinnamylzinc chloride (123c) to 
the polyfunctional aniline 139g in 71% yield. A subsequent Heck cyclization[19] led selectively to the 
exo-methylene quinolidine (140) in 89% yield. 
 
140  
Scheme 38: Heck reaction of the aniline derivative 139g, which was obtained by the one-pot reaction of aniline 
(133e) and cinnamylzinc chloride (123c).  
5.3.1 Synthesis of Novel Ephedrine Derivatives Containing a Tertiary Amine 
As shown in Chapter 5.2, this one-pot procedure proved to be general for the use of a range of 
functionalized amines as well as a variety of benzylic zinc reagents, leading selectively to the 
corresponding phenethylamines. The homologative amination procedure furthermore allowed the 
conversion of ephedrine derivatives to the corresponding benzylic and phenethylic amines which 
showed a promising structure for biological evaluation. Thus, the treatment of a THF solution of TBS 
protected (+)-ephedrine derivative (+)-141 with MeMgCl (1.1 equiv. 2.8 M in THF, –20 °C, 30 min) 
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provided the corresponding magnesium amide, which was added to the Potier salt 
[Me2NCH2+CF3COO−] (131), generated by the addition of trifluoroacetic anhydride (TFAA) (1.0 equiv.) 
to TMDAM (1.0 equiv., CH2Cl2, –20 °C, 15 min) (Scheme 39). The addition of TFAA (1.0 equiv.) to 
the aminal thus formed (143) led after 15 min at –20 °C selectively to the iminium salt 144 which was 
then treated with a variety of benzylzinc reagents of type 136 furnishing the expected tertiary amines of 
type 145 in 70–91% yield (Scheme 39 and Table 8).  
 
 
Scheme 39: Preparation of ephedrine derivatives of type 145 containing a tertiary amine by cleavage of the mixed 
aminal 143 and subsequent reaction with benzylic zinc reagents of type 136. Conditions: i) MeMgCl (1.1 equiv.), 
–20 °C, 30 min; ii) [Me2NCH2+CF3COO–] (131; 1.0 equiv.), –20 °C, 30 min; iii) (CF3CO)2O (1.0 equiv.), –20 °C, 
15 min; iv) benzylic zinc halide (136; 1.1 equiv.), –78 °C to room temperature, overnight. [a] LiCl is omitted for 
clarity. 
Thus, (4-methoxybenzyl)zinc chloride (136b) and the ester and trifluoromethyl containing benzylic zinc 
reagents 136c and 136d reacted with the iminium ion 144 to form the phenethylamines 145a-c in 
81-85% yield (Table 8, entries 1-3). Interestingly, the heterocyclic and the ortho-substituted zinc 
reagents 136e,f showed a similar behavior and led selectively to the desired phenethylamines 145d,e in 
75% and 91% yield (entries 4-5). Furthermore, the aromatic zinc reagent 136g was used according to 
the same protocol and furnished the benzylic amine 145f in 70% yield (entry 6). In addition, the (–)-
ephedrine derivatives 145g,h were prepared from the corresponding secondary (–)-ephedrine derivative 
using (4-methoxybenzyl)zinc chloride (136b) and (3-(trifluoromethyl)benzyl)zinc chloride (136d) 
(entries 7-8). 
Table 8: Preparation of (+/–)-ephedrine derivatives of type 145 in a one pot procedure 
Entry Zinc Reagent[a] Product[b] 
 
 
 
1 136b 145a: 85% 
 
 
 
2 136c 145b: 81% 
141  142  143  144  145  
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3 136d 145c: 85% 
 
 
 
4 136e 145d: 75% 
 
  
5 136f 145e: 91% 
 
 
 
6 136g 145f: 70% 
 
 
 
7 136b 145g: 85% 
 
 
 
8 136d 145h: 85% 
[a] Complexed LiCl is omitted for clarity. [b] Yields refer to analytically pure products. 
5.3.2 Deprotection of the Alcohol Using TBAF 
The facile and smooth removal of the TBS group was shown by the conversion of several TBS protected 
phenethylamines of type 145 to the corresponding alcohols using TBAF·3H2O (4 equiv., THF, 25 °C, 
12 h). Thus, the ephedrine derivatives 146a-h were obtained in 80–99% yield (Scheme 40). 
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146  
  
146a: 99% 146b: 94% 
  
  
146c: 80% 146d: 99% 
  
  
146e: 99% 146f: 98% 
  
  
146g: 99% 146h: 80% 
Scheme 40: TBS deprotection of tertiary amines 145a-h to the corresponding alcohols 146a-h which could be 
subjected to biological evaluation. 
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6 Summary 
This work focused on the development of solid allylzinc reagents prepared from the corresponding 
allylic bromides or chlorides through a one-pot insertion under mild conditions with commercial zinc 
powder, LiCl, and Mg(OPiv)2. After evaporation of the solvent, the resulting solid allylic zinc reagents 
can be stored under argon for an extended period of time (t1/2 between ca. 5 weeks and >2 years). These 
reagents show excellent reactivity in Pd-catalyzed cross-coupling reactions with aryl bromides when 
using PEPPSI-IPent and they undergo smooth additions to methyl ketones and aldehydes with high 
diastereoselectivity. In addition, the regioselective acylation of the reagents with acid chlorides produces 
β,γ-unsaturated ketones. Furthermore, the lack of air-stable organozinc enolates was overcome by a mild 
and convenient preparation of solid, salt stabilized zinc amide enolates which show an exceptional 
stability when exposed to air and furthermore react with a large variety of electrophiles. Moreover, the 
scalable preparation of (hetero-)aromatic zinc pivalates was established as a valuable tool for both 
synthetic and medicinal chemists for instance in high throughput screenings. In addition, it was 
demonstrated that allylic zinc reagents undergo highly regioselective cross-couplings with allylic 
bromides via an SN2-substitution fashion in a 1:1 mixture of THF and DMPU. Furthermore, 
unsymmetrical allylic zinc reagents undergo this cross-coupling almost exclusively from the most 
branched side of the allylic system. The stereochemistry of the double bond of the allylic bromide is 
maintained during the cross-coupling. This SN2-reaction can be extended to propargylic and benzylic 
bromides. Finally, a general synthesis of new mixed aminals using Tietze’s iminium salt was developed. 
The treatment of theses aminals with TFAA provided an entry to new polyfunctional iminium salts, 
which were trapped by numerous zinc and magnesium organometallics leading to a range of valuable 
amines using a convenient one-pot procedure. This reaction sequence allowed the preparation of 
complex amines, including biorelevant phenethylamines and ephedrine derivatives as well as a 
cyclization precursor, leading to the quinolidine scaffold. 
6.1 Preparation of Solid, Substituted Allylic Zinc Reagents and Their Reactions with 
Electrophiles 
The treatment of various allylic chlorides or bromides with zinc dust in the presence of lithium chloride 
and magnesium pivalate (Mg(OCOtBu)2) in THF affords allylic zinc reagents which, after evaporation 
of the solvent, produce solid zinc reagents that display excellent thermal stability (Scheme 41). 
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83b: 74% 83c: 77% 83f: 90% 83g: 81% 
t1/2 = 25 months t1/2 > 2 years t1/2 = 16 (40) weeks t1/2 = 33 (50) days 
Scheme 41: Preparation of solid functionalized allylzinc pivalates of type 83 from the corresponding allylic halides 
of type 84 by using Zn, Mg(OPiv)2 and LiCl. Values given in brackets show the half-lives when the reagents were 
stored at −24 °C. [a] Complexed Mg(OPiv)X (X=Cl, Br) and LiCl are omitted for clarity. 
The reactivity of the novel allylic zinc pivalates in Pd-catalyzed cross-couplings with various 
unsaturated bromides in the presence of various Pd-catalysts was examined. In our hands, PEPPSI-IPent 
gave by far the best results. In addition, the solid allylic zinc reagents of type 83 react as previously 
reported allylic zinc halides with electrophiles such as carbonyl derivatives or acid chlorides with 
complete regioselectivity (formation of the new carbon-carbon bond from the most substituted end of 
the allylic system) and very high diastereoselectivity as shown in Scheme 42. 
 
 
   
86c: 69%[b] 86e: 71% 86h: 75% 
   
89c: 89% 
d.r. > 99:1 
89e: 80% 
d.r. = 95:5 
91f: 77% 
Scheme 42: PEPPSI-IPent-catalyzed cross-coupling and reaction with various electrophiles of allylic organozinc 
pivalates of type 83 in THF. 
6.2 Preparation and Application of Solid, Salt Stabilized Amide Enolates 
A first general approach toward the preparation of solid, salt stabilized organozinc enolates via 
deprotonation using various metal TMP bases was developed. Thus, different morpholineamide zinc 
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pivalates were prepared from the corresponding morpholine amides under mild conditions and are 
obtained as easy-to-handle solids after evaporation of the solvent. These reagents show an excellent 
stability upon air-exposure and are furthermore suitable for a long-term storage under argon. In addition, 
these reagents undergo smooth Negishi cross-couplings with aryl bromides and iodides and furthermore 
react with carbonyl compounds to form the corresponding alcohols (Scheme 43). Moreover copper 
catalyzed allylation reactions were performed efficiently. 
 
 
    
94a: 99% 95a: 99% 94b: 99% 94d: 81% 
    
94e: 99% 94f: 90% 98a: 99% 98b: 97% 
Scheme 43: Preparation of solid zinc amide enolates of type 93 from the corresponding morphonyl amides of type 
92 by using TMPZnCl·LiCl (19) in the presence of Mg(OPiv)2 and subsequent reactions with various electrophiles. 
[a] Complexed Mg(OPiv)Cl and LiCl are omitted for clarity. 
6.3 Scalable Preparation of Functionalized (Hetero-)Arylzinc Pivalates 
The limited stability towards air and moisture represents a serious drawback of aromatic and 
heterocyclic organozinc reagents for their practical use in the laboratory and for industrial applications. 
To overcome this problem, we recently developed a method for the preparation of aryl and heteroaryl 
zinc pivalates, which are easy-to-handle solids with exceptional stability when exposed to air. To 
evaluate their use in industry applications e.g., in high throughput screenings in medicinal chemistry a 
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scale up procedure was developed for the preparation of solid pyridin-3-ylzinc pivalate (103) and the 
subsequent Pd-catalyzed cross-coupling to ethyl 4-(pyridin-3-yl)benzoate (105) (Scheme 44). 
 
 
Scheme 44: Scalable protocol for the preparation of pyridin-3-ylzinc pivalate (103) cross-coupling to 
ethyl 4-(pyridin-3-yl)benzoate (105). [a] Complexed Mg(OPiv)Br and LiCl are omitted for clarity. 
With this optimized preparation protocol in hands, various polyfunctional benzylic, aryl- and 
heteroarylzinc pivalates 106–122 were prepared on a 7.0 mmol scale each and stored in sealed/inerted 
ampules containing approximately 0.125 mmol of each reagent (Figure 5). This set of reagents could be 
used for high throughput screenings in medicinal chemistry e.g., in a late stage functionalization of drugs 
via palladium catalyzed Negishi cross-couplings. 
 
  
 
 
106: 71% 107: 86% 108: 92% 109: 83% 110: 69% 
 
  
 
111: 84% 112: 71% 113: 90% 114: 61% 
 
   
115: 77% 116: 70% 117: 87% 118: 76% 
    
119: 94% 120: 94% 121: 75% 122: 88% 
Figure 5: Set of 17 polyfunctional aryl, benzyl and heteroarylzinc pivalates prepared on a 7.0 mmol scale. 
Complexed Mg(OPiv)X (X=Cl, Br, I) and LiCl are omitted for clarity. 
6.4 Regioselective Transition-Metal-Free Allyl–Allyl Cross-Couplings 
Readily prepared allylic zinc halides undergo SN2-type substitutions with allylic bromides in a 1:1 
mixture of THF and DMPU providing 1,5-dienes regioselectively. The allylic zinc species reacts at the 
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most branched end (γ-position) of the allylic system furnishing exclusively γ,α’-allyl–allyl cross-
coupling products (Scheme 45). Several functional groups (ester, nitrile) are tolerated. DFT calculations 
show the importance of lithium chloride in this substitution. 
 
 
Scheme 45: Allyl-allyl cross-coupling leading to the γ,α’-products of type 125 with full retention of the double 
bond configuration. (values in parentheses represent the γ,α’/α,α'/α,γ’/γ,γ’ ratio) [a] LiCl is omitted for clarity.  
Furthermore, by inverting the polarity of the reagents, we were also able to prepare selectively the 
corresponding α,γ’-regioisomer (Scheme 46). 
 
Scheme 46: Transition-metal-free allyl-allyl cross-coupling leading to the γ,α’-products of type 125 after 3 h at 
room temperature in very high selectivity. [a] LiCl is omitted for clarity. Yield determined by titration with I2. 
Remarkably, the double bond stereochemistry of the allylic halide is maintained during the cross-
coupling process. This cross-coupling of allylic zinc reagents can be extended to propargylic and 
benzylic halides (Figure 6). 
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125c: 91% 125e: 96% 125i: 83% 125f: 92% 
 
 
 
 
125j: 79% 125h: 90% 125m: 74% 125l: 90% 
    
127a: 88% 127b: 79% 129a: 63% 129b: 72% 
Figure 6: Selected examples of cross-couplings in a 1:1 mixture of THF and DMPU within 1-3 h at 25 °C. 
6.5 Preparation of Tertiary Amines by the Reaction of Iminium Ions Derived from 
Unsymmetrical Aminals with Zinc and Magnesium Organometallics 
An efficient method for the preparation of new polyfunctional iminium salts was developed. The 
resulting compounds gave access to a wide range of valuable tertiary amines via a one-pot reaction with 
benzyl-, aryl-, and allylzinc reagents (Scheme 47). Moreover, this homologative amination procedure 
allowed the conversion of ephedrine derivatives to the corresponding benzylic and phenethylic amines 
which showed a promising structure for biological evaluation. 
 
   
 
139a: 84% 139d: 66% 139e: 77% 139f: 61% 
 
  
145b: 81% 145d: 75% 145h: 85% 
Scheme 47: Preparation of tertiary amines by cleavage of mixed aminals 134 to mixed iminium ions 135 and 
subsequent reaction with organometallic reagents. 
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1 General Considerations 
All reactions were carried out under an argon atmosphere in flame-dried glassware. Syringes which 
were used to transfer anhydrous solvents or reagents were purged with argon prior to use. THF was 
continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen and stored 
over molecular sieves. AcOEt was purchased from Sigma-Aldrich with a purity of 99% and used without 
distillation or drying prior to use. Yields refer to isolated yields of compounds estimated to be >95% 
pure as determined by 1H-NMR (25 °C) and capillary GC. 
1.1 Solvents 
Solvents were dried according to standard procedures by distillation over drying agents and stored under 
argon. 
CH2Cl2 was predried over CaCl2 and distilled from CaH2. 
EtOH was treated with phthalic anhydride (25 g/L) and sodium, heated to reflux for 6 h and distilled. 
Et2O was predried over CaH2 and dried with the solvent purification system SPS-400-2 from 
INNOVATIVE TECHNOLOGIES INC. 
Pyridine was dried over KOH and distilled. 
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen 
and then stored over molecular sieves. 
Solvents for column chromatography were distilled prior to use. 
1.2 Reagents 
All reagents were obtained from commercial sources and used without further purification unless 
otherwise stated. Liquid aldehydes and acyl chlorides were distilled prior to use.  
iPrMgCl·LiCl solution in THF was obtained from Rockwood Lithium. 
nBuLi solution in hexane was obtained from Rockwood Lithium. 
TMPMgCl·LiCl (17) was prepared according to a literature procedure.105 
Zinc dust (> 98%) was obtained from Sigma Aldrich. MgBu2 was purchased from Rockwood Lithium.  
All reagents not listed in the supporting information were obtained from commercial sources. Liquid 
aldehydes and acid chlorides were distilled prior to use. 
                                                     
105 a) A. Krasovskiy, V. Krasovskaya, P. Knochel, Angew. Chem. 2006, 118, 3024; Angew. Chem. Int. Ed. 2006, 
45, 2958; b) T. Kunz, P. Knochel, Angew. Chem. 2012, 124, 1994; Angew. Chem. Int. Ed. 2012, 51, 1958. 
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1.3 Content Determination of Organometallic Reagents 
Organzinc and organomagnesium reagents were titrated against I2 in THF.106 
Organolithium reagents were titrated against isopropanol using 1,10-phenanthroline as indicator in 
THF.107 
TMPMgCl·LiCl (17) was titrated against benzoic acid using 4-(phenylazo)diphenylamine as indicator 
in THF.  
1.4 Chromatography 
Flash column chromatography was performed using silica gel 60 (0.040–0.063 mm, 230–400 mesh 
ASTM) from Merck. 
Thin layer chromatography was performed using SiO2 pre-coated aluminum plates (Merck 60, F-254). 
The chromatograms were examined under UV light at 254 nm and/or by staining of the TLC plate with 
one of the solutions given below followed by heating with a heat gun: 
- Seebach’s stain (aka “Magic”): Phosphomolybdic acid (2.5 g), Ce(SO4)2 (1.0 g), conc. H2SO4 (6 mL), 
H2O (94 mL). 
- KMnO4 stain: KMnO4 (3.0 g), K2CO3 (20 g), 5% NaOH solution (5 mL), water (300 mL). 
1.5 Analytical Data 
NMR spectra were recorded on VARIAN Mercury 200, BRUKER AXR 300, VARIAN VXR 400 S 
and BRUKER AMX 600 instruments in CDCl3 or C6D6 and chemical shifts are reported in parts per 
million (ppm) relative to the residual solvent peak. Abbreviations for signal coupling are as follows: s, 
singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. 
Mass spectroscopy: High resolution (HR-MS) electron impact ionization (EI) and low resolution (MS) 
spectra were recorded on a FINNIGAN MAT 95Q instrument. EI was conducted with an electron energy 
of 70 eV. Electrospray ionization (ESI) spectra were recorded on a FINNIGAN LTQ FTICR instrument.  
GCs were recorded on machines of the types Hewlett-Packard 6890 or 5890 Series II (Hewlett Packard, 
5% phenylmethylpolysiloxane; length: 10 m, diameter: 0.25 mm; film thickness: 0.25 μm).  
Infrared spectra (IR) were recorded from 4500 cm-1 to 650 cm-1 on a PERKIN ELMER Spectrum BX-
59343 instrument. For detection a SMITHS DETECTION DuraSamplIR II Diamond ATR sensor was 
used. The absorption bands are reported in wavenumbers (cm-1). 
Melting points (M.p.) were determined on a BÜCHI B-540 apparatus and are uncorrected. 
                                                     
106 For a titration method of zinc organometallics, see: A. Krasovskiy, P. Knochel, Synthesis 2006, 890; As LiCl 
is already embedded in the organozinc materials, neat THF instead of a 0.5 M solution of LiCl in THF can be 
used as the titration medium 
107 H.-S. Lin, A. Paquette, Synth. Commun. 1994, 24, 2503. 
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2 Preparation of Solid, Substituted Allylic Zinc Reagents and Their 
Reactions with Electrophiles 
2.1 Titration of Organozinc Reagents Using Iodine 
Accurately weighted aliquots (350 mg) of the crude organozinc material were dissolved in dry THF, so 
that the total volume of the solution was 2 mL. To the solution thus formed, was added a standard 
solution of iodine (1 M, in dry THF) until the complete appearance of the dark brown color of iodine. 
Thus, the concentration of the active species (in mmol/g) is determined and thereof the yield of the 
insertion.106 
2.2 Stability Studies of Allylzinc Reagents under Argon 
To evaluate the stability of organozinc reagents under argon, accurately weighed aliquots of the solid 
material were placed in Schlenk-flasks at 25 °C. After an extended period of time under argon at the 
given temperature the solid material was dissolved in THF and the resulting solution was titrated against 
iodine, according to the procedure described above and the measured concentration was compared to 
the one before the storage. The stability of the allylzinc pivalates is presented in Table 9. 
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2.3 Stability of Allylzinc Pivalates after Storage under Argon at Room Temperature 
Table 9: Stability of allylzinc pivalates after storage under argon at room temperature 
 
  
 
 
 83a 83b 83c 83d 
time Percentage of the remaining active allylzinc speciesa 
4 weeks 96 98 100 100 
2 months 95 97 98 100 
  89b   
 
 
    
 83e 83f 83g 83h 
 Percentage of the remaining active allylzinc speciesa 
1 week   90  
4 weeks 89 86 48 70 
2 months 82c 76 25 61 
[a] Determined by titration with a stock solution of iodine; [b] titration after 6 months; [c] titration after 6 weeks. 
 
83a 83b 
  
t½ = 18 months 
 
t½ = 25 months 
 
83c 83d 
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t½ > 2 years 
 
t½ > 2 years 
 
83e 83f 
  
t½ = 17 weeks 
 
t½ = 16 weeks 
 
 
83g 83h 
  
t½ = 33 days t½ = 59 days 
C. EXPERIMENTAL PART   63 
2.4 Stability Tests after Storage under Argon at +5 °C 
Table 10: Stability tests after storage under argon at +5 °C 
 
   
 83f 83g 83h 
time Percentage of the remaining active allylzinc speciesa 
1 week n.d. n.d. n.d. 
2 weeks 100 96 100 
1 month 93 52 74 
[a] Determined by titration with a stock solution of iodine. 
 
83f (+5 °C) 83g (+5 °C) 
  
t½ = 29 weeks t½ = 33 days 
 
83h (+5 °C) 
 
 
  
t½ = 58 days   
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2.5 Stability Tests after Storage under Argon at −24 °C 
Table 11: Stability Tests after Storage under Argon at −24 °C 
 
   
 83f 83g 83h 
time Percentage of the remaining active allylzinc speciesa 
1 week 100 99 100 
2 weeks 100 92 98 
1 month 95 71 91 
[a] Determined by titration with a stock solution of iodine. 
 
83f (–24 °C) 83g (–24 °C) 
  
t½ = 40 weeks t½ = 50 days 
  
83h (–24 °C)  
 
 
t½ = 152 days   
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2.6 NMR-Spectra of Prenylzinc Pivalate Before and After Solvent Evaporation 
 
 
 
 
Scheme 48: NMR-Spectra of prenylzinc pivalate (83b) before and after solvent evaporation. Region 92–150 ppm 
is shown for clarity. [a] Complexed Mg(OPiv)X (X=Cl, Br) and LiCl are omitted for clarity. 
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2.7 Catalyst Evaluation for the Pd-Catalyzed Cross-Coupling 
Table 12: Catalyst Evaluation for the Pd-Catalyzed Cross-Coupling[a] 
 
entry catalyst conversion 
desired 
product 
Ar-Ar 
1 Pd(OAc)2 / SPhos 2 / 4 mol% 6 0 6 
2 Pd(OAc)2 / dppp 2 / 4 mol% 0 0 0 
3 Pd(dba)2 / TFP 2 / 4 mol% 20 18 2 
4 PEPPSI-IPr 2 mol% 15 14 1 
5 PEPPSI-IPent 2 mol% 94 92 (90)[c] 2 
6 Pd(PPh3)4 4 mol% 0 0 0 
[a] (2-Cyanocyclopent-2-en-1-yl)zinc pivalate (83g, 0.5 mmol) and 3-bromothiophene (85h, 0.4 mmol) were used. 
[b] Determined by GC with undecane (C11H24) used as an internal standard. [c] Yield of isolated product. 
2.8 Preparation of Starting Materials 
Compounds 84d,108 84e,109 84f,110 84g,110 84h,111 and 88e112 were prepared according to literature known 
procedures. 
2.9 Preparation of Mg(OPiv)2 
Pivalic acid (20.4 g, 22.6 mL, 200 mmol) was placed in a dry and argon-flushed 500 mL Schlenk-flask, 
equipped with a magnetic stirring bar and a septum, and dissolved in dry THF (100 mL). The solution 
was cooled to 0 °C and dibutylmagnesium (148 mL, 1.49 M in hexane, 220 mmol) was added over a 
period of 30 min under vigorous stirring. Then, the ice-bath was removed and stirring continued at 25 °C 
for 6 additional hours at which point bubbling was ceased (a white precipitation was formed). The 
solvent was removed in vacuo and the solid residue was dried for at least four additional hours. 
Mg(OPiv)2 was received in quantitative yield, as a puffy amorphous white solid.  
                                                     
108 P. E. Peterson, G. Grant, J. Org. Chem. 1991, 56, 16. 
109 Z. Peng, T. D. Blümke, P. Mayer, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 8516. 
110 C. Sämann, P. Knochel, Synthesis 2013, 1870.  
111 J.-B. Langlois, A. Alexakis, Adv. Synth. Catal. 2010, 352, 447. 
112 Y. Y. Novikov, P. Sampson, Org. Lett. 2003, 5, 2263. 
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2.10 Typical Procedures 
Typical Procedure for the Preparation of the Solid Allylzinc Pivalates of Type 83 (TP1): 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Mg(OPiv)2 (2.72 g, 12.0 mmol) and LiCl (466 mg, 11.0 mmol). The mixture was dried with a heat 
gun (330 °C, 10 min) under high vacuum followed by the addition of zinc dust (1.31 g, 20.0 mmol). The 
vessel was evacuated and refilled with argon. THF (10 mL) and 1,2-dibromoethane (215 μL, 
2.50 mmol) were added via syringe and the reaction mixture was heated to 50 °C until bubbling 
occurred. The allylic halide (10.0 mmol) was added as a solution in THF (10 mL) over a period of 
30 min using a syringe pump. The mixture was stirred for the given time at room temperature before the 
zinc powder was allowed to settle down. The supernatant solution was carefully filtrated using a syringe 
filter and the solvent was removed in vacuo to yield the corresponding zinc pivalate of type 1 as a solid. 
The yield for the insertion was determined by iodometric titration. 
Typical Procedure for the Cross-Coupling of the Allylzinc Pivalates of Type 83 with Aryl 
Bromides of Type 85 (TP2): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, the solid 
organozinc reagent (1.0 equiv) was dissolved in dry THF or the previously solved organozinc solution 
was added via syringe. PEPPSI-IPent (2 mol%) and the aryl bromide (0.80 equiv) were added and the 
mixture was stirred for 4 h at 50 °C. Then NH4Cl solution (5 mL, sat. aq.) was added, the aqueous layer 
was extracted with EtOAc (3 × 10 mL), washed with solutions of NaHCO3 (5 mL, sat. aq.), and NaCl 
(5 mL, sat. aq.) and the combined organic phases were dried over MgSO4. Evaporation of the solvents 
in vacuo and purification by column chromatography afforded the expected products. 
Typical Procedure for the Addition of the Allylzinc Pivalates of Type 83 to Aldehydes and 
Methyl Ketones of Type 88 (TP3): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, the solid 
organozinc reagent (1.0 equiv) was dissolved in dry THF or the previously solved organozinc solution 
was added via syringe. The solution was cooled to −78 °C and the carbonyl compound was added was 
added and the mixture was stirred 1 h at −78 °C. Then NH4Cl solution (5 mL, sat. aq.) was added, the 
aqueous layer was extracted with EtOAc (3 × 10 mL), washed with solutions of NaHCO3 (5 mL, sat. 
aq.) and NaCl (5 mL, sat. aq.) and the combined organic phases were dried over MgSO4. Evaporation 
of the solvents in vacuo and purification by column chromatography afforded the expected products. 
Typical Procedure for the Reaction of the Allylzinc Pivalates of Type 83 to Acid Chlorides of 
Type 91 (TP4): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, the solid 
organozinc reagent (1.0 equiv) was dissolved in dry THF or the previously solved organozinc solution 
was added via syringe. The solution was cooled to −78 °C and the acid chloride was added was added 
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and the mixture was stirred 1 h at −78 °C. Then NH4Cl solution (5 mL, sat. aq.) was added, the aqueous 
layer was extracted with EtOAc (3 × 10 mL), washed with solutions of NaHCO3 (5 mL, sat. aq.) and 
NaCl (5 mL, sat. aq.) and the combined organic phases were dried over MgSO4. Evaporation of the 
solvents in vacuo and purification by column chromatography afforded the expected products. 
2.11 Preparation of Allylzinc Pivalates 
Cyclohex-2-en-1-ylzinc pivalate (83a) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol), Mg(OPiv)2 
(2.72 g, 12.0 mmol) and THF (10 mL) was added 3-bromocyclohex-1-ene (1.61 g, 10.0 mmol) in THF 
(10 mL). After 1 h at 25 °C and subsequent filtration and evaporation of the solvent cyclohex-2-en-1-
ylzinc pivalate was obtained as a colorless solid. The content of active zinc species was determined by 
titration with a stock solution of iodine (1.00 M in THF). A concentration of 1.08 mmol/g, which 
corresponds to a yield of 67% was determined. 
 
Prenylzinc pivalate (83b) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol), Mg(OPiv)2 
(2.72 g, 12.0 mmol) and THF (10 mL) was added prenylbromide (1.49 g, 10.0 mmol) in THF (10 mL). 
After 1 h at 25 °C and subsequent filtration and evaporation of the solvent prenylzinc pivalate was 
obtained as a colorless solid. The content of active zinc species was determined by titration with a stock 
solution of iodine (1.00 M in THF). A concentration of 1.01 mmol/g, which corresponds to a yield of 
74% was determined. 
 
Myrtenylzinc pivalate (83c) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol), Mg(OPiv)2 
(2.72 g, 12.0 mmol) and THF (10 mL) was added myrtenylbromide (2.15 g, 10.0 mmol) in THF 
(10 mL). After 1 h at 25 °C and subsequent filtration and evaporation of the solvent myrtenylzinc 
pivalate was obtained as a colorless solid. The content of active zinc species was determined by titration 
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with a stock solution of iodine (1.00 M in THF). A concentration of 0.96 mmol/g, which corresponds to 
a yield of 77% was determined. 
 
Cinnamylzinc pivalate (83d) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol), Mg(OPiv)2 
(2.72 g, 12.0 mmol) and THF (10 mL) was added cinnamylchloride (1.52 g, 10.0 mmol) in THF 
(10 mL). After 1 h at 25 °C and subsequent filtration and evaporation of the solvent cinnamylzinc 
pivalate was obtained as a colorless solid. The content of active zinc species was determined by titration 
with a stock solution of iodine (1.00 M in THF). A concentration of 0.95 mmol/g, which corresponds to 
a yield of 78% was determined. 
 
(2-(Ethoxycarbonyl)cyclopent-2-en-1-yl)zinc pivalate (83e) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol), Mg(OPiv)2 
(2.72 g, 12.0 mmol) and THF (10 mL) was added ethyl 5-chlorocyclopent-1-enecarboxylate (1.75 g, 
10.0 mmol) in THF (10 mL). After 3 h at 25 °C and subsequent filtration and evaporation of the solvent 
(2-(ethoxycarbonyl)cyclopent-2-en-1-yl)zinc pivalate was obtained as a yellow solid. The content of 
active zinc species was determined by titration with a stock solution of iodine (1.00 M in THF). A 
concentration of 0.97 mmol/g, which corresponds to a yield of 51% was determined. 
 
(2-(Ethoxycarbonyl)cyclohex-2-en-1-yl)zinc pivalate (83f) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol), Mg(OPiv)2 
(2.72 g, 12.0 mmol) and THF (10 mL) was added ethyl 6-chlorocyclohex-1-enecarboxylate (1.89 g, 
10.0 mmol) in THF (10 mL). After 3 h at 25 °C and subsequent filtration and evaporation of the solvent 
(2-(ethoxycarbonyl)cyclohex-2-en-1-yl)zinc pivalate was obtained as a yellow solid. The content of 
active zinc species was determined by titration with a stock solution of iodine (1.00 M in THF). A 
concentration of 1.23 mmol/g, which corresponds to a yield of 90% was determined. 
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(2-Cyanocyclopent-2-en-1-yl)zinc pivalate (83g) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol), Mg(OPiv)2 
(2.72 g, 12.0 mmol) and THF (10 mL) was added 5-bromocyclopent-1-enecarbonitrile (1.72 g, 
10.0 mmol) in THF (10 mL). After 3 h at 25 °C and subsequent filtration and evaporation of the solvent 
(2-cyanocyclopent-2-en-1-yl)zinc pivalate was obtained as a dark yellow solid. The content of active 
zinc species was determined by titration with a stock solution of iodine (1.00 M in THF). A concentration 
of 1.04 mmol/g, which corresponds to a yield of 81% was determined. 
 
(2-Cyanocyclohex-2-en-1-yl)zinc pivalate (83h) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol), Mg(OPiv)2 
(2.72 g, 12.0 mmol) and THF (10 mL) was added 6-chlorocyclohex-1-enecarbonitrile (1.41 g, 
10.0 mmol) in THF (10 mL). After 3 h at 25 °C and subsequent filtration and evaporation of the solvent 
(2-cyanocyclohex-2-en-1-yl)zinc pivalate was obtained as a yellow solid. The content of active zinc 
species was determined by titration with a stock solution of iodine (1.00 M in THF). A concentration of 
1.00 mmol/g, which corresponds to a yield of 55% was determined. 
 
2.12 Preparation of Cross-Coupling Products of Type 86 
2,4-Dimethoxy-5-(3-methylbut-2-en-1-yl)pyrimidine (86a) 
 
According to TP2 prenylzinc pivalate in dry THF (0.38 M, 3.12 mL, 1.20 mmol) was added to 5-bromo-
2,4-dimethoxypyrimidine (219 mg, 1.00 mmol) and PEPPSI-IPent (16 mg, 0.02 mmol) in THF (0.5 mL) 
and the mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash chromatography 
(silica gel, isohexane/EtOAc = 10:1) afforded the title compound as a colorless oil (160 mg, 0.77 mmol, 
77%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 6.20 (s, 1H), 5.40–5.30 (m, 1H), 3.97 (s, 3H), 3.94 (s, 3H), 
3.32 (d, J = 7.3 Hz, 2H), 1.76 (s, 3H), 1.68 (s, 3H). 
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13C-NMR (151 MHz, CDCl3): δ / ppm = 172.4, 172.1, 165.4, 135.0, 119.6, 99.3, 54.7, 53.8, 36.4, 25.9, 
18.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3185, 2982, 2955, 2871, 1584, 1559, 1478, 1457, 1376, 1346, 
1282, 1202, 1146, 1097, 1058, 1038, 1007, 9834, 933, 827, 786, 713, 663. 
MS (EI, 70 eV): m/z (%) = 208 (M+, 73), 193 (100), 177 (20), 167 (46), 154 (11), 135 (10), 125 (11), 
106 (8), 93 (9), 82 (8), 72 (10). 
HRMS (EI): m/z calc. for [C11H16N2O2]: 208.1212; found: 208.1196 (M+). 
 
Ethyl 2'-methyl-1,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate (86b) 
 
According to TP2 (2-(ethoxycarbonyl)cyclohex-2-en-1-yl)zinc pivalate in dry THF (0.40 M, 1.25 mL, 
0.50 mmol) was added to 3-bromotoluene (68 mg, 0.40 mmol) and PEPPSI-IPent (8 mg, 0.01 mmol) in 
THF (0.5 mL) and the mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 30:1) afforded the title compound as a colorless oil (77 
mg, 0.32 mmol, 79%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.26–7.21 (m, 1H), 7.18–7.11 (m, 1H), 7.11–7.02 (m, 2H), 
7.00–6.91 (m, 1H), 4.15–4.06 (m, 1H), 4.07–3.90 (m, 2H), 2.42 (s, 3H), 2.38–2.15 (m, 2H), 1.73–1.45 
(m, 3H), 1.05 (t, J = 7.1 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 167.3, 143.2, 141.0, 135.5, 133.1, 130.5, 127.1, 126.0, 125.6, 
60.2, 35.8, 29.2, 26.0, 19.5, 17.6, 14.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2936, 2867, 1712, 1692, 1647, 1603, 1488, 1463, 1446, 1424, 
1390, 1369, 1344, 1288, 1238, 1168, 1146, 1096, 1081, 1059, 1018, 974, 932, 915, 882, 862, 842, 782, 
756, 728, 699. 
MS (EI, 70 eV): m/z (%) = 244 (M+, 50), 198 (100), 183 (75), 170 (42), 155 (25), 141 (33), 128 (35), 
115 (27), 105 (23), 91 (17), 79 (15). 
HRMS (EI): m/z calc. for [C16H20O2]: 244.1463; found: 244.1456 (M+). 
 
3'-(Trifluoromethyl)-1,2,3,4-tetrahydro-1,1'-biphenyl (86c) 
 
According to TP2 cyclohex-2-en-1-ylzinc pivalate in dry THF (0.31 M, 1.60 mL, 0.50 mmol) was added 
to 1-bromo-3-(trifluoromethyl)benzene (90 mg, 0.40 mmol) and PEPPSI-IPent (8 mg, 0.01 mmol) in 
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THF (0.5 mL) and the mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 100:1) afforded the title compound as a colorless oil 
(65 mg, 0.29 mmol, 72%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.50–7.43 (m, 2H), 7.43–7.37 (m, 2H), 6.00–5.89 (m, 1H), 
5.75–5.64 (m, 1H), 3.54–3.40 (m, 1H), 2.19–1.92 (m, 3H), 1.85–1.44 (m, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 147.7, 131.3 (q, J = 1.4 Hz), 130.7 (d, J = 31.9 Hz), 129.4, 
129.3, 128.8, 124.6 (q, J = 3.8 Hz), 124.5 (d, J = 272.3 Hz), 123.0 (q, J = 3.9 Hz), 41.8, 32.7, 25.1, 
21.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3406, 2943, 2876, 1658, 1613, 1491, 1435, 1327, 1230, 1163, 
1118, 1098, 1072, 1001, 960, 891, 800, 760, 696, 678, 654. 
MS (EI, 70 eV): m/z (%) = 226 (M+, 100), 211 (61), 198 (18), 185 (10), 172 (25), 157 (11), 142 (9), 
129 (65), 115 (10). 
HRMS (EI): m/z calc. for [C13H13F3]: 226.0969; found: 266.0955 (M+). 
 
1-Methyl-4-(3-methylbut-2-en-1-yl)benzene (86d) 
 
According to TP2 prenylzinc pivalate in dry THF (0.38 M, 2.60 mL, 1.00 mmol) was added to 2-
bromotoluene (136 mg, 0.80 mmol) and PEPPSI-IPent (16 mg, 0.02 mmol) in THF (0.5 mL) and the 
mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 100:1) afforded the title compound as a colorless oil (90 mg, 0.56 mmol, 70%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.22–7.08 (m, 4H), 5.34–5.22 (m, 1H), 3.34 (d, J = 7.3 Hz, 
2H), 2.33 (s, 3H), 1.81–1.71 (m, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 140.1, 136.3, 132.5, 130.2, 128.7, 126.1, 126.0, 122.7, 32.3, 
25.9, 19.6, 18.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3414, 3066, 2974, 2930, 1716, 1603, 1576, 1491, 1459, 1380, 
1286, 1251, 1220, 1160, 1142, 1075, 1052, 905, 863, 739, 692. 
MS (EI, 70 eV): m/z (%) = 160 (M+, 57), 145 (100), 130 (22), 117 (18), 104 (23), 91 (13), 77 (8). 
HRMS (EI): m/z calc. for [C12H16]: 160.1252; found: 160.1245 (M+). 
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1-Methoxy-3-(3-methylbut-2-en-1-yl)benzene (86e) 
 
According to TP2 prenylzinc pivalate in dry THF (0.38 M, 2.60 mL, 1.00 mmol) was added to 
3-bromoanisol (150 mg, 0.80 mmol) and PEPPSI-IPent (16 mg, 0.02 mmol) in THF (0.5 mL) and the 
mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 80:1) afforded the title compound as a colorless oil (100 mg, 0.57 mmol, 71%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.26–7.14 (m, 1H), 6.84–6.67 (m, 3H), 5.41–5.25 (m, 1H), 
3.80 (s, 3H), 3.38–3.27 (m, 2H), 1.80–1.66 (m, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 159.8, 143.6, 132.8, 129.4, 123.1, 120.9, 114.3, 111.1, 55.3, 
34.5, 25.9, 18.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3055, 3000, 2937, 2834, 1597, 1573, 1475, 1464, 1410, 1290, 
1278, 1231, 1202, 1168, 1091, 1055, 1046, 1029, 992, 908, 872, 851, 799, 771, 693. 
MS (EI, 70 eV): m/z (%) = 176 (M+, 88), 161 (100), 146 (16), 129 (13), 121 (24), 115 (14), 108 (11), 
91 (24), 77 (9). 
HRMS (EI): m/z calc. for [C12H16O]: 176.1201; found: 176.1186 (M+). 
 
(1R,5S)-2-(3-Fluorobenzyl)-6,6-dimethylbicyclo[3.1.1]hept-2-ene (86f) 
 
According to TP2 (−)-myrtenylzinc pivalate in dry THF (0.32 M, 1.88 mL, 0.60 mmol) was added to 
1-bromo-3-fluorobenzene (77 mg, 0.50 mmol) and PEPPSI-IPent (8 mg, 0.01 mmol) in THF (0.5 mL) 
and the mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash chromatography 
(silica gel, isohexane) afforded the title compound as a colorless oil (89 mg, 0.39 mmol, 77%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.2–7.1 (m, 1H), 6.9–6.8 (m, 1H), 6.8–6.7 (m, 2H), 5.2–5.2 
(m, 1H), 3.3–3.1 (m, 2H), 2.3–2.1 (m, 4H), 2.1–2.0 (m, 1H), 1.9 (td, J = 5.6, 1.5 Hz, 1H), 1.1 (s, 3H), 
0.7 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.0 (d, J = 244.9 Hz), 146.8, 142.4 (d, J = 7.1 Hz), 129.5 
(d, J = 8.2 Hz), 124.9 (d, J = 2.7 Hz), 118.4, 116.1 (d, J = 20.9 Hz), 112.9 (d, J = 21.1 Hz), 45.6, 43.4 
(d, J = 1.7 Hz), 40.8, 38.0, 32.0, 31.5, 26.3, 21.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2984, 2916, 2833, 1615, 1588, 1487, 1469, 1446, 1382, 1366, 
1266, 1250, 1221, 1204, 1135, 1074, 982, 949, 930, 886, 872, 806, 774, 744, 711, 701, 680. 
MS (EI, 70 eV): m/z (%) = 230 (M+, 12), 215 (5), 186 (61), 173 (7), 159 (10), 147 (10), 133 (9), 121 
(15), 109 (100), 91 (27), 79 (12), 65 (3). 
HRMS (EI): m/z calc. for [C16H19F]: 230.1471; found: 230.1461 (M+). 
74   
3-Cinnamylpyridine (86g) 
 
According to TP2 cinnamylzinc pivalate in dry THF (0.57 M, 0.88 mL, 0.50 mmol) was added to 
3-bromopyridine (69 mg, 0.40 mmol) and PEPPSI-IPent (8 mg, 0.01 mmol) in THF (0.5 mL) and the 
mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 20:1) afforded the title compound as a colorless oil (56 mg, 0.29 mmol, 72%). 
1H-NMR (400 MHz, benzene-d6): δ / ppm = 8.6–8.5 (m, 1H), 8.5–8.4 (m, 1H), 7.2–7.1 (m, 4H), 7.1–
6.9 (m, 2H), 6.8–6.6 (m, 1H), 6.3–6.1 (m, 1H), 6.0–5.9 (m, 1H), 3.1–3.0 (m, 2H). 
13C-NMR (101 MHz, benzene-d6): δ / ppm = 150.8, 148.3, 137.6, 135.6, 135.5, 132.2, 128.8, 128.1, 
127.6, 126.6, 123.3, 36.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3028, 2958, 2924, 1679, 1596, 1578, 1557, 1495, 1479, 1449, 
1424, 1372, 1272, 1190, 1125, 1103, 1076, 1045, 1027, 1002, 967, 920, 745, 693. 
MS (EI, 70 eV): m/z (%) = 195 (100, M+), 180 (17), 167 (14), 139 (6), 115 (17), 91 (12), 77 (6). 
HRMS (EI): m/z calc. for [C14H13N]: 195.2597; found: 195.1034 (M+). 
 
Ethyl 5-(Benzo[b]thiophen-3-yl)cyclopent-1-enecarboxylate (86h) 
 
According to TP2 (2-(ethoxycarbonyl)cyclopent-2-en-1-yl)zinc pivalate in dry THF (0.20 M, 3.00 mL, 
0.60 mmol) was added to 3-bromobenzo[b]thiophene (107 mg, 0.50 mmol) and PEPPSI-IPent (8 mg, 
0.01 mmol) in THF (0.5 mL) and the mixture was stirred for 4 h at 50 °C. Purification of the crude 
product by flash chromatography (silica gel, isohexane/EtOAc = 20:1) afforded the title compound as a 
colorless oil (80 mg, 0.38 mmol, 75%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.92–7.75 (m, 2H), 7.45–7.30 (m, 2H), 7.12–7.03 (m, 1H), 
6.94 (s, 1H), 4.63–4.50 (m, 1H), 4.17–4.02 (m, 2H), 2.76–2.43 (m, 3H), 2.11–1.95 (m, 1H), 1.11 (t, J = 
7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.9, 145.3, 141.0, 139.2, 138.7, 138.6, 124.3, 123.9, 123.0, 
122.1, 120.6, 60.3, 43.6, 32.4, 32.1, 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3064, 2978, 2937, 2902, 1712, 1630, 1459, 1428, 1391, 1369, 
1339, 1299, 1277, 1257, 1244, 1229, 1193, 1178, 1158, 1144, 1096, 1079, 1048, 1031, 1020, 946, 926, 
883, 860, 763, 733, 716, 693. 
MS (EI, 70 eV): m/z (%) = 272 (42, M+), 243 (24), 225 (42), 198 (91), 183 (61), 171 (100), 158 (30), 
147 (27), 134 (61), 115 (42), 102 (12), 89 (18). 
HRMS (EI): m/z calc. for [C16H16O2S]: 272.0871; found: 272.0864 (M+). 
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5-(Thiophen-3-yl)cyclopent-1-enecarbonitrile (86i) 
 
According to TP2 (2-cyanocyclopent-2-en-1-yl)zinc pivalate in dry THF (0.30 M, 1.67 mL, 0.50 mmol) 
was added to 3-bromothiophene (65 mg, 0.40 mmol) and PEPPSI-IPent (8 mg, 0.01 mmol) in THF 
(0.5 mL) and the mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 20:1) afforded the title compound as a colorless oil 
(63 mg, 0.36 mmol, 90%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.32 (ddd, J = 5.0, 2.9, 0.4 Hz, 1H), 7.08 (ddd, J = 3.0, 1.4, 
0.7 Hz, 1H), 6.96 (ddd, J = 5.0, 1.3, 0.3 Hz, 1H), 6.82–6.77 (m, 1H), 4.27–4.12 (m, 1H), 2.80–2.57 (m, 
2H), 2.57–2.40 (m, 1H), 2.07–1.90 (m, 1H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 149.4, 142.4, 126.7, 126.5, 121.1, 118.8, 116.4, 47.8, 33.0, 
32.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3400, 3103, 2945, 2842, 2218, 1714, 1611, 1514, 1454, 1432, 
1416, 1389, 1365, 1321, 1288, 1234, 1200, 1166, 1134, 1082, 1033, 967, 944, 924, 873, 842, 831, 779, 
726, 663. 
MS (EI, 70 eV): m/z (%) = 175 (M+, 100), 160 (35), 147 (29), 135 (11), 115 (12), 97 (6), 84 (29). 
HRMS (EI): m/z calc. for [C10H9NS]: 175.0456; found: 175.0449 (M+). 
 
Ethyl 6'-Cyano-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-4-carboxylate (86j) 
 
According to TP2 (2-cyanocyclohex-2-en-1-yl)zinc pivalate in dry THF (0.20 M, 3.00 mL, 0.60 mmol) 
was added to ethyl 4-bromobenzoate (108 mg, 0.50 mmol) and PEPPSI-IPent (8 mg, 0.01 mmol) in 
THF (0.5 mL) and the mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 10:1) afforded the title compound as a colorless oil 
(112 mg, 0.44 mmol, 88%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.06–7.95 (m, 2H), 7.31–7.19 (m, 2H), 6.88 (td, J = 4.0, 1.8 
Hz, 1H), 4.35 (q, J = 7.1 Hz, 2H), 3.67–3.52 (m, 1H), 2.37–2.20 (m, 2H), 2.14–1.94 (m, 1H), 1.80–1.47 
(m, 3H), 1.36 (t, J = 7.1 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 166.3, 147.3, 147.1, 130.0, 129.5, 127.8, 118.7, 114.9, 60.9, 
42.6, 31.3, 25.9, 18.4, 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2940, 2871, 2828, 2216, 1712, 1632, 1610, 1575, 1507, 1447, 
1417, 1391, 1366, 1310, 1273, 1180, 1149, 1102, 1080, 1020, 970, 932, 906, 875, 851, 806, 770, 707. 
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MS (EI, 70 eV): m/z (%) = 255 (21, M+), 227 (7), 210 (100), 182 (53), 167 (17), 154 (43), 140 (24), 127 
(39), 115 (29), 105 (14), 91 (11), 77 (21). 
HRMS (EI): m/z calc. for [C16H17NO2]: 255.1259; found: 255.1247 (M+). 
 
(E)-(5-Methylhexa-1,4-dien-1-yl)benzene (86k) 
 
According to TP2 prenylzinc pivalate in dry THF (0.34 M, 1.76 mL, 0.60 mmol) was added to 
(E)-β-bromostyrene (91.5 mg, 0.50 mmol) and PEPPSI-IPent (8 mg, 0.01 mmol) in THF (0.5 mL) and 
the mixture was stirred for 4 h at 50 °C. Purification of the crude product by flash chromatography (silica 
gel, isohexane) afforded the title compound as a colorless oil (70 mg, 0.41 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.32–7.26 (m, 2H), 7.28–7.15 (m, 2H), 7.19–7.07 (m, 1H), 
6.32 (dt, J = 15.7, 1.7 Hz, 1H), 6.13 (dt, J = 15.8, 6.5 Hz, 1H), 5.21–5.12 (m, 1H), 2.88–2.80 (m, 2H), 
1.69 (s, 3H), 1.61 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 138.0, 133.2, 129.7, 129.7, 128.6, 126.9, 126.1, 121.7, 31.8, 
25.9, 17.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3082, 3060, 3026, 2968, 2913, 2855, 1672, 1650, 1599, 1578, 
1495, 1448, 1376, 1306, 1262, 1206, 1156, 1104, 1074, 1029, 981, 962, 927, 908, 828, 766, 738, 729, 
690. 
MS (EI, 70 eV): m/z (%) = 172 (46, M+), 156 (38), 142 (23), 129 (100), 115 (30), 91 (31), 77 (9). 
HRMS (EI): m/z calc. for [C13H16]: 172.1252; found: 172.1260 (M+). 
2.13 Diastereoselective Preparation of Homoallylic Alcohols of Type 89 
(S*)-1-(4-Fluorophenyl)-1-((R*)-cyclohex-2-en-1-yl)ethanol (89a) 
 
According to TP3 cyclohex-2-en-1-ylzinc pivalate (4.29 mL, 0.28 M, 1.20 mmol) was added to a 
solution of 1-(4-fluorophenyl)ethanone (247 mg, 1.60 mmol) at −78 °C and the mixture was stirred 1 h 
at −78 °C. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 
20:1) afforded the title compound as a colorless oil (196 mg, 0.89 mmol, 89%, d.r. > 99:1). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.46–7.32 (m, 2H), 7.09–6.94 (m, 2H), 5.99–5.85 (m, 1H), 
5.82–5.70 (m, 1H), 2.58–2.44 (m, 1H), 2.00–1.89 (m, 2H), 1.79–1.65 (m, 2H), 1.58 (s, 3H), 1.52–1.33 
(m, 2H), 1.33–1.16 (m, 1H). 
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13C-NMR (75 MHz, CDCl3): δ / ppm = 161.7 (d, J = 244.6 Hz), 143.0 (d, J = 3.0 Hz), 132.0, 127.0 (d, 
J = 7.8 Hz), 126.3, 114.7 (d, J = 21.1 Hz), 75.9, 46.8, 28.2, 25.3, 24.5, 22.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3406, 3027, 2933, 2863, 1660, 1601, 1508, 1450, 1408, 1373, 
1345, 1306, 1222, 1160, 1112, 1081, 1014, 965, 942, 924, 906, 892, 880, 836, 821, 794, 753, 735, 727, 
716. 
MS (EI, 70 eV): m/z (%) = 202 (1), 159 (2), 146 (2), 139 (100), 123 (14), 109 (3), 95 (7), 79 (5). 
HRMS (EI): m/z calc. for [C14H15F]: 202.1158; found: 202.1132 ([M−H2O]+). 
 
(R*)-1-((R*)-cyclohex-2-en-1-yl)-1-cyclopropylethanol (89b) 
 
According to TP3 cyclohex-2-en-1-ylzinc pivalate (5.30 mL, 0.23 M, 1.20 mmol) was added to a 
solution of cyclopropyl methyl ketone (84 mg, 1.00 mmol) at −78 °C and the mixture was stirred 1.5 h 
at −78 °C. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 
5:1) afforded the title compound as a colorless oil (95 mg, 0.57 mmol, 92%, d.r. = 94:6). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.90–5.77 (m, 2H), 2.36–2.26 (m, 1H), 2.05–1.94 (m, 2H), 
1.94–1.76 (m, 2H), 1.55–1.37 (m, 2H), 1.10 (s, 1H), 1.02 (s, 3H), 1.01–0.90 (m, 1H), 0.47–0.25 (m, 
4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 129.5, 127.9, 73.3, 47.5, 25.4, 24.5, 23.3, 22.4, 19.3, 1.7, 0.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3448, 3083, 3027, 2971, 2929, 1700, 1684, 1653, 1559, 1576, 
1522, 1507, 1456, 1448, 1435,1371, 1308, 1272, 1254, 1201, 1178, 1141, 1106, 1078, 1050, 1035, 1020, 
998, 929, 910, 876, 827, 809, 789, 721, 672, 650. 
MS (EI, 70 eV): m/z (%) = 166 (M+, 1), 148 (45), 133 (45), 119 (40), 105 (100), 91 (100), 79 (80). 
HRMS (EI): m/z calc. for [C11H17]: 149.1330; found: 149.2278 ([M−H2O]+). 
 
(R)-((1R,3R,5R)-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-yl)(furan-2-yl)methanol (89c) 
 
According to TP3 (−)-myrtenylzinc pivalate (3.76 mL, 0.32 M, 1.20 mmol) was added to a solution of 
cyclopropyl methyl ketone (96 mg, 1.00 mmol) at −78 °C and the mixture was stirred 1 h at −78 °C. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 10:1) afforded 
the title compound as a colorless oil (206 mg, 0.89 mmol, 89%, d.r. > 99:1). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.4 (dd, J = 1.9, 0.9 Hz, 1H), 6.3 (dd, J = 3.3, 1.8 Hz, 1H), 
6.3–6.3 (m, 1H), 4.9 (dt, J = 7.9, 1.7 Hz, 2H), 4.5 (dd, J = 9.4, 2.4 Hz, 1H), 3.0–2.9 (m, 1H), 2.9 (d, J 
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= 2.6 Hz, 1H), 2.5 (t, J = 5.4 Hz, 1H), 2.3–2.2 (m, 1H), 2.0–1.9 (m, 2H), 1.6–1.5 (m, 1H), 1.3 (s, 3H), 
1.2 (d, J = 10.3 Hz, 1H), 0.8 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 155.0, 151.7, 142.2, 111.8, 110.3, 108.1, 72.3, 52.5, 41.4, 
40.6, 40.3, 27.5, 26.7, 25.9, 21.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3417, 2978, 2918, 2869, 1695, 1635, 1504, 1456, 1383, 1368, 
1316, 1262, 1224, 1211, 1186, 1149, 1107, 1076, 1052, 1029, 1009, 956, 941, 930, 920, 884, 841, 807, 
731, 702, 689, 656. 
MS (EI, 70 eV): m/z (%) = 232 (M+, 1), 214 (8), 199 (6), 189 (3), 171 (14), 136 (19), 121 (15), 105 (8), 
97 (100), 93 (66), 77 (16). 
HRMS (EI): m/z calc. for [C15H20O2]: 232.1463; found: 232.1467 (M+). 
 
(1R*,2R*)-1-(3-Bromophenyl)-2-phenylbut-3-en-1-ol (89d) 
 
According to TP3 cinnamylzinc pivalate (1.01 g, 0.95 mmol/g, 0.96 mmol) was solved in 3 mL THF. 
3-Bromobenzaldehyde (142 mg, 0.77 mmol) was added at −78 °C and the mixture was stirred 1 h at 
−78 °C. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 10:1) 
afforded the title compound as a colorless oil (201 mg, 0.663 mmol, 86%, d.r. > 99:1). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.48–7.10 (m, 5H), 7.10–6.92 (m, 4H), 6.31–6.12 (m, 1H), 
5.41–5.14 (m, 2H), 4.79 (d, J = 7.6 Hz, 1H), 3.53–3.42 (m, 1H), 2.33 (s, 1H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 144.1, 140.1, 137.2, 130.4, 129.6, 129.3, 128.5, 128.2, 126.8, 
125.4, 122.1, 118.9, 76.5, 59.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3537, 3415, 3062, 3029, 2899, 1684, 1638, 1596, 1570, 1493, 
1475, 1453, 1428, 1287, 1184, 1094, 1070, 1032, 996, 920, 849, 783, 757, 728, 696, 674. 
MS (EI, 70 eV): m/z (%) = 183 (67), 155 (30), 131 (3), 117 (100), 103 (10), 91 (27), 77 (28), 63 (13), 
51 (28). 
HRMS (EI): m/z calc. for [C16H13Br]: 284.0201; found: 284.0178 ([M−H2O]+). 
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Trimethyl(((1R*,2S*)-2-((R*)-1-phenylallyl)cyclohexyl)oxy)silane (89e) 
 
 
(See the complete X-ray data at the end of the section) 
According to TP3 cinnamylzinc pivalate (3.00 mL, 0.16 M, 0.48 mmol) was added to a solution of 
2-((trimethylsilyl)oxy)cyclohexanone (83 mg, 0.40 mmol) at −78 °C and the mixture was stirred 1 h at 
−78 °C. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 100:1) 
afforded the title compound as a colorless oil (92 mg, 0.32 mmol, 80%, d.r. = 95:5). 
M.p. (°C): 45.7–74.2. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.34–7.14 (m, 5H), 6.47–6.25 (m, 1H), 5.20–4.95 (m, 2H), 
3.77–3.56 (m, 1H), 3.56–3.42 (m, 1H), 2.35 (s, 1H), 1.79–1.43 (m, 6H), 1.36–1.25 (m, 1H), 1.17–1.03 
(m, 1H), 0.14 (s, 9H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 141.1, 138.2, 129.6, 128.0, 126.4, 116.6, 74.9, 72.7, 55.9, 30.6, 
30.6, 22.2, 21.1, 0.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3565, 3426, 3078, 3029, 2948, 2930, 2861, 1630, 1493, 1452, 
1446, 1401, 1359, 1346, 1321, 1253, 1150, 1088, 1046, 1032, 1008, 975, 967, 953, 910, 893, 840, 740, 
705. 
MS (EI, 70 eV): m/z (%) = 187 (29), 171 (100), 155 (2), 141 (7), 129 (15), 117 (34), 103 (8), 91 (15), 
73 (31). 
HRMS (EI): m/z calc. for [C15H18O]: 214.1358; found: 214.1358 ([M−TMSH]+). 
 
(R*)-Ethyl 5-((S*)-(3-Bromophenyl)(hydroxy)methyl)cyclopent-1-enecarboxylate (89f) 
 
According to TP3 (2-(ethoxycarbonyl)cyclopent-2-en-1-yl)zinc pivalate (5.22 mL, 0.23 M, 1.20 mmol) 
was added to a solution of 3-bromobenzaldehyde (185 mg, 1.00 mmol) at −78 °C and the mixture was 
stirred 1 h at −78 °C. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 5:1) afforded the title compound as a colorless oil (294 mg, 0.91 mmol, 91%, d.r. = 
97:3). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.5–7.5 (m, 1H), 7.4–7.3 (m, 1H), 7.3–7.2 (m, 1H), 7.2–7.1 
(m, 1H), 6.9–6.9 (m, 1H), 5.1 (d, J = 3.3 Hz, 1H), 4.3–4.2 (m, 2H), 3.5–3.3 (m, 1H), 3.1 (s, 1H), 2.4–
2.2 (m, 2H), 2.0–1.8 (m, 2H), 1.3 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.2, 148.1, 145.5, 136.0, 130.2, 129.7, 129.3, 124.8, 122.4, 
73.9, 60.9, 52.0, 32.2, 24.8, 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3458, 2979, 2939, 2906, 1690, 1628, 1595, 1569, 1473, 1452, 
1447, 1426, 1394, 1372, 1343, 1295, 1253, 1195, 1097, 1069, 1043, 1011, 980, 946, 897, 842, 785, 743, 
697, 674. 
MS (EI, 70 eV): m/z (%) = 281 (1), 261 (1), 185 (8), 171 (3), 157 (7), 140 (100), 112 (35), 94 (17), 77 
(26), 67 (28). 
HRMS (EI): m/z calc. for [C15H1781BrO3]: 326.0341; found: 326.0508 (M+). 
 
(3R*,3aS*)-3-Methyl-3-ferrocene-3a,4,5,6-tetrahydroisobenzofuran-1(3H)-one (89g) 
 
 
(See the complete X-ray data at the end of the section) 
According to TP3 ((2-(ethoxycarbonyl)cyclohex-2-en-1-yl)zinc pivalate (3.00 mL, 0.40 M, 1.20 mmol) 
was added to a solution of acetylferrocene (228 mg, 1.00 mmol) at −78 °C and the mixture was stirred 
1 h at −78 °C before it was slowly warmed to room temperature overnight. Purification of the crude 
product by flash chromatography (silica gel, isohexane/EtOAc = 10:1) afforded the title compound as a 
yellow solid (310 mg, 0.92 mmol, 92%, d.r. > 99:1). 
M.p. (°C): 171–173. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 6.9–6.7 (m, 1H), 4.2 (s, 5H), 4.2–4.1 (m, 2H), 4.0–3.9 (m, 1H), 
3.8–3.7 (m, 1H), 2.9–2.7 (m, 1H), 2.3–2.1 (m, 1H), 2.1–1.9 (m, 1H), 1.9 (s, 3H), 1.8–1.5 (m, 3H), 1.5–
1.3 (m, 1H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 170.4, 136.5, 130.8, 91.0, 86.6, 69.2, 68.3, 67.9, 67.2, 64.7, 
48.2, 26.8, 25.1, 23.8, 20.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 1749, 1680, 1376, 1254, 1242, 1201, 1154, 1112, 1105, 1025, 
998, 946, 932, 919, 899, 871, 862, 850, 830, 812, 791, 738, 715, 679. 
MS (EI, 70 eV): m/z (%) = 281 (1), 261 (1), 185 (8), 171 (3), 157 (7), 140 (100), 112 (35), 94 (17), 77 
(26), 67 (28). 
HRMS (EI): m/z calc. for [C19H20FeO2]: 336.0813; found: 336.0787 (M+). 
C. EXPERIMENTAL PART   81 
(S*)-5-((R*)-furan-2-yl(hydroxy)methyl)cyclopent-1-enecarbonitrile (89h) 
 
According to TP3 (2-cyanocyclopent-2-en-1-yl)zinc pivalate (2.70 mL, 0.37 M, 1.00 mmol) was added 
to a solution of furan-2-carbaldehyde (77 mg, 0.80 mmol) at −78 °C and the mixture was stirred 1 h at 
−78 °C. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 5:1) 
afforded the title compound as a colorless oil (138 mg, 0.73 mmol, 91%, d.r. > 99:1). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.5–7.4 (m, 1H), 6.8–6.7 (m, 1H), 6.4 (dd, J = 3.2, 1.8 Hz, 
1H), 6.3 (d, J = 3.3 Hz, 1H), 4.9 (d, J = 4.4 Hz, 1H), 3.5–3.3 (m, 1H), 2.6–2.4 (m, 2H), 2.2–2.0 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 154.6, 151.9, 142.4, 116.1, 115.5, 110.5, 107.4, 68.2, 52.1, 
33.1, 24.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3436, 2949, 2220, 1732, 1691, 1616, 1504, 1454, 1432, 1375, 
1324, 1224, 1149, 1072, 1006, 983, 951, 928, 916, 884, 815, 739. 
MS (EI, 70 eV): m/z (%) = 189 (1), 115 (1), 97 (100), 81 (1), 69 (5), 51 (2). 
HRMS (EI): m/z calc. for [C11H11NO2]: 189.0790; found: 189.0800 (M+). 
 
2.14 Regioselective Preparation of β,γ-Unsaturated Ketones of Type 91 
(4-Chlorophenyl)(cyclohex-2-en-1-yl)methanone (91a) 
 
According to TP4 cyclohex-2-en-1-ylzinc pivalate (3.45 mL, 0.29 M, 1.00 mmol) was added to a 
solution of 4-chlorobenzoyl chloride (350 mg, 1.50 mmol) at −78 °C and the mixture was stirred 1.5 h 
at −78 °C. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 
100:1) afforded the title compound as a colorless oil (172 mg, 0.78 mmol, 78%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.96–7.84 (m, 13H), 7.48–7.39 (m, 12H), 5.99–5.87 (m, 7H), 
5.76–5.66 (m, 7H), 4.09–3.95 (m, 7H), 2.15–2.03 (m, 13H), 2.02–1.76 (m, 22H), 1.76–1.61 (m, 8H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 200.7, 139.4, 134.7, 130.6, 130.1, 129.1, 124.5, 44.1, 25.9, 
24.9, 21.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3404, 3029, 2937, 2864, 2837, 1680, 1650, 1587, 1570, 1487, 
1449, 1431, 1399, 1348, 1302, 1265, 1248, 1230, 1210, 1175, 1158, 1106, 1090, 1012, 961, 927, 890, 
837, 798, 761, 740, 677. 
MS (EI, 70 eV): m/z (%) = 220 (M+, 17), 185 (3), 141 (100), 111 (82), 75 (34), 50 (11). 
HRMS (EI): m/z calc. for [C13H14ClO+]: 221.0728; found: 221.0731 ([M+H]+). 
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1-(4-Chlorophenyl)-2,2-dimethylbut-3-en-1-one (91b) 
 
According to TP4 prenylzinc pivalate (3.80 mL, 0.32 M, 1.20 mmol) was added to a solution of 4-
chlorobenzoyl chloride (175 mg, 1.00 mmol) at −78 °C and the mixture was stirred 1 h at −78 °C. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 100:1) 
afforded the title compound as a colorless oil (194 mg, 0.93 mmol, 93%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.88–7.80 (m, 2H), 7.38–7.31 (m, 2H), 6.23–6.10 (m, 1H), 
5.24 (d, J = 6.8 Hz, 1H), 5.20 (s, 1H), 1.38 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 203.3, 143.8, 138.2, 135.3, 131.0, 128.4, 114.5, 50.3, 26.1. 
IR (Diamond-ATR, neat): / cm-1 = 3539 (vw), 3084 (w), 2975 (m), 2932 (w), 2874 (vw), 1677 
(vs), 1633 (m), 1587 (s), 1569 (m), 1486 (m), 1466 (m), 1443 (w), 1412 (m), 1399 (m), 1379 (m), 
1363 (m), 1303 (w), 1255 (s), 1220 (m), 1170 (m), 1153 (m), 1090 (vs), 1044 (w), 1012 (s), 970 
(vs), 918 (vs), 886 (w), 840 (vs), 759 (vs), 741 (w), 733 (m), 665 (m). 
MS (EI, 70 eV): m/z (%) = 175 (95), 127 (15), 105 (100), 91 (7), 77 (42), 69 (93), 51 (14). 
HRMS (EI): m/z calc. for [C12H13ClO]: 208.0655; found: 208.0629 (M+). 
 
1-(4-Methoxyphenyl)-4-methylpent-3-en-1-one (91c) 
 
According to TP4 prenylzinc pivalate (0.28 M, 4.29 mL, 1.20 mmol) was added to a solution of 4-
methoxybenzoyl chloride (171 mg, 0.13 mL, 1.00 mmol) at −78 °C and the mixture was stirred 1 h at 
−78 °C before it was slowly warmed to room temperature overnight. Purification of the crude product 
by flash chromatography (silica gel, isohexane/EtOAc = 40:1) afforded the title compound as a colorless 
oil (233 mg, 1.14 mmol, 95%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.987.93 (m, 2H), 6.886.83 (m, 2H), 6.246.15 (m, 1H), 
5.245.16 (m, 2H), 3.83 (s, 3H), 1.39 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 202.5, 162.5, 144.6, 132.1, 129.3, 113.7, 113.2, 55.5, 50.0, 
26.4. 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 3082, 2972, 2934, 2840, 2360, 2340, 2047, 1668, 1633, 1598, 
1573, 1508, 1462, 1442, 1417, 1380, 1362, 1307, 1247, 1166, 1150, 1113, 1030, 1012, 996, 971, 917, 
839, 820, 787, 767, 736, 702, 670. 
MS (EI, 70 eV): m/z (%) = 135 (100), 107 (7), 92 (9), 77 (9). 
HRMS (ESI): m/z calc. for [C13H17O2]: 205.1229; found: 205.1213 ([M+H]+). 
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Ethyl 5-(3-Bromobenzoyl)cyclopent-1-enecarboxylate (91d) 
 
According to TP4 (2-(ethoxycarbonyl)cyclopent-2-en-1-yl)zinc pivalate (5.00 mL, 0.30 M, 1.5 mmol) 
was added to a solution of 3-bromobenzoyl chloride (296 mg, 1.30 mmol) at −78 °C and the mixture 
was stirred 1 h at −78 °C before it was slowly warmed to room temperature overnight. Purification of 
the crude product by flash chromatography (silica gel, isohexane/EtOAc = 15:1) afforded the title 
compound as a colorless oil (297 mg, 0.92 mmol, 68%). 
1H-NMR (599 MHz, CDCl3): δ / ppm = 8.13 (s, 1H), 7.93 (d, J = 8.1, 1.4 Hz, 1H), 7.73–7.67 (m, 1H), 
7.39–7.33 (m, 1H), 7.06–7.00 (m, 1H), 4.78–4.67 (m, 1H), 4.19–4.06 (m, 2H), 2.76–2.66 (m, 1H), 2.65–
2.56 (m, 1H), 2.49–2.40 (m, 1H), 2.08–1.99 (m, 1H), 1.18 (t, J = 7.1 Hz, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 199.9, 164.1, 146.3, 138.3, 135.8, 131.6, 130.1, 127.1, 122.9, 
60.4, 51.4, 32.8, 29.13, 14.1. 
IR (Diamond-ATR, neat): / cm-1 = 2982, 2936, 1721, 1687, 1638, 1566, 1467, 1446, 1421, 1372, 1296, 
1280, 1262, 1208, 1174, 1145, 1100, 1070, 1025, 998, 956, 862, 799, 754, 732, 706, 698, 673. 
MS (EI, 70 eV): m/z (%) = 322 (1), 278 (30), 183 (100), 155 (21), 139 (2), 93 (4), 76 (10). 
HRMS (EI): m/z calc. for [C13H10BrO2+]: 276.9864; found: 276.9853 ([M−OEt]+). 
 
Ethyl 5-(4-(tert-Butyl)benzoyl)cyclopent-1-ene-1-carboxylate (91e) 
 
According to TP4 (2-cyanocyclohex-2-enyl)zinc pivalate (0.21 M, 4.76 mL, 1.00 mmol) was added to a 
solution of 4-(tert-butyl)benzoyl chloride (295 mg, 0.29 mL, 1.50 mmol) at −78 °C and the mixture was 
stirred 1 h at −78 °C before it was slowly warmed to room temperature overnight. Purification of the 
crude product by flash chromatography (silica gel, isohexane/EtOAc = 40:1) afforded the title 
compound as a colorless oil (225 mg, 0.75 mmol, 75%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.987.93 (m, 2H), 7.51-7.46 (m, 2H), 7.03-7.00 (m, 1H), 
4.824.74 (m, 1H), 4.12 (q, J = 7.1 Hz, 2H), 2.74(m, 2H), 2.121.98 (m, 2H), 1.35 (s, 9H), 
1.17 (t, J = 7.1 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 200.9, 164.5, 156.9, 146.1, 136.4, 134.0, 128.8, 125.6, 60.4, 
51.5, 35.2, 32.9, 31.2, 29.5, 14.2. 
IR (Diamond-ATR, neat): ?̃? / cm-1 = 2963 (m), 2871 (w), 1712 (vs), 1679 (vs), 1635 (w), 1604 (m), 
1566 (w), 1463 (m), 1408 (m), 1394 (w), 1369 (m), 1331 (m), 1269 (vs), 1222 (vs), 1188 (s), 1144 (m), 
1096 (vs), 1031 (s), 996 (s), 951 (w), 923 (m), 878 (m), 849 (s), 829 (m), 761 (m), 732 (s), 702 (m). 
MS (EI, 70 eV): m/z (%) = 300 (M+, 1), 161 (100), 118 (8), 91 (6). 
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HRMS (EI): m/z calc. for [C19H24O3]: 300.1725; found: 300.1720 (M+). 
 
6-(Thiophene-2-carbonyl)cyclohex-1-enecarbonitrile (91f) 
 
According to TP4 (2-Cyanocyclohex-2-enyl)zinc pivalate (4.50 mL, 0.22 M, 1.00 mmol) was added to 
a solution of thiophene-2-carbonyl chloride (132 mg, 0.90 mmol) at −78 °C and the mixture was stirred 
1 h at −78 °C before it was slowly warmed to room temperature overnight. Purification of the crude 
product by flash chromatography (silica gel, isohexane/EtOAc = 5:1) afforded the title compound as a 
colorless solid (150 mg, 0.69 mmol, 77%). 
M.p. (°C): 78.5–79.3. 
1H-NMR (599 MHz, CDCl3): δ / ppm = 7.78 (dd, J = 3.8, 1.0 Hz, 1H), 7.71 (dd, J = 4.9, 1.1 Hz, 
1H), 7.17 (dd, J = 4.9, 3.9 Hz, 1H), 6.93 (td, J = 4.1, 1.5 Hz, 1H), 4.20–4.06 (m, 1H), 2.38–2.18 (m, 
2H), 2.14–1.94 (m, 2H), 1.84–1.64 (m, 2H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 191.3, 148.8, 142.6, 134.9, 132.8, 128.5, 118.7, 110.9, 
45.7, 26.8, 25.7, 18.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3113, 3092, 2934, 2862, 2215, 1645, 1518, 1449, 1412, 1353, 
1336, 1317, 1288, 1248, 1213, 1151, 1127, 1078, 1046, 995, 952, 941, 926, 888, 858, 828, 794, 762, 
736, 665. 
MS (EI, 70 eV): m/z (%) = 217 (5), 111 (100), 83 (10). 
HRMS (EI): m/z calc. for [C12H11ONS]: 217.0561; found: 217.0568 (M+). 
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2.15 Crystallographic Data 
Trimethyl(((1R,2S)-2-((R)-1-phenylallyl)cyclohexyl)oxy)silane (89e) 
CCDC 1061748 contains the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 7: ORTEP representation of 89e with the thermal ellipsoids set at 30% probability level. 
Crystal data: 
Chemical formula C18H29O2Si 
Mr 304.49 
Crystal system, space group Triclinic, P1 
Temperature (K) 173 
a, b, c (Å) 9.4526 (5), 9.9546 (6), 10.1993 (6) 
α, β, γ (°) 109.366 (5), 93.388 (5), 104.106 (5) 
V (Å3) 867.79 (9) 
Z 2 
Radiation type Mo Kα 
µ (mm−1) 0.14 
Crystal size (mm) 0.42 × 0.27 × 0.17 
Data collection 
Absorption correction Multi-scan  
Tmin, Tmax 0.984, 0.992 
No. of measured, independent and 
observed [I > 2σ(I)] reflections 
4566, 3130, 2645 
Rint 0.025 
(sin θ/λ)max (Å−1) 0.602 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.056, 0.159, 1.08 
No. of reflections 3130 
No. of parameters 194 
H-atom treatment H atoms treated by a mixture of independent and constrained refinement 
Δρmax, Δρmin (e Å−3) 1.14, −0.44 
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(3R*,3aS*)-3-Methyl-3-ferrocene-3a,4,5,6-tetrahydroisobenzofuran-1(3H)-one (89g) 
CCDC 1061747 contains the supplementary crystallographic data for this compound. The data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Figure 8: ORTEP representation of 89g with the thermal ellipsoids set at 30% probability level. 
 
Crystal data: 
Chemical formula C19H20FeO2 
Mr 336.20 
Crystal system, space group Monoclinic, P21/n 
Temperature (K) 173 
a, b, c (Å) 6.0951 (2), 13.0246 (5), 19.2405 (7) 
β (°) 93.758 (1) 
V (Å3) 1524.15 (9) 
Z 4 
Radiation type Mo Kα 
µ (mm−1) 0.99 
Crystal size (mm) 0.12 × 0.08 × 0.06 
Data collection 
Absorption correction Multi-scan 
Tmin, Tmax 0.890, 0.943 
No. of measured, independent and 
observed [I > 2σ(I)] reflections 
26281, 3131, 2736 
Rint 0.028 
(sin θ/λ)max (Å−1) 0.626 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.028, 0.094, 1.19 
No. of reflections 3131 
No. of parameters 200 
H-atom treatment H atoms treated by a mixture of independent and constrained refinement 
Δρmax, Δρmin (e Å−3) 0.41, −0.30 
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3 Preparation and Application of Solid, Salt Stabilized Amide Enolates 
3.1 Typical Procedures 
TP1: Typical Procedure for the Preparation of the Solid Morpholine Amide Zinc Pivalates 
A dry and argon-flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with the morpholine amide (10.0 mmol) and THF to give a 1 M solution. TMPZnCl·LiCl (1.31 M in 
THF, 13.0 mmol) was added. After stirring the reaction mixture for 2 h at room temperature Mg(OPiv)2 
(2.72 g, 12.0 mmol) was added and the mixture was strirred 15 min until a clear solution was formed. 
The solvent was removed in vacuo and the dried solid morpholine amide zinc pivalate was titrated using 
iodine (see Chapter 2.1) in order to determine the yield. 
TP2: Typical Procedure for Negishi Couplings using Morpholine Amide Zinc Pivalates 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with the 
solid morpholine amide zinc pivalate (0.50 mmol), Pd(dba)2 (2 mol%), DavePhos (4 mol%) and THF to 
give a 0.5 M solution respective to the morpholine amide zinc pivalate. The electrophile (0.38 mmol) 
was added and the suspension was stirred at 40 °C for 4 h. The reaction was quenched with sat. aq. 
NH4Cl solution (10 mL) and extracted with EtOAc (3 × 30 mL). The combined organic layers were 
washed with sat. aq. NH4Cl solution (30 mL) and dried over MgSO4. After filtration, the solvent was 
removed in vacuo. Purification via flash column chromatography yielded the Negishi coupling product. 
TP3: Typical Procedure for Aldol type reactions using Morpholine Amide Zinc Pivalates 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with the 
solid morpholine amide zinc pivalate (0.50 mmol) and THF to give a 0.5 M solution respective to the 
morpholine amide zinc pivalate. The solution was cooled to 0 °C and the carbonyl compound 
(0.40 mmol) was added. The reaction mixture was stirred for 3 h at 0 °C before quenching it with sat. 
aq. NH4Cl solution (10 mL). The mixture was extracted with EtOAc (3 × 30 mL). The combined organic 
layers were washed with sat. aq. NH4Cl solution (30 mL) and dried over MgSO4. After filtration, the 
solvent was removed in vacuo. Purification via flash column chromatography yielded the aldol product. 
TP4: Typical Procedure for Allylation reactions using Morpholine Amide Zinc Pivalates 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with the 
solid morpholine amide zinc pivalate (0.30 mmol) and THF to give a 0.3 M solution respective to the 
morpholine amide zinc pivalate. The solution was cooled to –30 °C and 20 mol% CuCN·2LiCl was 
added. The allylic electrophile (0.24 mmol) was added and the solution was stirred for 4 h at –30 °C. A 
mixture of sat. aq. NH4Cl and aq. NH3 (25%) solutions (8:1, 10 mL) was added and the mixture was 
extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with sat. aq. NaCl 
solution 30 mL and dried over MgSO4. After filtration, the solvent was removed in vacuo. Purification 
via flash column chromatography furnished the allylation product. 
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TP5: Typical Procedure for the Substitution of the Morpholine Moiety using Grignard Reagents 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with 
LaCl3·2LiCl (0.50 M in THF, 0.70 mmol), the Grignard reagent (1.64 M in THF, 0.70 mmol) and cooled 
to 0 °C. The morpholine amide (0.48 mmol) dissolved in THF (1 mL) was added and the resulting dark 
solution was stirred for 4.5 h at 0 °C. The reaction was quenched with sat. aq. NH4Cl solution (20 mL) 
and water (40 mL). The mixture was extracted with EtOAc (3 × 50 mL). The combined organic layers 
were washed with sat. aq. NH4Cl solution (50 mL) and dried over MgSO4. After filtration, the solvent 
was removed in vacuo. Purification via flash column chromatography yielded the substituted product. 
3.2 Preparation of the Solid Morpholine Amide Zinc Pivalates 
(2-Morpholino-2-oxoethyl)zinc pivalate (93a) 
 
According to TP1 TMPZnCl·LiCl (1.31 M in THF, 15.6 mL, 12.0 mmol) was added to a solution of 
1-morpholinoethan-1-one 92a (1.29 g, 10.0 mmol) in THF (10 mL). The mixture was stirred for 1.5 h 
at room temperature. Addition of Mg(OPiv)2 (2.72 g, 12.0 mmol) and removal of the solvent furnished 
the title compound as a light yellow solid. Determination of the content of active zinc species by titration 
with iodine indicated a concentration of 0.80 mmol g−1 corresponding a yield of 78%. 
 
(1-Morpholino-1-oxopropan-2-yl)zinc pivalate (93b) 
 
According to TP1 TMPZnCl·LiCl (1.31 M in THF, 15.6 mL, 12.0 mmol) was added to a solution of 
1-morpholinopropan-1-one 92b (1.43 g, 10.0 mmol) in THF (10 mL). The mixture was stirred for 2 h 
at room temperature. Addition of Mg(OPiv)2 (2.72 g, 12.0 mmol) and removal of the solvent furnished 
the title compound as a yellow solid. Determination of the content of active zinc species by titration with 
iodine indicated a concentration of 0.90 mmol g−1 corresponding a yield of 86%. 
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(1-Morpholino-1-oxopent-4-en-2-yl)zinc pivalate (93c) 
 
According to TP1 TMPZnCl·LiCl (1.31 M in THF, 15.6 mL, 12.0 mmol) was added to a solution of 
1-morpholinopent-4-en-1-one 92c (1.68 g, 10.0 mmol) in THF (10 mL). The mixture was stirred for 2 h 
at room temperature. Addition of Mg(OPiv)2 (2.72 g, 12.0 mmol) and removal of the solvent furnished 
the title compound as a yellow solid. Determination of the content of active zinc species by titration with 
iodine indicated a concentration of 0.64 mmol g−1 corresponding a yield of 65%. 
 
(1-((diphenylmethylene)amino)-2-morpholino-2-oxoethyl)zinc pivalate (93d) 
 
According to TP1 TMPZnCl·LiCl (1.31 M in THF, 15.6 mL, 12.0 mmol) was added to a solution of 
2-((diphenylmethylene)amino)-1-morpholinoethanone 92d (3.08 g, 10.0 mmol) in THF (10 mL). The 
mixture was stirred for 2 h at room temperature. Addition of Mg(OPiv)2 (2.72 g, 12.0 mmol) and 
removal of the solvent furnished the title compound as a yellow solid. Determination of the content of 
active zinc species by titration with iodine indicated a concentration of 0.72 mmol g−1 corresponding a 
yield of 83%. 
3.3 Preparation of Cross-Coupling, Allylation and Carbonyl Addition Products 
2-(4-(Methylthio)phenyl)-1-morpholinoethanone (94a) 
 
According to TP2 4-bromothioanisole 3f (906 mg, 4.46 mmol) was added to a solution of 
(2-morpholino-2-oxoethyl)zinc pivalate 93a (0.65 mmol g−1, 8.52 g, 5.57 mmol), Pd(dba)2 (2 mol%, 
63.3 mg) and DavePhos (4 mol%, 87.7 mg) in THF (19 mL) and the resulting dark mixture was stirred 
at room temperature over night. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 1:2) afforded the title compound as a yellow oil (1.11 g, 4.42 mmol, 99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.23–7.20 (m, 2H), 7.17–7.14 (m, 2H), 3.68 (s, 2H), 3.64 (m, 
4H), 3.52–3.48 (m, 2H), 3.42 (m, 2H), 2.47 (s, 3H). 
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13C-NMR (100 MHz, CDCl3): δ / ppm = 169.6, 137.1, 131.7, 129.2, 127.2, 66.9, 66.6, 46.6, 42.3, 40.4, 
16.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2962 (w), 2918 (w), 2853 (w), 1640 (vs), 1494 (m), 1456 (m), 
1433 (m), 1406 (w), 1361 (w), 1328 (w), 1300 (w), 1271 (m), 1251 (w), 1230 (m), 1195 (w), 1159 (w), 
1114 (s), 1093 (w), 1068 (w), 1036 (w), 1017 (w), 966 (w), 852 (w), 806 (w), 775 (w). 
MS (EI, 70 eV): m/z (%) = 251 (M+, 100), 164 (7), 137 (78), 114 (45), 70 (21). 
HRMS (EI): m/z calc. for [C13H17NO232S]: 251.0980; found: 251.0980 (M+). 
 
3-(Furan-2-yl)-3-hydroxy-1-morpholinopropan-1-one (95a) 
 
According to TP3 furfural 88c (37.0 mg, 0.39 mmol) was added to a solution of (2-morpholino-2-
oxoethyl)zinc pivalate 93a (0.65 mmol g−1, 736 mg, 0.48 mmol) in THF (1 mL) and the resulting dark 
mixture was stirred for 4 h at 0 °C. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 1:2) afforded the title compound as a colorless oil (87 mg, 0.39 mmol, 99%). 
1H-NMR (800 MHz, CDCl3): δ / ppm = 7.13–7.12 (m, 1H), 6.36 (d, J = 3.1 Hz, 1H), 6.14 (dd, J = 3.3, 
1.8 Hz, 1H), 5.29 (dt, J = 9.4, 3.2 Hz, 1H), 5.01 (d, J = 3.7 Hz, 1H), 3.33 (m, 1H), 3.21 (m, 1H), 3.14 
(m, 2H), 2.96 (m, 2H), 2.44 (dd, J = 16.3, 9.3 Hz, 1H), 2.40 (m, 2H), 2.27 (dd, J = 16.3, 2.8 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 170.2, 156.9, 141.6, 110.8, 106.3, 66.5, 66.2, 65.2, 45.2, 41.8, 
38.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3395 (w), 3117 (w), 2964 (w), 2918 (w), 2859 (w), 2762 (vw), 
1614 (vs), 1504 (w), 1463 (m), 1439 (s), 1362 (w), 1343 (w), 1330 (w), 1302 (m), 1271 (m), 1228 (m), 
1172 (w), 1145 (m), 1111 (vs), 1066 (s), 1039 (m), 1008 (s), 965 (m), 944 (w), 914 (w), 882 (w), 852 
(m), 815 (w), 742 (m). 
MS (EI, 70 eV): m/z (%) = 225 (M+, 100), 197 (13), 179 (2), 156 (9), 129 (15), 114 (19), 
97 (54), 70 (10), 56 (16). 
HRMS (EI): m/z calc. for [C11H15NO4]: 225.1001; found: 225.1002 (M+). 
 
2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-morpholinopropan-1-one (94b) 
 
According to TP2 6-bromo-2,3-dihydrobenzo[b][1,4]dioxine 85k (86.2mg, 0.40 mmol) was added to a 
solution of (1-morpholino-1-oxopropan-2-yl)zinc pivalate 93b (0.79 mmol g−1, 633 mg, 0.50 mmol) 
Pd(dba)2 (2 mol%, 5.76 mg) and DavePhos (4 mol%, 7.89 mg) in THF (0.5 mL) and the resulting dark 
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mixture was stirred at room temperature over night. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 1:1) afforded the title compound as a yellow oil 
(117 mg, 0.42 mmol, 99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.80 (d, J = 8.3 Hz, 1H), 6.74 (d, J = 2.1 Hz, 1H), 6.68 (dd, 
J = 8.3, 2.2 Hz, 1H), 4.24 (m, 4H), 3.73 (q, J = 6.9 Hz, 1H), 3.70–3.17 (m, 8H), 1.41 (d, J = 6.8 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 172.4, 143.9, 142.6, 135.2, 120.2, 117.8, 116.1, 66.9, 66.6, 
64.5, 64.4, 46.2, 42.6, 42.5, 20.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2970 (w), 2928 (w), 2896 (w), 2856 (w), 1732 (vw), 1638 (vs), 
1588 (m), 1504 (vs), 1456 (s), 1430 (s), 1362 (w), 1284 (vs), 1262 (s), 1248 (s), 1224 (s), 1198 (m), 
1148 (w), 1114 (vs), 1092 (w), 1066 (vs), 1030 (s), 1010 (m), 948 (m), 936 (w), 912 (m), 900 (m), 884 
(s), 846 (m), 818 (m), 792 (m), 768 (w), 738 (m), 724 (w), 698 (w). 
MS (EI, 70 eV): m/z (%) = 277 (M+, 20), 163 (100), 119 (3), 91 (13), 65 (5). 
HRMS (EI): m/z calc. for [C15H19NO4]: 277.1314; found: 277.1309 (M+). 
 
2-(4-(Dimethylamino)phenyl)-1-morpholinopropan-1-one (94c) 
 
According to TP2 4-bromo-N,N-dimethylaniline 85l (90.6 mg, 0.45 mmol) was added to a solution of 
(1-morpholino-1-oxopropan-2-yl)zinc pivalate 93b (0.79 mmol g−1, 715 mg, 0.57 mmol), Pd(dba)2 
(2 mol%, 6.50 mg) and DavePhos (4 mol%, 8.67 mg) in THF (0.6 mL) and the resulting dark mixture 
was stirred at 40 °C for 4 h. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 5:1 + 4% NEt3 → 3:1 + 4% NEt3) afforded the title compound as a yellow oil 
(115 mg, 0.44 mmol, 97%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.13–7.03 (m, 2H), 6.72–6.63 (m, 2H), 3.81–3.71 (m, 2H), 
3.69–3.61 (m, 1H), 3.57–3.44 (m, 3H), 3.44–3.30 (m, 2H), 3.14 (m, 1H), 2.92 (s, 6H), 1.41 (d, J = 6.8 
Hz, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 172.9, 149.5, 129.7, 127.9, 113.1, 66.9, 66.5, 46.1, 
42.5, 42.3, 40.8, 20.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2966 (w), 2926 (w), 2894 (w), 2854 (m), 2802 (w), 1640 (vs), 
1614 (s), 1564 (w), 1520 (vs), 1480 (w), 1454 (s), 1444 (s), 1428 (s), 1348 (m), 1298 (m), 1268 (m), 
1230 (s), 1198 (s), 1182 (m), 1164 (m), 1112 (vs), 1066 (m), 1030 (s), 1010 (m), 998 (m), 946 (m), 906 
(w), 846 (m), 820 (s), 780 (m), 742 (m), 730 (m), 700 (w), 662 (m). 
MS (EI, 70 eV): m/z (%) = 262 (M+, 17), 148 (100), 132 (5), 118 (2), 104 (2). 
HRMS (EI): m/z calc. for [C15H22N2O2]: 262.1681; found: 262.1678 (M+). 
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2-(6-Methoxynaphthalen-2-yl)-1-morpholinopropan-1-one (94d) 
 
According to TP2 2-bromo-6-methoxynaphthalene 85m (61.2 mg, 0.27 mmol) was added to a solution 
of (1-morpholino-1-oxopropan-2-yl)zinc pivalate 93b (0.73 mmol g−1, 455 mg, 0.33 mmol), Pd(dba)2 
(2 mol%, 3.85 mg) and DavePhos (4 mol%, 5.24 mg) in THF (0.7 mL) and the resulting dark mixture 
was stirred at 40 °C for 4 h. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 2:1) afforded the title compound as a colorless oil (80.0 mg, 0.27 mmol, 99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.71 (d, J =8.5 Hz, 1H), 7.68 (d, J = 8.9 Hz, 1H), 7.59 (d, 
J = 1.8 Hz, 1H), 7.34 (dd, J = 8.4, 1.9 Hz, 1H), 7.15 (dd, J = 8.8, 2.6 Hz, 1H), 7.11 (d, J = 2.5 Hz, 1H), 
3.97 (q, J = 6.8 Hz, 1H), 3.92 (s, 3H), 3.79 (m, 1H), 3.73–3.63 (m, 1H), 3.54 (m 2H), 3.50–3.39 (m, 
2H), 3.34 (m, 1H), 3.08 (m, 1H), 1.52 (d, J = 6.8 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 172.4, 157.8, 137.1, 133.6, 129.3, 129.2, 127.8, 126.1, 125.6, 
119.3, 105.8, 66.9, 66.5, 55.5, 46.2, 43.4, 42.6, 20.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2966 (w), 2928 (w), 2900 (w), 2854 (w), 1640 (vs), 1606 (s), 
1504 (w), 1484 (m), 1458 (m), 1430 (s), 1392 (m), 1366 (w), 1300 (w), 1266 (s), 1228 (s), 1212 (s), 
1172 (m), 1116 (s), 1092 (w), 1068 (w), 1030 (s), 944 (w), 924 (w), 894 (w), 854 (m), 814 (w), 728 (w), 
676 (w). 
MS (EI, 70 eV): m/z (%) = 299 (M+, 25), 185 (100), 170 (10), 155 (6), 141 (9), 115 (5). 
HRMS (EI): m/z calc. for [C18H21NO3]: 299.1521; found: 299.1517 (M+). 
 
2-(4-((tert-Butyldimethylsilyl)oxy)phenyl)-1-morpholinopropan-1-one (94e) 
 
According to TP2 tert-butyl(4-iodophenoxy)dimethylsilane 96a (130 mg, 0.39 mmol) was added to a 
solution of (1-morpholino-1-oxopropan-2-yl)zinc pivalate 93b (0.73 mmol g−1, 662 mg, 0.49 mmol), 
Pd(dba)2 (2 mol%, 5.58 mg) and DavePhos (4 mol%, 7.63 mg) in THF (0.5 mL) and the resulting dark 
mixture was stirred at 25 °C for 5.5 h. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 3:1) afforded the title compound as a slightly brown solid (122 mg, 0.35 mmol, 
90%). 
M.p. (°C): 67.5–71.0. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.12–7.03 (m, 2H), 6.82–6.74 (m, 2H), 3.77 (m, 2H), 3.66 (m, 
1H), 3.50 (m, 3H), 3.34 (m, 2H), 3.10 (m, 1H), 1.42 (d, J = 6.8 Hz, 3H), 0.97 (s, 9H), 0.18 (s, 6H). 
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13C-NMR (100 MHz, CDCl3): δ / ppm = 172.6, 154.6, 134.7, 128.3, 120.7, 66.9, 66.5, 46.2, 42.6, 42.5, 
25.8, 20.8, 18.4, –4.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3028 (vw), 2958 (m), 2930 (m), 2896 (w), 2858 (m), 1732 (vw), 
1646 (s), 1608 (m), 1580 (vw), 1558 (vw), 1508 (s), 1472 (m), 1460 (m), 1430 (m), 1390 (w), 1362 (w), 
1298 (w), 1252 (vs), 1230 (s), 1172 (m), 1114 (s), 1090 (w), 1068 (m), 1030 (m), 1014 (w), 1006 (w), 
938 (m), 912 (vs), 838 (vs), 812 (s), 780 (s), 734 (w), 724 (w), 680 (m). 
MS (EI, 70 eV): m/z (%) = 349 (M+, 5), 235 (100), 177 (5), 163 (5), 144 (8), 73 (4). 
HRMS (EI): m/z calc. for [C19H31NO328Si:]: 349.2073; found: 349.2067 (M+). 
 
1-Morpholino-2-(thiophen-3-yl)propan-1-one (94f) 
 
According to TP2 3-bromothiophene 85h (192 mg, 1.18 mmol) was added to a solution of 
(1-morpholino-1-oxopropan-2-yl)zinc pivalate 93b (0.79 mmol g−1, 1.85 g, 1.47 mmol), Pd(dba)2 
(2 mol%, 16.9 mg) and DavePhos (4 mol%, 23.1 mg) in THF (1.5 mL) and the resulting dark mixture 
was stirred at 40 °C for 3 h. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 2:1) afforded the title compound as a yellow oil (215 mg, 0.95 mmol, 81%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.29 (dd, J = 5.0, 3.0 Hz, 1H), 7.05–7.03 (m, 1H), 6.99 (dd, 
J = 5.0, 1.3 Hz, 1H), 4.00 (q, J = 6.9 Hz, 1H), 3.78 (m, 1H), 3.71–3.64 (m, 1H), 3.58–3.50 (m, 3H), 
3.44–3.36 (m, 2H), 3.27–3.21 (m, 1H), 1.45 (d, J = 6.9 Hz, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 172.2, 142.0, 126.9, 126.5, 120.8, 66.9, 66.6, 46.3, 42.6, 38.4, 
19.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3094 (vw), 2970 (w), 2930 (w), 2898 (w), 2856 (w), 1644 (vs), 
1530 (vw), 1458 (m), 1432 (m), 1386 (w), 1362 (w), 1332 (vw), 1300 (w), 1270 (w), 1232 (m), 1194 
(w), 1152 (vw), 1114 (s), 1090 (w), 1068 (w), 1030 (m), 1014 (w), 946 (w), 918 (vw), 902 (vw), 862 
(w), 846 (w), 830 (vw), 800 (w), 774 (w), 748 (vw), 694 (vw), 662 (w). 
MS (EI, 70 eV): m/z (%) = 225 (M+, 71), 210 (22), 192 (4), 167 (5), 138 (6), 111 (100), 85 (7), 
70 (30), 56 (8). 
HRMS (EI): m/z calc. for [C11H15NO232S]: 225.0823; found: 225.0821 (M+). 
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2-(4-((tert-Butyldimethylsilyl)oxy)phenyl)-1-morpholinopropan-1-one (98a) 
 
According to TP4 CuCN·2LiCl (10 mol%, 1.00 M in THF, 0.03 mL) was added to a solution of 
(1-morpholino-1-oxopropan-2-yl)zinc pivalate 93b (0.73 mmol g−1, 434 mg, 0.32 mmol) in THF (1 mL) 
at 0 °C. Allyl bromide 97a (30.8 mg, 0.25 mmol) was added and the resulting orange solution was stirred 
at 0 °C for 2.5 h. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc 
= 1:1) afforded the title compound as a colorless oil (59.0 mg, 0.32 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.76 (dddd, J = 16.9, 10.1, 7.6, 6.5 Hz, 1H), 5.07–4.96 (m, 
2H), 3.48–2.72 (m, 8H), 2.53 (m, 1H), 2.27 (m, 1H), 2.08 (m, 1H), 1.01 (d, J = 6.8 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 173.5, 136.8, 116.5, 67.0, 66.8, 45.8, 42.3, 38.6, 35.2, 17.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3480 (w), 3076 (w), 2970 (w), 2856 (m), 1636 (vs), 1462 (m), 
1432 (s), 1362 (w), 1326 (w), 1300 (w), 1268 (m), 1234 (s), 1218 (m), 1156 (w), 1114 (vs), 1068 (m), 
1028 (s), 996 (m), 956 (w), 914 (m), 878 (w), 844 (m), 748 (w), 724 (w).  
MS (EI, 70 eV): m/z (%) = 183 (M+, 34), 168 (33), 154 (18), 140 (25), 114 (47), 100 (10), 86 (51), 69 
(100), 55 (36). 
HRMS (EI): m/z calc. for [C10H17NO2]: 183.1259; found: 183.1246 (M+). 
 
2-(4-((tert-Butyldimethylsilyl)oxy)phenyl)-1-morpholinopropan-1-one (98b) 
 
According to TP4 CuCN·2LiCl (10 mol%, 1.00 M in THF, 0.03 mL) was added to a solution of 
(1-morpholino-1-oxopropan-2-yl)zinc pivalate 93b (0.73 mmol g−1, 394 mg, 0.29 mmol) in THF (1 mL) 
at –20 °C. Ethyl 2-(bromomethyl)acrylate 97b (44.5 mg, 0.23 mmol) was added and the resulting orange 
solution was stirred at –20 °C for 2 h. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 9:1) afforded the title compound as a colorless oil (57.0 mg, 0.22 mmol, 97%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.15 (d, J = 1.8 Hz, 1H), 5.41 (m, 1H), 3.95 (m, 2H), 3.59–
2.97 (m, 8H), 2.97–2.81 (m, 2H), 2.40 (m, 1H), 1.09 (d, J = 6.6 Hz, 3H), 0.92 (t, J = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 173.6, 166.9, 138.7, 127.3, 67.0, 66.9, 60.6, 45.9, 42.4, 37.5, 
34.1, 17.2, 14.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2972 (w), 2930 (w), 2856 (w), 1710 (s), 1640 (s), 1462 (m), 1434 
(s), 1370 (m), 1326 (m), 1302 (m), 1280 (m), 1268 (m), 1236 (s), 1210 (m), 1192 (m), 1156 (s), 1114 
(vs), 1068 (m), 1026 (s), 948 (m), 890 (w), 846 (w), 818 (w), 682 (w).  
MS (EI, 70 eV): m/z (%) = 255 (M+, 23), 241 (4), 227 (14), 210 (46), 182 (100), 168 (56), 141 (56), 
127 (4), 113 (90), 95 (45), 81 (16), 67 (23), 53 (11). 
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HRMS (EI): m/z calc. for [C13H21NO4]: 255.1471; found: 255.1462 (M+). 
 
1-Phenyl-2-(thiophen-3-yl)propan-1-one (99) 
 
According to TP5 PhMgCl·LiCl (1.64 M in THF, 0.43 mL, 0.71 mmol) was added to a solution of 
LaCl3·2LiCl (0.50 M in THF, 1.43 mL, 0.71 mmol) at 0 °C. 1-Morpholino-2-(thiophen-3-yl)propan-1-
one 4c (107mg, 0.48 mmol) dissolved in THF (1 mL) was added and the resulting dark solution was 
stirred for 4.5 h at 0 °C. Purification of the crude product by flash chromatography (silica gel, isohexane) 
afforded the title compound as a colorless oil (99 mg, 0.46 mmol, 96%). 
1H-NMR (400 MHz, C6D6): δ / ppm = 7.90–7.85 (m, 2H), 7.07–6.96 (m, 3H), 6.81 (dd, J = 5.0, 1.4 Hz, 
1H), 6.76 (dd, J = 5.0, 2.9 Hz, 1H), 6.71 (dd, J = 2.9, 1.2 Hz, 1H), 4.38 (q, J = 6.8 Hz, 1H), 1.43 (d, J = 
6.8 Hz, 3H). 
13C-NMR (100 MHz, C6D6): δ / ppm = 199.0, 142.1, 137.0, 132.6, 129.0, 128.6, 127.3, 126.2, 121.5, 
43.1, 19.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3102 (w), 3062 (w), 2976 (w), 2932 (w), 2874 (w), 1680 (vs), 
1648 (w), 1596 (m), 1580 (w), 1528 (w), 1448 (m), 1410 (w), 1372 (w), 1334 (m), 1306 (w), 1272 (w), 
1224 (s), 1182 (m), 1154 (w), 1080 (w), 1002 (w), 958 (s), 930 (w), 910 (w), 862 (m), 830 (w), 782 (m), 
754 (m), 722 (s), 688 (m), 658 (m). 
MS (EI, 70 eV): m/z (%) = 216 (M+, 30), 105 (100), 77 (34), 51 (7). 
HRMS (EI): m/z calc. for [C13H12O32S]: 216.0609; found: 216.0603 (M+). 
4 Scalable Preparation of Functionalized (Hetero-)Arylzinc Pivalates 
4.1 Zinc Pivalate 
 
A flame-dried and argon-flushed 500 mL three-necked round-bottom flask, equipped with a 5 × 2-cm 
Teflon-coated magnetic stirring bar, a rubber septum an argon line inlet and a pressure equalizer, was 
charged with dry THF (60 mL).113 The apparatus was maintained under an atmosphere of argon during 
the course of the reaction. Pivalic acid (101, 10.2 g, 11.3 mL, 100 mmol)114 was added to form a colorless 
                                                     
113 Pivalic acid (99%) was obtained from Acros Organics and warmed to 60 °C ca. 1 h prior to the addition. The 
molten pivalic acid can be easily added by quickly handling via syringe. 
114 THF was continuously refluxed and freshly distilled from sodium benzophenone. 
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solution. The mixture was cooled in an ice bath and stirred at 0 °C. In a second flame dried and argon-
flushed 250 mL Schlenk flask, equipped with a 3.5 × 1.5-cm Teflon-coated magnetic stirring bar and a 
rubber septum, neat diethylzinc (6.50 g, 5.40 mL, 52.5 mmol) was added to 60 mL dry THF.115,116 The 
solution should be prepared shortly before the addition (<15 min), as Et2Zn reacts slowly with THF. The 
freshly prepared Et2Zn solution was cannulated to the three-necked round-bottom flask at 0 °C over a 
period of 15 min under vigorous stirring (Figure 9).117 
 
Figure 9: Cannulation of the diethylzinc solution to the reaction flask and evaporation of the solvent using a 
liquid nitrogen cold trap. 
The ice-bath was removed and stirring continued at 25 °C for two additional hours at which point 
bubbling was ceased (a thick slurry was formed). Then, the pressure equalizer was replaced with a glass 
cap and the solvent was removed in vacuo using a vacuum line and a liquid nitrogen cold trap (1000 mL) 
(Figure 9). The flask was warmed in a 20 °C water bath and the solid residue was dried for at least 4 h 
longer.118 Zn(OPiv)2 (100) was received in quantitative yield, as a puffy amorphous white solid.119 
1H NMR (800 MHz, DMSO-d6): δ/ppm = 1.08 (s, 9H) 
13C NMR (201 MHz, DMSO-d6): δ/ppm = 183.9, 37.7, 28.2. 
4.2 Pyridin-3-ylzinc Pivalate 
 
A dry and argon flushed 1 L Schlenk-flask equipped with a 5 × 2-cm Teflon-coated magnetic stirring 
bar and a septum was filled with argon and then weighed. The flask was charged with 3-bromopyridine 
                                                     
115 Care should be taken for the addition of Et2Zn to avoid exposure of the pyrophoric reagent to ambient 
atmosphere. 
116 Diethylzinc was obtained in a steel cylinder from Chemtura Corporation and used as received. 
117 A BOLA tube (0.8 × 1.6 mm, ca. 20 cm length) was used. The mixture was stirred at 900 rpm throughout the 
reaction. 
118 The flask is connected to high vacuum (0.1 mmHg) with liquid nitrogen cold trap. Vigorous stirring (800 rpm) 
was maintained to keep the solid from forming solvent cages. 
119 Zinc pivalate should be stored under argon, but can be weighed on air. 
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(6.32 g, 40.0 mmol)120 and dry THF (50 mL). The solution was cooled in an ice bath and stirred for at 
least 5 min at 0 °C before iPrMgCl·LiCl (34.9 mL, 1.26 M, 44.0 mmol)121 was added with a syringe 
pump over the period of 30 min. The ice bath was removed and the solution is stirred for 3 h at 25 °C 
during which time it gradually turns from yellow to dark red.122 Upon completion of the reaction, solid 
Zn(OPiv)2 (100, 12.3 g, 46.0 mmol) was added in one portion under argon counterflow. A slight 
exotherm was noted. The mixture was stirred at r.t. for 30 min during which a clear dark red solution 
was formed. The solvent was removed using a vacuum line (0.1 mmHg) and a liquid nitrogen cold trap 
and the solid residue was dried for at least 2 h longer during which a voluminous yellow foam was 
formed (Figure 10).123 The foam was crushed with a spatula under argon counterflow to form a yellow 
fine powder. The powder was dried under high vacuum for further 2 h. Pyridine-3-ylzinc pivalate (103, 
30.0 g, 1.19 mmol g-1, 35.6 mmol, 89%) is stored under an inert atmosphere in the dark for long-term 
storage and can be weighed on air without significant loss of activity. 
 
 
Figure 10: The color of the reaction mixture turns from yellow to dark red. Photographs of the solid foam and 
powder. 
After the drying process was complete the argon flushed flask was weighed to determine the weight of 
the formed powder. To determine the actual content in zinc species and the yield of the reaction, a small 
                                                     
120 3-Bromopyridine (99%) was purchased from Apollo Scientific and used as received. 
121 A solution of iPrMgCl·LiCl in THF was obtained from Rockwood Lithium and titrated against Iodine prior to 
use. For the titration accurately weighted aliquots (e.g. 221 mg) I2 were placed in a dry and argon flushed 20 mL 
Schlenk flask with a septum and dissolved in ca. 2 mL dry THF. To the solution thus formed, was added the 
iPrMgCl·LiCl solution using a 1 mL NORM-JECT syringe from Henke Sass Wolf until the complete 
disappearance of the dark brown color of iodine (0.69 mL equals a concentration of 1.26 M). 
122 The progress of the halogen-magnesium exchange was monitored by GC-analysis of reaction aliquots quenched 
with I2. 
123 The flask was warmed in a 20 °C water bath to accelerate the solvent evaporation. 
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aliquot of the powder (ca. 1 g, see Figure 3: A) was titrated using a 1 M solution of iodine in THF124 
with a color change from red (B) to bright yellow (C) until the persisting brown color of the iodine (D) 
indicates the completion of the titration.125 
 
Figure 11: Titration of the organozinc reagent. 
4.3 Ethyl 4-(Pyridin-3-yl)benzoate 
 
In a dry and argon-flushed 250 mL Schlenk-flask, equipped with a 5 × 2-cm Teflon-coated magnetic 
stirring bar and a septum, the solid pyridine-3-ylzinc pivalate (23.4 g, 30.4 mmol, 1.30 mmol g-1) was 
dissolved in dry THF (60 mL). Ethyl 4-bromobenzoate (104, 4.32 mL, 6.06 g, 26.4 mmol)126 was added 
followed by PEPPSI-IPr (207 mg, 0.30 mmol, 1 mol%)2 and the red solution was stirred for 2 h at room 
temperature (25 °C) during which time it gradually turns dark grey. Then sat. aq. NH4Cl (50 mL) was 
added and the aqueous layer was extracted with EtOAc (3 × 70 mL). The combined organic phases were 
dried (MgSO4). Evaporation of the solvents in vacuo and purification by column chromatography 
(iso-hexane:EtOAc:NEt3 = 50:10:1 afforded ethyl 4-(pyridin-3-yl)benzoate (105, 5.52 g, 24.3 mmol, 
92%) as a yellow solid.127 
M.p.: 46–48 °C. 
1H NMR (600 MHz, CDCl3): δ = 8.88 (dd, J = 2.3, 1.0 Hz, 1H), 8.63 (dd, J = 4.8, 1.7 Hz, 1H), 8.21–
8.08 (m, 2H), 7.95–7.88 (m, 1H), 7.69–7.59 (m, 2H), 7.40 (ddd, J = 7.8, 4.8, 0.9 Hz, 1H), 4.40 (q, J = 
7.1 Hz, 2H), 1.41 (t, J = 7.1 Hz, 2H). 
                                                     
124 A 1 M solution of iodine in THF was prepared in a dry and argon flushed 20 mL Schlenk flask by solving 
2.538 g I2 in 9.30 mL dry THF. 
125 For the titration accurately weighted aliquots (e.g., 913 mg) of the powder were placed in a dry and argon 
flushed 20 mL Schlenk flask with a septum and dissolved in ca. 3 mL dry THF. To the solution thus formed, was 
added the 1 M I2 solution using a 1 mL NORM-JECT syringe from Henke Sass Wolf until the complete appearance 
of the dark brown color of iodine (e.g., 1.19 mL equals a concentration of 1.30 mmol/g). 
126 The following reagents in this section were purchased from commercial sources and used without further 
purification: Ethyl 4-bromobenzoate (99+%, Apollo Scientific), PEPPSI-IPr (98%, Sigma-Aldrich). 
127 ISOLUTE® HM-N adsorbed with the crude product is dry-loaded onto a column (diameter: 6.0 cm, height: 25.0 
cm) packed with silica gel (250 g) slurry in 50:10:1 iso-hexane:EtOAc:NEt3 (Rf(product): 0.12; visualized with 
UV light) and 100 mL fractions are collected. The desired product is obtained in fractions 21-60, which are 
concentrated by rotary evaporation (40 °C, 250 mmHg). The purified product is stored under an inert atmosphere 
in the dark for long-term storage. 
A)                  B)                    C)                         D) 
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13C NMR (150 MHz, CDCl3): δ = 166.3, 149.1, 148.3, 142.1, 135.8, 134.8, 130.5, 130.3, 127.2, 123.8, 
61.3, 14.5. 
HRMS (EI): m/z calc. for [C14H13NO2]: 227.0946; found: 227.0934 (M+). 
4.4 Titration of Organozinc Reagents Using Iodine 
Accurately weighted aliquots (150–250 mg) of the crude organozinc material were dissolved in dry THF 
(ca. 1 mL/100 mg). To the resulting solution was added a standard solution of iodine (0.50 M in dry 
THF), until the color of the iodine remained. Thus, the concentration of the active species (in mmol/g) 
was determined and thereof the yield of the zinc reagent. In cases where the reaction with iodine was 
not instantaneous, catalytic amounts of CuCN·2LiCl were added prior to the titration.106 
In some cases the end point of the titration could not be accurately determined due to the orange or 
brownish color of the zinc reagent. In these cases 2 mL of the 0.25 M (e.g., 0.5 mmol) iodine stock 
solution were added and the mixture was then stirred 5 min at room temperature. The excess of iodine 
was then titrated with a stock solution of Na2S2O3 in water (0.1 M), therefore the mixture must be 
vigorously stirred. The amount of active zinc species can then be determined by calculating the 
difference between the amount of iodine used and the amount of iodine determined by the reverse 
titration with Na2S2O3 (this procedure is referred to as reverse titration). 
4.5 Preparation of Zn(OPiv)2128 
Pivalic acid (20.4 g, 22.6 mL, 200 mmol) was placed in a dry and argon-flushed 500 mL three-necked 
round-bottom flask, equipped with a magnetic stirring bar, a septum and a pressure equalizer, and was 
dissolved in dry THF (120 mL). The mixture was cooled to 0 °C, and a solution of Et2Zn (13.0 g, 
10.8 mL, 105 mmol) in dry THF (120 mL) was cannulated to it over a period of 30 min under vigorous 
stirring. Then, the ice-bath was removed and stirring continued at 25 °C for one additional hour at which 
point bubbling ceased (a thick slurry was formed). The solvent was removed in vacuo and the solid 
residue was dried for at least 4 h longer. Zn(OPiv)2 was obtained in quantitative yield, as a puffy 
amorphous white solid. 
4.6 Preparation of TMPMgCl·LiCl129 
In a dry and argon-flushed Schlenk-flask TMPH (23.6 g, 28.4 mL, 150 mmol) was added to 
iPrMgCl·LiCl (113 mL, 1.26 M in THF, 143 mmol) at 25 °C and the mixture was stirred for 2 days at 
this temperature. The freshly prepared TMPMgCl·LiCl was titrated prior to use at 0 °C with benzoic 
acid using 4-(phenylazo)diphenylamine as indicator (1.21 M). 
                                                     
128 S. Bernhardt, G. Manolikakes, T. Kunz, P. Knochel, Angew.Chem. Int. Ed. 2011, 50, 9205. 
129 A. Krasovskiy, V. Krasovskaya, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 2958. 
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4.7 Preparation of TMPZnOPiv·Mg(OPiv)Cl·LiCl130 
A dry and argon flushed 250-mL Schlenk-flask, equipped with a magnetic stirring bar, was charged with 
a solution of TMPMgCl·LiCl (123 mL, 150 mmol) and cooled to 0 °C. Then, solid Zn(OPiv)2 (42.2 g, 
158 mmol, dried in vacuo at 300 °C prior to use) was added in one portion and the mixture was allowed 
to slowly warm up to 25 °C over ca. 1.5 h. Then THF (ca. 10-20 mL) was added to give the base as a 
bright yellow solution. The freshly prepared TMPZnOPiv·Mg(OPiv)Cl·LiCl was titrated prior to use at 
0 °C with benzoic acid using 4-(phenylazo)diphenylamine as indicator (0.77 M). 
4.8 Typical Procedures 
Typical procedure for the preparation of the solid organozinc pivalates by magnesium insertion 
and subsequent transmetalation with Zn(OPiv)2 (TP1)128,131 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with magnesium turnings (4.25 g, 175 mmol), LiCl (3.71 g, 87.5 mmol) and THF (140 mL). The 
aromatic halide (70.0 mmol) was added. If necessary the Schlenk-flask was placed in a water bath for 
cooling during the initial heat evolution due to the Mg-insertion reaction. The progress of the insertion 
reaction was monitored by GC-analysis of reaction aliquots quenched with aq. sat. aq. NH4Cl solution 
and/or I2. Upon completion of the insertion, solid Zn(OPiv)2 (23.4 g, 87.5 mmol) was added in one 
portion. After stirring at ambient temperature for 15 min, the solvent was carefully removed in vacuo. 
The dried material was titrated using iodine in order to determine its actual content in zinc species and 
the yield of the reaction. 
Typical procedure for the preparation of the solid organozinc pivalates by halogen-magnesium 
exchange and subsequent transmetalation with solid Zn(OPiv)2 (TP2)128,131 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with the aromatic substrate (70.0 mmol) and dry THF (100 mL). The reaction mixture was cooled to the 
appropriate temperature, before iPrMgCl·LiCl (62.8 mL, 1.17 M, 73.5 mmol) was added dropwise. The 
progress of the halogen-magnesium exchange was monitored by GC-analysis of reaction aliquots 
quenched with aq. sat. aq. NH4Cl solution and/or I2. Upon completion of the exchange, solid Zn(OPiv)2 
(22.5 g, 84.0 mmol) was added in one portion and the mixture was allowed to slowly warm up to 25 °C. 
After stirring at ambient temperature for 15 min, the solvent was carefully removed in vacuo. The dried 
material was titrated using iodine in order to determine its actual content in organozinc species as well 
as the reaction yield. 
                                                     
130 C. I. Stathakis, S. M. Manolikakes, P. Knochel, Org. Lett. 2013, 15, 1302. 
131 S. M. Manolikakes, M. Ellwart, C. I. Stathakis, P. Knochel, Chem. Eur. J. 2014, 20, 12289. 
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Typical procedure for the preparation of the organozinc pivalates by metalation with 
TMPMgCl·LiCl (2) and subsequent transmetalation with Zn(OPiv)2 (TP3)131,132 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with the aromatic substrate (70.0 mmol) and dry THF (20 mL). The reaction mixture was cooled to the 
appropriate temperature, before TMPMgCl·LiCl (63.6 mL, 1.21 M, 77.0 mmol) was added dropwise. 
The progress of the deprotonation was monitored by GC-analysis of reaction aliquots quenched with I2. 
Upon completion of the metalation, solid Zn(OPiv)2 (22.5 g, 84.0 mmol) was added in one portion and 
the mixture was allowed to slowly warm up to 25 °C. After stirring at ambient temperature for 15 min, 
the solvent was carefully removed in vacuo. The dried material was titrated using iodine in order to 
determine its actual content in organozinc species as well as the metalation yield. 
Typical procedure for the preparation of the organozinc pivalates by metalation with 
TMPZnOPiv·Mg(OPiv)Cl·LiCl (TP4)130,131 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with the aromatic substrate (70.0 mmol) and dry THF (20 mL). The solution was cooled to the given 
temperature followed by dropwise addition of TMPZnOPiv·Mg(OPiv)Cl·LiCl (130 mL, 0.77 M, 100 
mmol) and stirred at the indicated temperature for the given time. Complete metalation was monitored 
by GC analysis of reaction aliquots, quenched with iodine in dry THF. The solvent was carefully 
removed in vacuo and the dried material was titrated using iodine in order to determine its actual content 
in organozinc species as well as the metalation yield. 
4.9 Preparation of a Set of 17 Polyfunctional Aryl, Benzyl and Heteroarylzinc Pivalates 
(5-Methylpyridin-2-yl)zinc Pivalate (106) 
 
According to TP2 2-bromo-5-methylpyridine (1.20 g, 7 mmol) was dissolved in THF (7 mL) and treated 
with iPrMgCl·LiCl (6.27 mL, 1.23 M in THF, 7.7 mmol) at 25 °C for 6 h. Then Zn(OPiv)2 (2.25 g, 
8.4 mmol) was added in one portion and the mixture was stirred until all the salts went in solution (ca. 
15 min). After solvent removal in vacuo zinc reagent 106 (5.56 g) was obtained as a light yellow solid. 
The content of active zinc species was determined by titration of 281 mg of the reagent with a stock 
solution of iodine (0.25 M in THF). A concentration of 0.87 mmol/g was determined which corresponds 
to a yield of 71%. 
 
                                                     
132 C. I. Stathakis, S. Bernhardt, V. Quint, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 9428. 
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(4,6-Dichloropyrimidin-5-yl)zinc Pivalate (107) 
 
According to TP4 4,6-dichloropyrimidine (1.04 g, 7 mmol) was treated with 
TMPZnOPiv·Mg(OPiv)Cl·LiCl (7.78 mL, 0.99 M in THF, 7.7 mmol) at 25 °C for 30 min. After solvent 
removal in vacuo zinc reagent 107 (6.06 g) was obtained as a light orange solid. The content of active 
zinc species was determined by titration of 140 mg of the reagent with a stock solution of iodine (0.25 M 
in THF). A concentration of 0.96 mmol/g was determined which corresponds to a yield of 86%. 
 
(3-(Trifluoromethyl)phenyl)zinc Pivalate (108) 
 
According to TP2 1-bromo-3-(trifluoromethyl)benzene (1.58 g, 7.00 mmol) was dissolved in dry THF 
(10 mL) and treated with iPrMgCl·LiCl (6.27 mL, 1.23 M in THF, 7.70 mmol) at 0 °C for 8 h. Then 
Zn(OPiv)2 (2.25 g, 8.40 mmol) was added in one portion and the mixture was slowly warmed to room 
temperature and was stirred until all the salts went in solution (ca. 15 min). After solvent removal in 
vacuo zinc reagent 108 (4.79 g) was obtained as a white solid. The content of active zinc species was 
determined by titration of 270 mg of the reagent with a stock solution of iodine (0.25 M in THF). A 
concentration of 1.35 mmol/g was determined which corresponds to a yield of 92%. 
 
(4-Methoxyphenyl)zinc Pivalate (109) 
 
According to TP1 LiCl (371 mg, 8.75 mmol) and Zn(OPiv)2 (2.34 g, 8.75 mmol) were dissolved in dry 
THF (14 mL). After addition of Mg turnings (425 mg, 17.5 mmol), 1-bromo-4-methoxybenzene (1.31 g, 
7 mmol) was added at 25 °C and the reaction mixture was stirred at 50 °C for 15 h. After subsequent 
cannulation to another argon-flushed Schlenk-tube the solvent was removed in vacuo. Zinc reagent 109 
was obtained as a white solid (4.76 g). The content of active zinc species was determined by titration of 
282 mg of the reagent with a stock solution of iodine (0.25 M in THF). A concentration of 1.22 mmol/g 
was determined which corresponds to a yield of 83%. 
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(3-Methyl-1-phenyl-1H-pyrazol-5-yl)zinc Pivalate (110) 
 
According to TP1 Mg turnings (425 mg, 17.5 mmol) and Zn(OPiv)2 (2.34 g, 8.75 mmol) were 
suspended in dry THF (14 mL). After addition of 5-chloro-3-methyl-1-phenyl-1H-pyrazole (1.35 g, 
7 mmol) the reaction mixture was stirred at 25 °C for 15 h. After subsequent cannulation to another 
argon-flushed Schlenk-tube the solvent was removed in vacuo. Zinc reagent 110 was obtained as a white 
solid (6.41 g). The content of active zinc species was determined by titration of 222 mg of the reagent 
with a stock solution of iodine (0.25 M in THF). A concentration of 0.75 mmol/g was determined which 
corresponds to a yield of 69%. 
 
(4-Cyanophenyl)zinc Pivalate (111) 
 
According to TP2 4-bromobenzonitrile (1.27 g, 7.00 mmol) was dissolved in THF (10 mL) and treated 
with iPrMgCl·LiCl (6.00 mL, 1.23 M in THF, 7.35 mmol) at 0 °C for 15 h. Then Zn(OPiv)2 (2.25 g, 
8.40 mmol) was added in one portion and the mixture was slowly warmed to room temperature and was 
stirred until all the salts went in solution (ca. 15 min). After solvent removal in vacuo zinc reagent 111 
(5.40 g) was obtained as a white solid. The content of active zinc species was determined by titration of 
241 mg of the reagent with a stock solution of iodine (0.25 M in THF). A concentration of 1.09 mmol/g 
was determined which corresponds to a yield of 84%. 
 
(Pyridin-2-ylmethyl)zinc Pivalate (112) 
 
According to TP4 2-picoline (559 mg, 6.00 mmol) was treated with TMPZnOPiv·Mg(OPiv)Cl·LiCl 
(6.67 mL, 0.99 M in THF, 6.60 mmol) at 25 °C for 1 h. After solvent removal in vacuo zinc reagent 112 
(5.63 g) was obtained as a light orange solid. The content of active zinc species was determined by 
titration of 155 mg of the reagent with a stock solution of iodine (0.25 M in THF). A concentration of 
0.76 mmol/g was determined which corresponds to a yield of 71%. 
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(Pyridin-3-yl)zinc Pivalate (113) 
 
According to TP2 3-bromopyridine (1.11 g, 7.00 mmol) was dissolved in THF (14 mL) and treated with 
iPrMgCl·LiCl (6.27 mL, 1.23 M in THF, 7.70 mmol) at 0 °C for 1 h. Then Zn(OPiv)2 (2.25 g, 
8.40 mmol) was added in one portion and the mixture was slowly warmed to room temperature and was 
stirred until all the salts went in solution (ca. 15 min). After solvent removal in vacuo zinc reagent 113 
(4.50 g) was obtained as a light brown solid. The content of active zinc species was determined by 
titration of 134 mg of the reagent with a stock solution of iodine (0.25 M in THF). A concentration of 
1.40 mmol/g was determined which corresponds to a yield of 90%. 
 
(3-(Ethoxycarbonyl)benzyl)zinc Pivalate (114) 
 
According to TP1 Mg turnings (425 mg, 17.5 mmol) and Zn(OPiv)2 (2.34 g, 8.75 mmol) were 
suspended in dry THF (14 mL). After addition of ethyl 3-(chloromethyl)benzoate (1.39 g, 7.00 mmol) 
the reaction mixture was stirred at 25 °C for 15 h. After subsequent cannulation to another argon-flushed 
Schlenk-tube the solvent was removed in vacuo. Zinc reagent 114 was obtained as an orange solid 
(6.01 g). To determine the content of active zinc species 2.00 mL of an iodine stock solution (0.25 M) 
were added to a solution of 120 mg of zinc reagent 114 in dry THF (1.2 mL). After stirring this mixture 
for 5 min at 25 °C the excess of iodine was determined by titration with a 0.1 M stock solution of 
Na2S2O3 (see above). A concentration of 0.71 mmol/g was determined which corresponds to a yield of 
61%.  
 
(3,5-Dimethylisoxazol-4-yl)zinc Pivalate (115) 
 
According to TP1 LiCl (371 mg, 8.75 mmol) and Zn(OPiv)2 (2.34 g, 8.75 mmol) were dissolved in dry 
THF (14 mL). After addition of Mg turnings (425 mg, 17.5 mmol), 4-bromo-3,5-dimethylisoxazole 
(1.23 g, 7.00 mmol) was added at 25 °C and the reaction mixture was stirred at the same temperature 
for 2 h. After subsequent cannulation to another argon-flushed Schlenk-tube the solvent was removed in 
vacuo. Zinc reagent 115 was obtained as a grey solid (5.47 g). The content of active zinc species was 
determined by titration of 197 mg of the reagent with a stock solution of iodine (0.25 M in THF). A 
concentration of 0.99 mmol/g was determined which corresponds to a yield of 77%. 
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(3-((Diethylcarbamoyl)oxy)phenyl)zinc Pivalate (116) 
 
According to TP1 LiCl (371 mg, 8.75 mmol) and Zn(OPiv)2 (2.34 g, 8.75 mmol) were dissolved in dry 
THF (14 mL). After addition of Mg turnings (425 mg, 17.5 mmol), 4-bromo-3,5-dimethylisoxazole 
(1.23 g, 7.00 mmol) was added at 25 °C and the reaction mixture was stirred at the same temperature 
for 4 h. After subsequent cannulation to another argon-flushed Schlenk-tube the solvent was removed in 
vacuo. Zinc reagent 116 was obtained as a yellow solid (6.17 g). The content of active zinc species was 
determined by titration of 298 mg of the reagent with a stock solution of iodine (0.25 M in THF). A 
concentration of 0.79 mmol/g was determined which corresponds to a yield of 70%. 
 
(Pivaloyloxy)methyl)zinc Pivalate (117) 
 
According to TP2 iodomethyl pivalate (1.69 g, 7.00 mmol) was dissolved in THF (14 mL) and treated 
with iPrMgCl·LiCl (6.27 mL, 1.23 M in THF, 7.70 mmol) at -78 °C for 15 min. Then Zn(OPiv)2 (2.25 g, 
8.40 mmol) was added in one portion and the mixture was stirred at the same temperature for 30 min, 
slowly warmed to room temperature and stirred until all the salts went in solution. After solvent removal 
in vacuo zinc reagent 117 (5.33 g) was obtained as a white solid. The content of active zinc species was 
determined by titration of 161 mg of the reagent with a stock solution of iodine (0.25 M in THF). A 
concentration of 1.14 mmol/g was determined which corresponds to a yield of 87%. 
 
((6-Chloropyridin-3-yl)methyl)zinc Pivalate (118) 
 
According to TP1 LiCl (371 mg, 8.75 mmol) and Zn(OPiv)2 (2.34 g, 8.75 mmol) were dissolved in dry 
THF (14 mL). After addition of Mg turnings (425 mg, 17.5 mmol), 2-chloro-5-(chloromethyl)pyridine 
(1.13 g, 7.00 mmol) was added at 25 °C and the reaction mixture was stirred at the same temperature 
for 6 h. After subsequent cannulation to another argon-flushed Schlenk-tube the solvent was removed in 
vacuo. Zinc reagent 118 was obtained as a brown solid (5.40 g). To determine the content of active zinc 
species 2.00 mL of an iodine stock solution (0.25 M) were added to a solution of 198 mg of the reagent 
in dry THF (2.0 mL). After stirring this mixture for 5 min at 25 °C the excess of iodine was determined 
by titration with a 0.1 M stock solution of Na2S2O3 (see above). A concentration of 0.98 mmol/g was 
determined which corresponds to a yield of 76%. 
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(5,6-Dichloropyrazin-2-yl)zinc Pivalate (119) 
 
According to TP3 2-picoline (559 mg, 6.00 mmol) was treated with TMPMgCl·LiCl (6.94 mL, 1.11 M 
in THF, 7.70 mmol) at –45 °C for 2 h. Then Zn(OPiv)2 (2.25 g, 8.40 mmol) was added in one portion 
and the mixture was slowly warmed to room temperature and was stirred until all the salts went in 
solution. After solvent removal in vacuo zinc reagent 119 (5.90 g) was obtained as a brown solid. To 
determine the content of active zinc species 2.00 mL of an iodine stock solution (0.25 M) were added to 
a solution of 255 mg of zinc reagent 119 in dry THF (2.5 mL). After stirring this mixture for 5 min at 
25 °C the excess of iodine was determined by titration with a 0.1 M stock solution of Na2S2O3 (see 
above). A concentration of 1.12 mmol/g was determined which corresponds to a yield of 94%. 
 
(3-Chloropyridin-2-yl)zinc Pivalate (120) 
 
According to TP4 3-chloropyridine (795 mg, 7.00 mmol) was treated with 
TMPZnOPiv·Mg(OPiv)Cl·LiCl (11.4 mL, 0.92 M in THF, 10.5 mmol) at 50 °C for 1.5 h. After solvent 
removal in vacuo zinc reagent 120 (6.33 g) was obtained as a light brown solid. To determine the content 
of active zinc species 2.00 mL of an iodine stock solution (0.25 M) were added to a solution of 254 mg 
of zinc reagent 120 in dry THF (2.5 mL). After stirring this mixture for 5 min at 25 °C the excess of 
iodine was determined by titration with a 0.1 M stock solution of Na2S2O3 (see above). A concentration 
of 1.04 mmol/g was determined which corresponds to a yield of 94%. 
 
((5-(Morpholinomethyl)pyridin-2-yl)methyl)zinc Pivalate (121) 
 
According to TP4 4-((6-methylpyridin-3-yl)methyl)morpholine (1.20 g, 7.00 mmol) was treated with 
TMPZnOPiv·Mg(OPiv)Cl·LiCl (8.06 mL, 0.93 M in THF, 7.5 mmol) at 50 °C for 2 h. After solvent 
removal in vacuo zinc reagent 121 (6.30 g) was obtained as a light brown solid. To determine the content 
of active zinc species 2.00 mL of an iodine stock solution (0.25 M) were added to a solution of 163 mg 
of 121 in dry THF (1.6 mL). After stirring this mixture for 5 min at 25 °C the excess of iodine was 
determined by titration with a 0.1 M stock solution of Na2S2O3 (see above). A concentration of 
0.74 mmol/g was determined which corresponds to a yield of 75%. 
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(3-Formyl-1-methyl-1H-indol-2-yl)zinc Pivalate (122) 
 
According to TP4 1-methyl-1H-indole-3-carbaldehyde (1.11 g, 7.00 mmol) in THF (7 mL) was treated 
with TMPZnOPiv·Mg(OPiv)Cl·LiCl (9.10 mL, 0.85 M, 7.70 mmol) at 25 °C and stirred at this 
temperature for 0.5 h. After solvent removal in vacuo zinc reagent 122 (6.97 g) was obtained as a yellow 
solid. To determine the content of active zinc species 2.00 mL of an iodine stock solution (0.25 M) were 
added to a solution of 295 mg of 122 in dry THF (3.0 mL). After stirring this mixture for 5 min at 25 °C 
the excess of iodine was determined by titration with a 0.1 M stock solution of Na2S2O3 (see above). A 
concentration of 0.89 mmol/g was determined which corresponds to a yield of 88%. 
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5 Regioselective Transition-Metal-Free Allyl–Allyl Cross-Couplings 
 
Zinc dust (> 98%) was obtained from Sigma Aldrich. Following compounds were prepared according 
to literature procedures: ethyl 5-chlorocyclopent-1-enecarboxylate,133 (E)-1-bromonon-2-ene (124a),134 
tert-butyl 2-(bromomethyl)acrylate (124c),135 5-bromocyclopent-1-enecarbonitrile (124d),136 ethyl 
2-(bromomethyl)acrylate (124e),137 ethyl 6-bromocyclohex-1-enecarboxylate (124f),138 
(E)-(3-bromoprop-1-en-1-yl)trimethylsilane (124g),139 (E)-1-bromo-3,7-dimethylocta-2,6-diene 
(124i),140 (E)-(((4-bromobut-2-en-1-yl)oxy)methyl)benzene (124j),141 (Z)-(((4-bromobut-2-en-1-
yl)oxy)methyl)benzene (124k),141 (3-chloroprop-1-yn-1-yl)trimethylsilane (126a),142 ethyl 
7-bromohept-5-ynoate (126b),143 1,4-dibromobut-2-yne (126c).144 
5.1 Titration of Organozinc Reagents Using Iodine 
A dry flask was charged with accurately weighed I2 (63.5 mg, 0.25 mmol), fitted with a rubber septum, 
and flushed with argon. THF (3–5 mL) was added and stirring was started. After the iodine was 
completely dissolved, the resulting brown solution was cooled to 0 °C in an ice bath and the organozinc 
reagent was added dropwise via a 1.00-mL syringe (0.01-mL graduations) until the brown color 
disappeared.106 
                                                     
133 Z. Peng, T. D. Blümke, P. Mayer, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 8516. 
134 J. Tan, C.-H. Cheon, H. Yamamoto, Angew. Chem. Int. Ed. 2012, 51, 8264. 
135 A. Bergmann, O. Reiser, Chem. Eur. J. 2014, 20, 7613. 
136 J.-B. Langlois, A. Alexakis, Adv. Synth. Catal. 2010, 352, 447. 
137 J. Villieras, M. Rambaud, Synthesis 1982, 924. 
138 C. Sämann, P. Knochel, Synthesis 2013, 1870.  
139 D. J. Vyas, M. Oestreich, Chem. Commun. 2010, 46, 568. 
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143 K. Belyk, M. J. Rozema, P. Knochel, J. Org. Chem. 1992, 57, 4070. 
144 A. Geny, N. Agenet, L. Iannazzo, M. Malacria, C. Aubert, V. Gandon, Angew. Chem. Int. Ed. 2009, 48, 1810. 
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5.2 Cosolvent Evaluation for the Allyl-Allyl Cross-Coupling 
Table 13: Optimization of the conditions for the allyl-allyl cross-coupling 
 
Entry Temp. 
[°C] 
Cosolvent[b] α,α' α,γ γ,α' γ,γ’ Yield[c] 
[%] 
1 25 none 33 25 35 7 75 
2 –10 none 57 27 10 6 65 
3 –40 none 88 8 4 0 61 
4 25 toluene 4 5 89 2 94 
5 25 n-hexane 16 2 82 0 82 
6 25 1,4-dioxane 5 10 81 4 92 
7 25 DMSO 0 5 91 4 100 
8 25 NMP 0 5 95 0 100 
9 25 DMPU 0 0 100 0 100 
10 25 DMPU[d] 10 15 71 4 100 
[a] LiCl is omitted for clarity. [b] A 1:1 mixture with THF was used. [c] Determined by GC-analysis using 
undecane as an internal standard. [d] DMPU was just used as an additive (3.0 equiv. in respect to the organozinc). 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, (E)-1-
bromonon-2-ene (124a, 51.3 mg, 0.25 mmol) was dissolved in the corresponding cosolvent (0.79 mL). 
Prenylzinc bromide (123a) in dry THF (0.38 M in THF, 0.79 mL, 0.30 mmol) was added dropwise and 
the mixture was stirred for 2 h at room temperature. The resulting α,α'/α,γ’/γ,α’/γ,γ’ ratio and the yield 
were determined by GC-analysis using undecane as an internal standard (retention time of isolated 
compounds as reference). 
5.3 Typical Procedures 
Typical Procedure for the Preparation of the Allylzinc Halides of Type 123 (TP1): 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with LiCl (466 mg, 11.0 mmol). The flask was heated to 450 °C for 10 min (heat gun) under high 
vacuum followed by the addition of zinc dust (1.31 g, 20.0 mmol). The vessel was evacuated and refilled 
with argon. THF (10 mL) and 1,2-dibromoethane (215 μL, 2.50 mmol) were added via syringe and the 
reaction mixture was heated to 50 °C until bubbling occurred. The allylic halide (10.0 mmol) was added 
dropwise as a solution in THF (10 mL) over a period of 15 min. The mixture was stirred for the given 
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time at room temperature before the zinc powder was allowed to settle down. The supernatant solution 
was carefully filtrated using a syringe filter and the yield of the resulting solution of the allylzinc halide 
was determined by iodometric titration. 
Typical Procedure for the Allyl-Allyl-Coupling of the Allylzinc Halides of Type 123 with Allylic 
Halides of Type 124 (TP2): 
In a dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, the allylic 
halide (1.0 equiv) was dissolved in dry DMPU (1 M). The allylic zinc halide (1.20 equiv) was added 
dropwise and the mixture was stirred for 1 h at room temperature. Then a sat. aq. NH4Cl solution (5 mL) 
was added, the aqueous layer was extracted with EtOAc (3 × 10 mL), washed with solutions of NaHCO3 
(5 mL, sat. aq.) and NaCl (5 mL, sat. aq.) and the combined organic phases were dried over MgSO4. 
Evaporation of the solvents in vacuo and purification by column chromatography afforded the expected 
products of type 125. 
5.4 Preparation of the Allylzinc Halides 
Prenylzinc Bromide (123a) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol) and THF 
(10 mL) was added prenyl bromide (1.49 g, 10.0 mmol) in THF (10 mL). After 1 h at 25 °C and 
subsequent filtration prenylzinc bromide was obtained as a solution in THF. The content of active zinc 
species was determined by titration with a stock solution of iodine (1.00 M in THF). A concentration of 
0.36 mmol/mL, which corresponds to a yield of 72% was determined. 
 
(E)-Non-2-en-1-ylzinc Bromide (123b) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol) and THF 
(10 mL) was added (E)-non-2-en-1-yl bromide (2.05 g, 10.0 mmol) in THF (10 mL). After 1 h at 25 °C 
and subsequent filtration (E)-non-2-en-1-ylzinc bromide was obtained as a solution in THF. The content 
of active zinc species was determined by titration with a stock solution of iodine (1.00 M in THF). A 
concentration of 0.35 mmol/mL, which corresponds to a yield of 77% was determined. 
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Cinnamylzinc Chloride (123c) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol) and THF 
(10 mL) was added cinnamylchloride (1.52 g, 10.0 mmol) in THF (10 mL). After 2 h at 25 °C and 
subsequent filtration cinnamyl zinc chloride was obtained as a solution in THF. The content of active 
zinc species was determined by titration with a stock solution of iodine (1.00 M in THF). A concentration 
of 0.43 mmol/mL, which corresponds to a yield of 86% was determined. 
 
Geranylzinc Bromide (123d) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol) and THF 
(10 mL) was added geranyl bromide (2.17 g, 10.0 mmol) in THF (10 mL). After 1 h at 25 °C and 
subsequent filtration geranylzinc bromide was obtained as a solution in THF. The content of active zinc 
species was determined by titration with a stock solution of iodine (1.00 M in THF). A concentration of 
0.42 mmol/mL, which corresponds to a yield of 83% was determined. 
 
Nerylzinc Bromide (123e) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol) and THF 
(10 mL) was added neryl bromide (2.17 g, 10.0 mmol) in THF (10 mL). After 1 h at 25 °C and 
subsequent filtration nerylzinc bromide was obtained as a solution in THF. The content of active zinc 
species was determined by titration with a stock solution of iodine (1.00 M in THF). A concentration of 
0.24 mmol/mL, which corresponds to a yield of 58% was determined. 
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(2-((Benzyloxy)methyl)allyl)zinc Chloride (123f) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol) and THF 
(10 mL) was added (((2-(chloromethyl)allyl)oxy)methyl)benzene (1.97 g, 10.0 mmol) in THF (10 mL). 
After 8 h at 50 °C and subsequent filtration (2-((benzyloxy)methyl)allyl)zinc chloride was obtained as 
a solution in THF. The content of active zinc species was determined by titration with a stock solution 
of iodine (1.00 M in THF). A concentration of 0.19 mmol/mL, which corresponds to a yield of 41% was 
determined. 
 
(2-(Ethoxycarbonyl)cyclopent-2-en-1-yl)zinc Chloride (123g) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol) and THF 
(10 mL) was added 5-chlorocyclopent-1-enecarboxylate (1.75 g, 10.0 mmol) in THF (10 mL). After 1 h 
at 25 °C and subsequent filtration (2-(ethoxycarbonyl)cyclopent-2-en-1-yl)zinc chloride was obtained 
as a solution in THF. The content of active zinc species was determined by titration with a stock solution 
of iodine (1.00 M in THF). A concentration of 0.29 mmol/mL, which corresponds to a yield of 60% was 
determined. 
 
(2-Methylallyl)zinc Bromide (123h) 
 
According to TP1 to a mixture of zinc dust (655 mg, 10.0 mmol), LiCl (233 mg, 5.5 mmol) and THF 
(5 mL) was added 3-bromo-2-methylprop-1-ene (675 mg, 5.00 mmol) in THF (5 mL). After 1 h at 25 °C 
and subsequent filtration (2-methylallyl)zinc bromide was obtained as a solution in THF. The content 
of active zinc species was determined by titration with a stock solution of iodine (1.00 M in THF). A 
concentration of 0.30 mmol/mL, which corresponds to a yield of 66% was determined. 
 
Cyclohex-2-en-1-ylzinc Bromide (123i) 
 
According to TP1 to a mixture of zinc dust (1.31 g, 20.0 mmol), LiCl (466 mg, 11.0 mmol) and THF 
(10 mL) was added 3-bromocyclohex-1-ene (1.61 g, 10.0 mmol) in THF (10 mL). After 1 h at 25 °C 
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and subsequent filtration cyclohex-2-en-1-ylzinc bromide was obtained as a solution in THF. The 
content of active zinc species was determined by titration with a stock solution of iodine (1.00 M in 
THF). A concentration of 0.45 mmol/mL, which corresponds to a yield of 89% was determined. 
5.5 Preparation of the Allyl-Allyl-Coupling Products 
(E)-3,3-Dimethyldodeca-1,5-diene (γ,α’-125a) 
 
According to TP2 prenylzinc bromide in dry THF (0.35 M in THF, 1.70 mL, 0.60 mmol) was added to 
(E)-1-bromonon-2-ene (103 mg, 0.50 mmol) in DMPU (1.70 mL) and the mixture was stirred for 1 h at 
room temperature. Purification of the crude product by flash chromatography (silica gel, isohexane) 
afforded the title compound as a colorless oil (90 mg, 0.46 mmol, 93%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.80 (dd, J = 17.8, 10.4 Hz, 1H), 5.43–5.30 (m, 2H), 4.91 (m, 
1H), 4.87 (m, 1H), 2.06–1.93 (m, 4H), 1.22–1.17 (m, 8H), 0.96 (s, 6H), 0.88 (t, J = 6.6 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 148.5, 133.1, 126.5, 110.0, 45.7, 32.6, 31.7, 29.7, 29.6, 28.8, 
26.5, 22.7, 14.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2957 (s), 2907 (vs), 2853 (s), 1746 (w), 1639 (m), 1462 (m), 1413 
(w), 1378 (m), 1362 (w), 1237 (w), 1047 (w), 998 (m), 968 (vs), 909 (vs), 723 (m), 684 (m). 
MS (EI, 70 eV): m/z (%) = 179.3 (1), 151.2 (8), 124.2 (2), 69.1 (100), 55.1 (11), 41.0 (30). 
HRMS (EI): m/z calc. for [C14H26]+: 194.2040; found 194.2026. 
 
2-Methyl-5-vinylundec-2-ene (α,γ’-125a) 
 
According to TP2 (E)-non-2-en-1-ylzinc bromide in dry THF (0.36 M, 1.70 mL, 0.60 mmol) was added 
to prenyl bromide (74 mg, 0.50 mmol) in DMPU (1.70 mL) and the mixture was stirred for 24 h at room 
temperature. Purification of the crude product by flash chromatography (silica gel, isohexane) afforded 
the title compound as a colorless oil (76 mg, 0.39 mmol, 78% (97:3:0:0)). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.68–5.51 (m, 1H), 5.16–5.05 (m, 1H), 5.01–4.86 (m, 2H), 
2.14–1.86 (m, 3H), 1.70 (d, J = 1.4 Hz, 2H), 1.60 (d, J = 1.4 Hz, 3H), 1.49–1.11 (m, 10H), 0.96–0.80 
(m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 143.5, 132.1, 122.9, 113.8, 44.5, 34.4, 33.7, 32.0, 29.6, 27.3, 
25.9, 22.8, 18.1, 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2956, 2908, 2854, 1641, 1461, 1378, 1069, 965, 910. 
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MS (EI, 70 eV): m/z (%) = 194.2 (M+, 2), 151.2 (18), 109.2 (10), 69.2 (100). 
HRMS (EI): m/z calc. for [C14H26]: 194.2035; found: 194.2034 (M+). 
 
tert-butyl 4,4-dimethyl-2-methylenehex-5-enoate (125b) 
 
According to TP2 prenylzinc bromide in dry THF (0.39 M, 1.9 mL, 0.75 mmol) was added to tert-butyl 
2-(bromomethyl)acrylate (133 mg, 0.6 mmol) in DMPU (1.9 mL) and the mixture was stirred for 3 h at 
room temperature. Purification of the crude product by flash chromatography (silica gel, isohexane:Et2O 
20:1) afforded the title compound as a colorless oil (104 mg, 0.49 mmol, 82%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.07 (s, 1H), 5.79 (m, 1H), 5.35 (s, 1H), 4.88 (s, 1H), 4.85 (d, 
J = 4.2, 1H), 2.32 (s, 2H), 1.47 (s, 9H), 0.98 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 167.4, 147.7, 139.7, 126.4, 110.7, 80.5, 43.5, 37.5, 28.1, 26.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 668 (vw), 687 (w), 751 (w), 761 (w), 816 (m), 851 (m), 870 (w), 
886 (w), 909 (m), 942 (w), 1000 (w), 1007 (w), 1047 (vw), 1127 (s), 1151 (vs), 1210 (w), 1255 (w), 
1288 (w), 1311 (w), 1343 (w), 1367 (m), 1380 (w), 1392 (w), 1415 (w), 1458 (w), 1474 (w), 1628 (w), 
1640 (w), 1712 (s), 2871 (vw), 2931 (w), 2966 (w). 
MS (EI, 70 eV): m/z (%) = 154.1 (8), 137.1 (12), 112.1 (15), 69.1 (100), 57.1 (63), 41.0 (37). 
HRMS (EI): m/z calc. for [C9H14O2]+: 154.0994; found: 154.0998 (M − tBu + H+). 
 
5-(2-Methylbut-3-en-2-yl)cyclopent-1-ene-1-carbonitrile (125c) 
 
According to TP2 prenylzinc bromide in dry THF (0.35 M in THF, 1.70 mL, 0.60 mmol) was added to 
5-bromocyclopent-1-ene-1-carbonitrile (86 mg, 0.50 mmol) in DMPU (1.70 mL) and the mixture was 
stirred for 24 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane) afforded the title compound as a colorless oil (73 mg, 0.45 mmol, 91%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.70 (td, J = 2.7, 1.8 Hz, 1H), 5.77 (dd, J = 17.7, 10.5 Hz, 1H), 
5.02–4.90 (m, 2H), 2.82–2.71 (m, 1H), 2.43–2.25 (m, 2H), 2.00–1.84 (m, 1H), 1.80–1.64 (m, 1H), 1.04 
(s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 152.5, 145.4, 118.2, 116.7, 112.7, 56.6, 40.4, 33.0, 26.3, 25.0, 
24.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2966 (s), 2917 (s), 2217 (m), 1726 (vs), 1657 (m), 1474 (s), 1410 
(s), 1367 (s), 1266 (s), 1170 (vs), 1045 (vs), 917 (vs), 801 (s). 
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MS (EI, 70 eV): m/z (%) = 161.3 (4), 104.2 (2), 93.2 (7), 69.1 (100). 
HRMS (EI): m/z calc. for [C7H6N]+: 161.1199; found 161.1204. 
 
tert-Butyl 2-methylene-4-vinyldecanoate (125d) 
 
According to TP2 (E)-oct-2-en-1-ylzinc bromide in dry THF (0.30 M, 2.00 mL, 0.60 mmol) was added 
to tert-butyl 2-(bromomethyl)acrylate (96.5 mg, 0.50 mmol) in DMPU (0.5 mL) and the mixture was 
stirred for 1 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 20:1) afforded the title compound as a colorless oil (122 mg, 0.46 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.05 (d, J = 1.8 Hz, 1H), 5.50 (ddd, J = 17.1, 10.3, 8.4 Hz, 
1H), 5.42–5.33 (m, 1H), 4.99–4.81 (m, 2H), 2.43–2.27 (m, 1H), 2.26–2.11 (m, 2H), 1.48 (s, 9H), 1.43–
1.14 (m, 10H), 0.94–0.80 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.8, 142.5, 140.9, 125.1, 114.7, 80.5, 43.5, 38.1, 34.8, 32.0, 
29.5, 28.2, 27.2, 22.8, 14.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2958, 2926, 2856, 1712, 1632, 1457, 1419, 1392, 1367, 1340, 
1309, 1253, 1212, 1150, 1112, 1037, 994, 939, 910, 877, 852, 816, 760, 724, 698. 
MS (EI, 70 eV): m/z (%) = 210 (M–tBu, 62), 193 (15), 165 (M–CO2tBu, 57), 139 (33), 122 (39), 111 
(33), 95 (34), 83 (39), 69 (50), 57 (100). 
HRMS (EI): m/z calc. for [C13H22O2]: 210.1620; found: 210.1643 (M–tBu). 
 
tert-Butyl 2-methylene-4-phenylhex-5-enoate (125e) 
 
According to TP2 (3-Phenylprop-2-enyl)zinc chloride in dry THF (0.31 M in THF, 3.90 mL, 1.20 mmol) 
was added to tert-butyl(2-bromomethyl)acrylate (221 mg, 1.00 mmol) in DMPU (1.00 mL) and the 
mixture was stirred for 1 h at room temperature. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 100:1) afforded the title compound as a colorless oil 
(250 mg, 0.96 mmol, 96%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.35–7.24 (m, 2H), 7.23–7.09 (m, 3H), 6.03 (d, J = 1.6 
Hz, 1H), 6.01–5.90 (m, 1H), 5.31 (dd, J = 2.7, 1.1 Hz, 1H), 5.08–4.95 (m, 2H), 3.56 (q, J = 7.7 Hz, 
1H), 2.77–2.59 (m, 2H), 1.49 (s, 9H). 
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13C-NMR (75 MHz, CDCl3): δ / ppm = 166.5, 143.8, 141.3, 140.1, 128.6, 127.9, 126.4, 126.0, 
114.9, 80.6, 49.1, 38.7, 28.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3062, 3026, 2976, 2891, 1706, 1631, 1600, 1491, 1477, 1452, 
1391, 1366, 1337, 1305, 1250, 1211, 1142, 1075, 1030, 991, 941, 912, 877, 815, 786, 752, 698, 665. 
MS (EI, 70 eV): m/z (%) = 258.1 (M, 1), 202.0 (20), 185.0 (M -tBuO, 15), 141.0 (5), 117.0 (100). 
HRMS (EI): m/z calc. for [C13H13O]+: 185.0966; found: 185.0960 ([M-OtBu]+). 
 
Ethyl 4,8-Dimethyl-2-methylene-4-vinylnon-7-enoate (125f) 
 
According to TP2 geranylzinc bromide in dry THF (0.37 M, 1.40 mL, 0.45 mmol) was added to ethyl 
2-(bromomethyl)acrylate (97 mg, 0.50 mmol) in DMPU (1.35 mL) and the mixture was stirred for 12 h 
at room temperature. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 20:1) afforded the title compound as a colorless oil (115 mg, 0.46 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.13 (d, J = 1.8 Hz, 1H), 5.69 (dd, J = 17.5, 10.8 Hz, 1H), 5.41 
(dt, J = 1.7, 0.9 Hz, 1H), 5.11–5.02 (m, 1H), 4.95 (dd, J = 10.8, 1.4 Hz, 1H), 4.83 (dd, J = 17.5, 1.4 Hz, 
1H), 4.16 (q, J = 7.2 Hz, 2H), 2.43 (dd, J = 13.2, 0.9 Hz, 1H), 2.32 (dd, J = 13.2, 0.9 Hz, 1H), 1.98–1.81 
(m, 2H), 1.72–1.61 (m, 3H), 1.57 (s, 3H), 1.42–1.20 (m, 5H), 0.93 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 168.3, 145.9, 138.3, 131.3, 127.1, 124.9, 112.3, 60.7, 42.6, 
41.1, 40.6, 25.8, 23.1, 21.2, 17.7, 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2969 (m), 2917 (m), 1717 (vs), 1627 (m), 1445 (m), 1413 (m), 
1369 (m), 1177 (vs), 1147 (s), 1115 (s), 1028 (m), 1003 (m), 942 (m), 911 (s), 857 (w), 815 (m), 754 
(w). 
MS (EI, 70 eV): m/z (%) = 250.3 (M+, 1), 207.3 (7), 137.2 (22), 69.1 (100). 
HRMS (EI): m/z calc. for [C16H26O2]+: 250.1933; found 250.1933. 
 
tert-butyl 4,8-dimethyl-2-methylene-4-vinylnon-7-enoate (125g) 
 
According to TP2 geranylzinc bromide in dry THF (0.29 M, 1.7 mL, 0.5 mmol) was added to tert-butyl 
2-(bromomethyl)acrylate (88 mg, 0.4 mmol) in DMPU (1.7 mL) and the mixture was stirred for 3 h at 
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room temperature. Purification of the crude product by flash chromatography (silica gel, isohexane) 
afforded the title compound as a colorless oil (100 mg, 0.36 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.06 (d, J=2.0, 1H), 5.70 (dd, J=17.5, 10.8, 1H), 5.34 (dd, 
J=2.0, 1.0, 1H), 5.10–5.03 (m, 1H), 4.95 (dd, J=10.8, 1.4, 1H), 4.85 (dd, J=17.5, 1.4, 1H), 2.39 (dd, 
J=13.1, 0.9, 1H), 2.28 (dd, J=13.1, 0.9, 1H), 1.93–1.83 (m, 2H), 1.66 (d, J=1.3, 3H), 1.59–1.54 (m, 4H), 
1.47 (s, 9H), 1.35–1.28 (m, 2H), 0.94 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 167.5, 146.0, 139.6, 131.3, 126.4, 125.0, 112.3, 80.5, 42.6, 
41.2, 40.6, 28.1, 25.8, 23.1, 21.2, 17.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 666 (w), 760 (w), 783 (w), 802 (w), 815 (m), 833 (w), 852 (m), 
874 (w), 888 (w), 910 (m), 940 (m), 987 (w), 1003 (m), 1118 (m), 1147 (vs), 1208 (w), 1254 (m), 1294 
(m), 1306 (w), 1345 (w), 1367 (m), 1392 (m), 1414 (w), 1455 (m), 1478 (w), 1548 (w), 1628 (w), 1662 
(w), 1712 (s), 2920 (w), 2971 (w), 3083 (vw). 
MS (EI, 70 eV): m/z (%) = 222.2 (11), 179.1 (22), 137.1 (29), 82.1 (26), 81.1 (56), 69.1 (100). 
HRMS (EI): m/z calc. for [C14H22O2]+: 222.1630; found: 222.1611 (M−tBu+H+). 
 
Ethyl 6-(2-(Benzyloxy)allyl)cyclohex-1-enecarboxylate (125h) 
 
According to TP2 (2-((benzyloxy)methyl)allyl)zinc chloride in dry THF (0.21 M, 3.33 mL, 0.70 mmol) 
was added to ethyl 6-bromocyclohex-1-enecarboxylate (135 mg, 0.58 mmol) in DMPU (3.3 mL) and 
the mixture was stirred for 2 h at room temperature. Purification of the crude product by flash 
chromatography (silica gel, isohexane:Et2O 20:1) afforded the title compound as a colorless oil (157 mg, 
0.523 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.33–7.24 (m, 4H), 7.24–7.17 (m, 1H), 6.71 (td, J = 2.6, 1.4 
Hz, 1H), 5.09–5.01 (m, 1H), 4.92–4.85 (m, 1H), 4.45 (d, J = 1.3 Hz, 2H), 4.18–4.04 (m, 2H), 3.93 (s, 
2H), 3.14–3.02 (m, 1H), 2.59–2.50 (m, 1H), 2.50–2.24 (m, 2H), 2.06–1.93 (m, 1H), 1.92–1.81 (m, 1H), 
1.75–1.65 (m, 1H), 1.20 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.2, 144.9, 143.9, 140.1, 138.6, 128.4, 127.7, 127.6, 112.8, 
73.1, 72.1, 60.1, 42.3, 37.7, 31.5, 29.2, 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3422, 3065, 2938, 2361, 1714, 1654, 1603, 1584, 1559, 1540, 
1496, 1452, 1371, 1270, 1205, 1176, 1095, 1070, 1025, 914, 860, 828, 749, 714, 698, 668, 648. 
MS (EI, 70 eV): m/z (%) = 300 (M+, 1), 255 (2), 194 (9), 163 (19), 139 (20), 117 (11), 91 (100), 67 
(13). 
HRMS (EI): m/z calc. for [C18H21O3]+: 285.1491; found 285.2805 (M–Me). 
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Ethyl 5-(3-Methylbut-2-en-1-yl)cyclopent-1-enecarboxylate (125i) 
 
According to TP2 (2-(ethoxycarbonyl)cyclopent-2-en-1-yl)zinc chloride in dry THF (0.23 M, 4.35 mL, 
1.00 mmol) was added to prenyl bromide (119 mg, 0.80 mmol) in DMPU (4.35 mL) and the mixture 
was stirred for 12 h at room temperature. Purification of the crude product by flash chromatography 
(silica gel, isohexane/EtOAc = 20:1) afforded the title compound as a colorless oil (139 mg, 0.67 mmol, 
84%). 
1H-NMR (800 MHz, CDCl3): δ / ppm = 6.79 (td, J = 2.6, 1.4 Hz, 1H), 5.19–5.10 (m, 1H), 4.27–4.15 
(m, 2H), 3.04–2.95 (m, 1H), 2.52–2.44 (m, 1H), 2.44–2.33 (m, 2H), 2.10–1.97 (m, 2H), 1.75–1.66 (m, 
4H), 1.63 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H). 
13C-NMR (201 MHz, CDCl3): δ / ppm = 165.5, 144.0, 140.0, 132.8, 122.5, 60.1, 44.6, 32.0, 31.8, 29.1, 
26.0, 18.0, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3418, 2968, 2928, 2858, 1711, 1628, 1588, 1446, 1371, 1345, 
1294, 1256, 1238, 1194, 1094, 1049, 1024, 986, 920, 861, 823, 751, 668. 
MS (EI, 70 eV): m/z (%) = 208 (M+, 39), 162 (28), 139 (73), 111 (72), 93 (34), 69 (100). 
HRMS (EI): m/z calc. for [C13H20O2]+: 208.1463; found 208.1459. 
 
(E)-(4,4-dimethylhexa-2,5-dien-1-yl)trimethylsilane (125j) 
 
According to TP2 prenylzinc bromide in dry THF (0.4 M, 1.86 mL, 0.75 mmol) was added to (E)-(3-
bromoprop-1-en-1-yl)trimethylsilane (116 mg, 0.6 mmol) in DMPU (1.9 mL) and the mixture was 
stirred for 3 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, pentane) afforded the title compound as a colorless oil (86 mg, 0.47 mmol, 79%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.96 (dt, J = 18.5, 7.0, 1H), 5.85–5.75 (m, 1H), 5.61 (dt, J = 
18.5, 1.3, 1H), 4.92 (s, 1H), 4.88 (d, J = 5.8, 1H), 2.08 (dd, J = 7.0, 1.3, 2H), 0.97 (s, 7H), 0.04 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 148.4, 143.8, 133.2, 110.4, 50.0, 36.9, 26.7, -1.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 690 (m), 705 (m), 748 (m), 767 (w), 834 (vs), 858 (s), 885 (w), 
911 (m), 991 (m), 1126 (vw), 1194 (vw), 1247 (m), 1301 (vw), 1363 (w), 1379 (w), 1416 (w), 1470 
(vw), 1617 (w), 1640 (w), 2957 (m). 
MS (EI, 70 eV): m/z (%) = 182.1 (M+, 2), 113.2 (13), 108.1 (24), 73.0 (69), 69.1 (100). 
HRMS (EI): m/z calc. for [C11H22Si]+: 182.1491; found: 182.1484 (M+). 
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2,5,9-trimethyl-5-vinyldeca-2,8-diene (125k) 
 
According to TP2 geranylzinc bromide in dry THF (0.31 M, 2.4 mL, 0.75 mmol) was added to 1-bromo-
3-methylbut-2-ene (89 mg, 0.6 mmol) in DMPU (2.4 mL) and the mixture was stirred for 3 h at room 
temperature. Purification of the crude product by flash chromatography (silica gel, isohexane) afforded 
the title compound as a colorless oil (103 mg, 0.50 mmol, 83% (94:6:0:0)). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.73 (dd, J = 17.5, 10.8, 1H), 5.06–5.14 (m, 2H), 4.98 (dd, J 
= 10.8, 1.5, 1H), 4.90 (dd, J = 17.5, 1.5, 1H), 1.99 (p, J = 7.7, 2H), 1.86 (q, J = 7.7, 2H), 1.71–1.68 (m, 
4H), 1.68–1.66 (m, 3H), 1.59 (d, J = 5.2, 6H), 1.32–1.26 (m, 2H), 0.95 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.3, 132.9, 131.1, 125.2, 120.9, 111.6, 40.5, 40.4, 39.2, 
26.2, 25.9, 23.1, 22.7, 18.1, 17.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 654 (m), 683 (m), 732 (m), 782 (m), 800 (m), 834 (m), 866 (m), 
886 (m), 909 (vs), 987 (m), 1001 (s), 1055 (m), 1102 (m), 1133 (m), 1255 (m), 1376 (m), 1413 (m), 
1453 (s), 1484 (m), 1549 (m), 1638 (m), 1662 (m), 2857 (m), 2915 (m), 2924 (m), 2967 (m). 
MS (EI, 70 eV): m/z (%) = 206.2 (M+, 15), 191.2 (17), 163.1 (51), 137.1 (100), 95.1 (92), 82.1 (57), 
69.2 (48). 
HRMS (EI): m/z calc. for [C15H26]+: 206.2035; found: 206.2026 (M+). 
 
(E)-2,9-Dimethyldeca-1,5,9-triene (125l) 
 
According to TP2 (2-methylallyl)zinc bromide in dry THF (0.30 M, 4.00 mL, 1.20 mmol) was added to 
(E)-1,4-dibromobut-2-ene (107 mg, 0.50 mmol) in DMPU (4.00 mL) and the mixture was stirred for 3 h 
at room temperature. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 20:1) afforded the title compound as a colorless oil (74 mg, 0.45 mmol, 90%). 
1H-NMR (800 MHz, CDCl3): δ / ppm = 5.47–5.39 (m, 2H), 4.73–4.63 (m, 4H), 2.19–2.09 (m, 4H), 
2.09–2.01 (m, 4H), 1.75–1.68 (m, 6H). 
13C-NMR (201 MHz, CDCl3): δ / ppm = 145.8, 130.1, 110.0, 77.5, 77.2, 76.8, 38.0, 30.9, 22.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2956 (m), 2924 (m), 2854 (m), 1740 (m), 1716 (m), 1458 (m), 
1377 (m), 1261 (m), 1092 (m), 1022 (m), 799 (m). 
MS (EI, 70 eV): m/z (%) = 164 (M+, 1), 149 (51), 135 (7), 122 (10), 108 (30), 93 (50), 81 (54), 67 (100), 
55 (64). 
HRMS (EI): m/z calc. for [C11H17]+: 149.1330; found 149.1335 (M–Me). 
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(E)-3-(3,7-dimethylocta-2,6-dien-1-yl)cyclohex-1-ene (125m) 
 
According to TP2 cyclohex-2-en-1-ylzinc bromide in dry THF (0.24 M, 2.5 mL, 0.6 mmol) was added 
to (E)-1-bromo-3,7-dimethylocta-2,6-diene (104 mg, 0.48 mmol) in DMPU (2.5 mL) and the mixture 
was stirred for 3 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane) afforded the title compound as a colorless oil (78 mg, 0.36 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.69–5.64 (m, 1H), 5.60–5.56 (m, 1H), 5.21–5.13 (m, 1H), 
5.12–5.07 (m, 1H), 2.14–2.05 (m, 3H), 2.04–1.93 (m, 6H), 1.80–1.69 (m, 2H), 1.68 (d, J = 1.4, 3H), 
1.60 (d, J = 3.1, 6H), 1.57–1.45 (m, 2H), 1.29–1.16 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 136.0, 132.2, 131.4, 127.0, 124.5, 123.2, 40.0, 36.1, 34.7, 
29.1, 26.8, 25.9, 25.5, 21.7, 17.8, 16.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 558 (m), 567 (w), 591 (w), 604 (w), 675 (s), 700 (m), 720 (vs), 
835 (m), 859 (m), 887 (m), 956 (w), 1108 (w), 1376 (m), 1436 (m), 1446 (s), 2839 (m), 2856 (s), 2922 
(vs), 2966 (m), 3017 (w). 
MS (EI, 70 eV): m/z (%) = 218.2 (M+, 6), 137.0 (14), 95.0 (16), 81.1 (100), 69.1 (52), 40.7 (10). 
HRMS (EI): m/z calc. for [C16H26]+: 218.2035; found: 218.2026 (M+). 
 
(Z)-2,6-Dimethyl-9-vinylpentadeca-2,6-diene (125n) 
 
According to TP2 (E)-non-2-en-1-ylzinc bromide in dry THF (0.30 M, 2.00 mL, 0.60 mmol) was added 
to geranyl bromide (109 mg, 0.50 mmol) in DMPU (0.5 mL) and the mixture was stirred for 1 h at room 
temperature. Purification of the crude product by flash chromatography (silica gel, isohexane) afforded 
the title compound as a colorless oil (110 mg, 0.42 mmol, 84%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.66–5.51 (m, 1H), 5.18–5.01 (m, 2H), 4.99–4.85 (m, 2H), 
2.15–1.88 (m, 7H), 1.71–1.63 (m, 3H), 1.63–1.54 (m, 5H), 1.44–1.07 (m, 10H), 0.86 (t, J = 6.7 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 143.5, 135.7, 131.3, 124.6, 122.9, 113.8, 44.5, 40.0, 34.4, 
33.6, 32.0, 29.6, 27.3, 26.9, 25.8, 22.8, 17.8, 16.3, 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3423, 2955, 2927, 2872, 2857, 1717, 1641, 1457, 1418, 1378, 
1165, 1071, 995, 951, 912, 725, 668. 
MS (EI, 70 eV): m/z (%) = 262 (M+, 1), 247 (2), 219 (4), 95 (14), 81 (38), 69 (100), 55 (28). 
HRMS (EI): m/z calc. for [C19H34]: 262.2661; found: 262.2657 (M+). 
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(E)-(((5,5-Dimethylhepta-2,6-dien-1-yl)oxy)methyl)benzene ((E)-γ,α’-125o) 
 
According to TP2 prenylzinc bromide in dry THF (0.44 M, 1.5 mL, 0.66 mmol) was added to (E)-(((4-
bromobut-2-en-1-yl)oxy)methyl)benzene (130 mg, 0.54 mmol) in DMPU (1.5 mL) and the mixture was 
stirred for 24 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane:ether 20:1) afforded the title compound as a colorless oil (96 mg, 0.42 mmol, 77%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.34 (m, 4H), 7.30 (m, 1H), 5.86–5.76 (m, 1H), 5.72–5.52 (m, 
2H), 4.94 (s, 1H), 4.90 (dd, J = 6.2, 1.3, 1H), 4.50 (s, 2H), 3.98 (d, J = 6.0, 2H), 2.06 (d, J = 6.0, 2H), 
1.00 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 148.2, 138.5, 131.6, 128.9, 128.5, 127.9, 127.7, 110.6, 71.8, 
70.9, 45.5, 36.9, 26.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 696 (vs), 733 (s), 818 (w), 910 (s), 972 (s), 1000 (m), 1028 (m), 
1061 (m), 1107 (s), 1156 (w), 1202 (w), 1362 (m), 1379 (w), 1414 (w), 1454 (m), 1470 (w), 1496 (w), 
1639 (w), 2853 (w), 2927 (w), 2961 (w). 
MS (EI, 70 eV): m/z (%) = 230.2 (M+, 1), 108.0 (11), 107.0 (10), 92.0 (13), 91.0 (100), 69.1 (89). 
HRMS (EI): m/z calc. for [C16H22O]: 230.1671; found: 230.1654 (M+). 
 
(Z)-(((5,5-dimethylhepta-2,6-dien-1-yl)oxy)methyl)benzene ((Z)-γ,α’-125o) 
 
According to TP2 prenylzinc bromide in dry THF (0.4 M, 1.86 mL, 0.75 mmol) was added to (Z)-(((4-
bromobut-2-en-1-yl)oxy)methyl)benzene (145 mg, 0.6 mmol) in DMPU (1.9 mL) and the mixture was 
stirred for 1 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane:ether 20:1) afforded the title compound as a colorless oil (105 mg, 0.46 mmol, 76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.37–7.27 (m, 4H), 5.83–5.72 (m, 1H), 5.73–5.65 (m, 1H), 
5.63–5.55 (m, 1H), 4.94 (s, 1H), 4.93–4.87 (m, 1H), 4.51 (s, 2H), 4.07 (dd, J = 6.4, 1.3, 2H), 2.04 (dd, 
J = 7.6, 1.3, 2H), 0.99 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.9, 138.5, 130.2, 128.5, 127.9, 127.9, 127.7, 110.8, 72.3, 
66.0, 40.2, 37.1, 26.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 696 (vs), 712 (s), 736 (s), 828 (m), 876 (m), 911 (s), 999 (s), 1027 
(m), 1070 (s), 1097 (s), 1176 (w), 1203 (m), 1272 (m), 1313 (w), 1344 (w), 1363 (m), 1380 (m), 1414 
(w), 1454 (m), 1470 (w), 1496 (w), 1641 (w), 1704 (w), 1722 (w), 2868 (w), 2961 (m), 3030 (w). 
MS (EI, 70 eV): m/z (%) = 229.2 (0.3), 108.8 (13), 107.7 (12), 92.0 (13). 
HRMS (EI): m/z calc. for [C16H21O]+: 229.1568; found: 229.1592 (M − H+). 
122   
Trimethyl(4-vinyldec-1-yn-1-yl)silane (127a) 
 
According to TP2 (E)-oct-2-en-1-ylzinc bromide in dry THF (0.24 M, 2.76 mL, 0.66 mmol) was added 
to (3-chloroprop-1-yn-1-yl)trimethylsilane (81 mg, 0.55 mmol) in DMPU (2.75 mL) and the mixture 
was stirred for 2 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 80:1) afforded the title compound as a colorless oil (114 mg, 0.48 mmol, 88%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.74–5.60 (m, 1H), 5.08–4.96 (m, 2H), 2.27–2.23 (m, 2H), 
2.22–2.13 (m, 1H), 1.36–1.19 (m, 8H), 0.92–0.83 (m, 3H), 0.14 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 141.6, 114.8, 106.0, 85.9, 42.9, 33.7, 31.9, 29.4, 27.0, 25.9, 
22.8, 14.2, 0.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2923, 2361, 2340, 1734, 1559, 1458, 668. 
MS (EI, 70 eV): m/z (%) = 236 (M+, 1), 221 (2), 165 (9), 152 (8), 128 (20), 85 (18), 73 (100). 
HRMS (EI): m/z calc. for [C14H25Si]+: 221.1726; found 221.1726 (M–Me). 
 
Ethyl 8,8-Dimethyldec-9-en-5-ynoate (127b) 
 
According to TP2 prenylzinc bromide in dry THF (0.36 M, 2.1 mL, 0.75 mmol) was added to ethyl 7-
bromohept-5-ynoate (140 mg, 0.6 mmol) in DMPU (2.1 mL) and the mixture was stirred for 3 h at room 
temperature. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 
25:1) afforded the title compound as a colorless oil (106 mg, 0.48 mmol, 79%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.87 (dd, J = 17.5, 10.7, 1H), 5.01–4.91 (m, 2H), 4.13 (q, J = 
7.1, 2H), 2.43 (t, J = 7.5, 2H), 2.24 (tt, J = 6.9, 2.4, 2H), 2.12 (t, J = 2.4, 2H), 1.85–1.75 (m, 2H), 1.26 
(t, J = 7.1, 4H), 1.07 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.5, 147.3, 110.9, 80.9, 78.8, 60.4, 36.8, 33.3, 32.6, 26.5, 
24.5, 18.4, 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 683 (w), 805 (w), 868 (w), 912 (m), 999 (w), 1008 (w), 1028 (m), 
1054 (m), 1097 (w), 1115 (w), 1156 (s), 1176 (m), 1207 (m), 1243 (m), 1311 (w), 1323 (w), 1364 (w), 
1375 (m), 1416 (w), 1464 (w), 1641 (w), 1734 (vs), 2873 (w), 2909 (w), 2934 (w), 2963 (w). 
MS (EI, 70 eV): m/z (%) = 222 (M+, 0.4), 207 (19), 177 (10), 161 (10), 134 (20), 121 (23), 69 (100). 
HRMS (EI): m/z calc. for [C14H22O2]+: 222.1620; found 222.1614 (M+). 
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3,3,8,8-Tetramethyldeca-1,9-dien-5-yne (127c) 
 
According to TP2 prenylzinc bromide in dry THF (0.36 M, 6.94 mL, 2.50 mmol) was added to 1,4-
dibromobut-2-yne (212 mg, 1.00 mmol) in DMPU (7 mL) and the mixture was stirred for 3 h at room 
temperature. Purification of the crude product by flash chromatography (silica gel, isohexane) afforded 
the title compound as a colorless oil (162 mg, 0.85 mmol, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 5.82 (dd, J = 17.5, 10.7 Hz, 2H), 4.96–4.82 (m, 4H), 2.08 (s, 
4H), 1.02 (s, 12H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.5, 110.8, 79.6, 37.0, 32.7, 26.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3084, 3002, 2962, 2928, 2908, 2870, 2832, 1642, 1468, 1416, 
1380, 1362, 1318, 1262, 1194, 1180, 1142, 1048, 998, 910, 872, 806, 722, 686. 
MS (EI, 70 eV): m/z (%) = 190 (M+, 1), 175 (18), 147 (20), 119 (13), 105 (14), 91 (11), 79 (8), 69 (100), 
53 (8). 
HRMS (EI): m/z calc. for [C13H19]+: 175.1487; found: 175.1496 ([M–Me]+). 
 
1-Bromo-3-(2,2-dimethylbut-3-en-1-yl)benzene (129a) 
 
According to TP2 prenylzinc bromide in dry THF (0.36 M, 1.67 mL, 0.6 mmol) was added to 1-bromo-
3-(bromomethyl)benzene (125 mg, 0.50 mmol) in DMPU (1.7 mL) and the mixture was stirred for 1 h 
at room temperature. Purification of the crude product by flash chromatography (silica gel, isohexane) 
afforded the title compound as a colorless oil (75 mg, 0.31 mmol, 63%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.31–7.23 (m, 1H), 7.23–7.17 (m, 1H), 7.05 (t, J = 7.7 Hz, 
1H), 6.97 (dt, J = 7.7, 1.3 Hz, 1H), 5.76 (dd, J = 17.5, 10.7 Hz, 1H), 4.87 (dd, J = 10.7, 1.3 Hz, 1H), 
4.79 (dd, J = 17.5, 1.3 Hz, 1H), 2.48 (s, 2H), 0.94 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.6, 141.3, 133.5, 129.3, 129.2, 129.2, 121.8, 111.2, 48.8, 
37.8, 26.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3083, 2961, 2927, 2869, 2361, 2340, 1639, 1593, 1566, 1472, 
1425, 1362, 1206, 1072, 998, 912, 886, 844, 782, 726, 697, 668. 
MS (EI, 70 eV): m/z (%) = 238 (M+, 8), 171 (10), 115 (7), 90 (9), 69 (100). 
HRMS (EI): m/z calc. for [C12H15Br]+: 238.0357; found: 238.0346 (M+). 
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Methyl 4-(2,2-Dimethylbut-3-en-1-yl)benzoate (129b) 
 
According to a modified TP2 prenylzinc bromide in dry THF (0.36 M, 1.39 mL, 0.5 mmol) was added 
to methyl 4-(bromomethyl)benzoate (115 mg, 0.50 mmol) in DMPU (1.4 mL) and the mixture was 
stirred for 3 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane/ether 20:1) afforded the title compound as a colorless oil (78 mg, 0.36 mmol, 72%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.92 (d, J = 8.2, 2H), 7.17 (d, J = 8.2, 2H), 5.83 (dd, J = 17.4, 
10.7, 1H), 4.92 (dd, J = 10.7, 1.2, 1H), 4.82 (dd, J = 17.4, 1.2, 1H), 3.90 (s, 3H), 2.63 (s, 2H), 1.00 (s, 
6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 167.4, 147.6, 144.6, 130.7, 129.0, 128.0, 111.2, 52.1, 49.2, 
38.0, 26.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 684 (w), 702 (m), 722 (s), 772 (m), 804 (w), 836 (w), 860 (m), 
912 (m), 970 (w), 1006 (w), 1020 (m), 1100 (s), 1110 (s), 1178 (s), 1274 (vs), 1310 (w), 1364 (w), 1380 
(w), 1416 (m), 1434 (m), 1462 (w), 1574 (vw), 1612 (m), 1638 (w), 1720 (vs), 2870 (vw), 2928 (w), 
2960 (w), 3084 (vw). 
MS (EI, 70 eV): m/z (%) = 218 (M+, 0.4), 187 (8), 150 (100), 90 (6), 69 (20). 
HRMS (EI): m/z calc. for [C14H18O2]+: 218.1307; found: 218.1304 (M+). 
 
6 Preparation of Tertiary Amines by the Reaction of Iminium Ions 
Derived from Unsymmetrical Aminals with Zinc and Magnesium 
Organometallics 
 
MeLi was purchased as a solution in diethylether from Rockwood Lithium GmbH and the content of 
organometallic reagent was determined by the method of Paquette using iPrOH and 1,10-phenanthroline 
as indicator.145 MeMgCl was purchased as a solution in THF from Rockwood Lithium GmbH and 
titrated against iodine prior to use. Following compounds were prepared according to literature 
procedures: 136a, 137a, 138a,b and titrated against iodine prior to use.146 
 
Procedure A 
 A dry and argon-flushed Schlenk flask, equipped with a magnetic stirring bar and a septum, was charged 
with N,N,N’,N’-tetramethylmethanediamine (2, 1.0 equiv) and anhydrous CH2Cl2 to obtain a 1 M 
                                                     
145 H.-S. Lin, A. Paquette, Synth. Commun.1994, 24, 2503. 
146 F. M. Piller, A Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 7192. 
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solution. After cooling to 0 °C, trifluoroacetic anhydride (1.0 equiv) was added dropwise and the 
solution was allowed to stirr for 15 min at 0 °C. A second dry and argon-flushed Schlenk flask, equipped 
with a magnetic stirring bar and a septum, was charged with the corresponding amine (1.0 equiv) and 
THF to obtain a 0.2 M solution. After cooling to 0 °C, MeMgCl (1.1 equiv. 3.1 M in THF) was added 
dropwise and the solution was stirred for 30 min. Next, the magnesium amide was added over 15 min 
to the previously prepared methylene(dimethyl)iminium trifluoroacetate (1) at 0 °C and stirring was 
continued for another 30 min. After, trifluoroacetic anhydride (1.0 equiv) was added, resulting in the 
formation of a white precipitate and the mixture was stirred for 15 min. Finally, the desired 
organomagnesium / organozinc reagent (1.1 equiv) was added at –78 °C and the reaction mixture 
warmed to room temperature giving a clear solution. The crude mixture was quenched with sat. aq. 
NaHCO3 and extracted with EtOAc (3 x 20 mL). The combined organic layers were washed with sat. 
aq. NaCl and the solvent was removed in vacuo. 
 
Procedure B 
A dry and argon-flushed Schlenk flask, equipped with a magnetic stirring bar and a septum, was charged 
with N,N,N’,N’-tetramethylmethanediamine (2, 1.0 equiv) and anhydrous CH2Cl2 to obtain a 1 M 
solution. After cooling to 0 °C, trifluoroacetic anhydride (1.0 equiv) was added dropwise and the 
solution was allowed to stirr for 15 min at 0 °C.  
A second dry and argon-flushed Schlenk flask, equipped with a magnetic stirring bar and a septum, was 
charged with the corresponding amine (1.0 equiv) and THF to obtain a 0.2 M solution. After cooling to 
–78 °C, MeLi (1.1 equiv., 1.6 M in Et2O) was added dropwise and the solution was stirred for 30 min. 
Next, the lithium amide was added over 15 min to the previously prepared methylene(dimethyl)iminium 
trifluoroacetate (1) –78 °C and stirring was continued for another 30 min. Then, trifluoroacetic anhydride 
(1.0 equiv) was added, resulting in the formation of a white precipitate and the mixture was stirred for 
15 min. Finally, the desired organomagnesium / organozinc reagent (1.1 equiv) was added at –78 °C 
and the reaction mixture warmed to room temperature giving a clear solution. The crude mixture was 
quenched with sat. aq. NaHCO3 and extracted with EtOAc (3 x 20 mL). The combined organic layers 
were washed with sat. aq. NaCl and the solvent was removed in vacuo. 
 
5-((tert-Butyl(isopropyl)amino)methyl)cyclopent-1-enecarbonitrile (139a) 
 
Prepared according to Procedure B from N-isopropyl-2-methylpropan-2-amine (133a, 1.2 mmol, 135 
mg, 1.2 equiv) and (2-cyanocyclopent-2-en-1-yl)zinc chloride (123g, 3.16 mL, 0.38 M in THF, 
1.2 mmol, 1.2equiv). Purification of the crude product by flash chromatography (Al2O3, 
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isohexane/EtOAc = 20:1) afforded 5-((tert-butyl(isopropyl)amino)methyl)cyclopent-1-enecarbonitrile 
as a colorless liquid (185 mg, 0.84 mmol, 84%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 6.66–6.57 (m, 1H), 3.27 (p, J = 7.0 Hz, 1H), 3.00–2.93 (m, 
1H), 2.68 (dd, J = 14.3, 7.1 Hz, 1H), 2.51–2.35 (m, 3H), 2.10–1.91 (m, 1H), 1.85–1.69 (m, 1H), 1.07 
(s, 9H), 0.99 (dd, J = 13.1, 6.7 Hz, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.2, 119.4, 117.5, 55.9, 49.2, 46.7, 32.3, 28.7, 27.9, 23.3, 
22.6. 
IR (Diamond-ATR, neat):𝜈 / cm-1 = 2971, 2872, 2845, 2217, 1611, 1466, 1436, 1392, 1362, 1278, 
1247, 1204, 1160, 1112, 1062, 1054, 1016, 999, 956, 906, 862, 848, 785, 717, 668. 
MS (EI, 70 eV):m/z (%) = 205 (M-CH3, 4), 163 (11), 149 (8), 128 (53), 106 (4), 92 (5), 72 (100), 57 
(19). 
HRMS (EI):m/z calc. for [C13H21N2+]: 205.1705; found: 205.1686 (M-CH3). 
 
1-(Cyclohex-2-en-1-yl)-N-(3-fluorobenzyl)-N-methylmethanamine (139b) 
 
Prepared according to Procedure B from 1-(3-fluorophenyl)-N-methylmethanamine (133b, 1.0 mmol, 
153 mg, 1.1 equiv) and cyclohex-2-en-1-ylzinc bromide (123i, 4.00 mL, 0.30 M in THF, 1.2 mmol, 
1.2equiv). Purification of the crude product by flash chromatography (SiO2, isohexane + 2% TEA) 
afforded 1-(cyclohex-2-en-1-yl)-N-(3-fluorobenzyl)-N-methylmethanamine as a colorless liquid (177 
mg, 0.76 mmol,76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.28–7.18 (m, 1H), 7.11–7.01 (m, 2H), 6.95–6.85 (m, 1H), 
5.74–5.61 (m, 2H), 3.53–3.38 (m, 2H), 2.36–2.26 (m, 1H), 2.26–2.20 (m, 2H), 2.17 (s, 3H), 2.04–1.89 
(m, 2H), 1.88–1.74 (m, 1H), 1.72–1.59 (m, 1H), 1.58–1.43 (m, 1H), 1.38–1.20 (m, 1H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 163.10 (d, J = 245.0 Hz), 142.64 (d, J = 7.0 Hz), 130.24 , 
129.62 (d, J = 8.2 Hz), 127.79 , 124.41 (d, J = 2.8 Hz), 115.64 (d, J = 21.3 Hz), 113.78 (d, J = 21.3 
Hz), 63.48 , 62.32 (d, J = 1.9 Hz), 42.69 , 33.57 , 27.62 , 25.70 , 21.27. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3019, 2926, 2838, 2786, 1616, 1589, 1486, 1447, 1364, 1348, 
1319, 1272, 1254, 1151, 1128, 1091, 1072, 1050, 1028, 944, 926, 880, 864, 845, 781, 749, 722, 684. 
MS (EI, 70 eV):m/z (%) = 232 (M-H, 1), 152 (100), 136 (2), 109 (99), 96 (2), 83 (11), 67 (3). 
HRMS (EI):m/z calc. for [C15H19FN-]: 232.1502; found: 232.1508 (M-H). 
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4-(2-(tert-Butyl(isopropyl)amino)ethyl)benzonitrile (139c) 
 
Prepared according to Procedure B from N-isopropyl-2-methylpropan-2-amine (133a, 1.0 mmol, 115 
mg, 1.0 equiv) and (4-cyanobenzyl)zinc chloride (136a, 1.25 mL, 0.8 M in THF, 1.0 mmol, 1.0 equiv). 
Purification of the crude product by flash chromatography (SiO2, isohexane/EtOAc = 5:1 + 2% TEA) 
afforded 4-(2-(tert-butyl(isopropyl)amino)ethyl)benzonitrile as a yellow oil (176 mg, 0.72 mmol, 72%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.55 (d, J = 8.2 Hz, 1H), 7.26 (d, J = 8.4 Hz, 1H), 3.38 (hept, 
J = 6.6 Hz, 1H), 2.80–2.60 (m, 4H), 1.11 (s, 9H), 1.00 (d, J = 6.6 Hz, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 147.2, 132.3, 129.6, 119.3, 109.8, 55.6, 46.9, 44.7, 42.4, 29.2, 
22.7. 
IR (Diamond-ATR, neat):𝜈 / cm-1 = 2971, 2872, 2228, 1608, 1504, 1476, 1468, 1414, 1391, 1378, 1361, 
1260, 1229, 1187, 1176, 1158, 1110, 1048, 1018, 964, 864, 848, 822. 
MS (EI, 70 eV):m/z (%) = 229 (M-CH3+, 13), 187 (15), 173 (12), 128 (67), 116 (9), 103 (8), 89 (6), 72 
(100). 
HRMS (EI):m/z calc. for C15H21N2+ (229.1705, M+-CH3); found: 229.1699. 
 
1-(3-Chlorobenzyl)indoline (139d) 
 
Prepared according to Procedure B from indoline (133c, 1.0 mmol, 119 mg, 1.0 equiv) and 
(3-chlorophenyl)zinc iodide (137a, 2.33 mL, 0.43 M in THF, 1.0 mmol, 1.0 equiv). Purification of the 
crude product by flash chromatography (Al2O3, isohexane/EtOAc = 100:1) afforded 
1-(3-chlorobenzyl)indoline as a colorless oil (160 mg, 0.66 mmol, 66%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.40–7.32 (m, 1H), 7.28–7.17 (m, 3H), 7.09 (d, J = 7.2 Hz, 1H), 
7.06–7.01 (m, 1H), 6.73–6.60 (m, 1H), 6.45 (d, J = 7.8 Hz, 1H), 4.20 (s, 2H), 3.31 (t, J = 8.3 Hz, 2H), 
2.97 (t, J = 8.2 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 152.4, 140.9, 134.6, 130.1, 129.9, 128.0, 127.5, 127.5, 126.0, 
124.7, 118.2, 107.2, 54.0, 53.6, 28.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3049, 2921, 2821, 1701, 1606, 1597, 1575, 1486, 1472, 1430, 1378, 
1343, 1304, 1264, 1225, 1196, 1155, 1146, 1075, 1052, 1020, 980, 943, 862, 778, 741, 682. 
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MS (EI, 70 eV): m/z (%) = 243 (M +, 100), 207 (7), 132 (54), 118 (52), 103 (11), 91 (29), 77 (11), 65 
(14). 
HRMS (EI):m/z calc. for [C15H14ClN]: 243.0815; found: 243.0809 (M +). 
 
10-(3-chlorobenzyl)-10H-phenoxazine (139e) 
 
Prepared according to Procedure A from 10H-phenoxazine (133d, 183 mg, 1.0 mmol, 1.0 equiv) and 
3-chlorophenylmagnesium chloride (138a, 2.75 mL, 0.40 M in THF, 1.1 mmol, 1.1 equiv). Purification 
of the crude product by flash chromatography (Al2O3, isohexane/EtOAc = 99:1) afforded 139e as a 
yellow oil (246 mg, 80%). 
Mp. : 114.8–115.9 °C 
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.21-7.09 (m, 4H), 6.62-6.57 (m, 6H), 6.20 (d, J = 6.83 Hz, 2H), 
4.65 (s, 2H). 
13C-NMR (75 MHz, CDCl3) δ/ppm = 145.1, 138.8, 134.9, 133.5, 130.2, 127.5, 126.1, 124.1, 123.7, 
121.5, 115.4, 112.1, 49.1. 
IR (cm-1):  = 3070, 3056, 3025, 2943, 2924, 2888, 2854, 1628, 1591, 1578, 1488, 1475, 1463, 1428, 
1378, 1325, 1313, 1294, 1272, 1253, 1200, 1186, 1130, 1082, 1051, 1004, 910, 867, 850, 825, 768, 727, 
708, 678. 
MS (70 eV, EI) m/z (%) = 307 (11) [M+], 183 (14), 182 (100), 127 (5). 
HRMS for C19H1435ClNO (307.0764): found: 307.0757. 
 
N-((2,4-Dimethoxypyrimidin-5-yl)methyl)-N-isopropyl-2-methylpropan-2-amine (139f) 
 
Prepared according to Procedure B from N-isopropyl-2-methylpropan-2-amine (133a, 1.0 mmol, 97 
mg, 1.0 equiv) and (2,4-dimethoxypyrimidin-5-yl)magnesium bromide (138b, 0.83 mL, 1.2 M in THF, 
1.0 mmol, 1.0 equiv). Purification of the crude product by flash chromatography (SiO2, 
isohexane/EtOAc = 20:1 + 2% TEA) afforded N-((2,4-dimethoxypyrimidin-5-yl)methyl)-N-isopropyl-
2-methylpropan-2-amine as a yellow oil (164 mg, 0.61 mmol, 61%). 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.50 (t, J = 1.2 Hz, 1H), 3.99 (s, 3H), 3.97 (s, 3H), 3.60 (d, J 
= 1.2 Hz, 2H), 3.55–3.42 (m, 1H), 1.07 (s, 9H), 0.98 (d, J = 6.6 Hz, 6H). 


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13C-NMR (75 MHz, CDCl3): δ / ppm = 168.0, 163.9, 157.7, 118.5, 55.6, 54.6, 53.8, 47.0, 37.6, 28.8, 
22.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2971, 2872, 1600, 1571, 1458, 1375, 1315, 1292, 1264, 1253, 
1234, 1195, 1173, 1154, 1097, 1074, 1054, 1041, 1017, 972, 936, 788, 756. 
MS (EI, 70 eV): m/z (%) = 267 (M+, 7), 252 (32), 196(3), 153 (100), 123 (6). 
HRMS (EI): m/z calc. for [C14H25N3O2]: 267.1947; found: 267.1928 (M+). 
 
N-Benzyl-2-bromo-N-(2-phenylbut-3-en-1-yl)aniline (139g) 
 
Prepared according to Procedure B from N-benzyl-2-bromoaniline (133e, 1.0 mmol, 262 mg, 
1.0 equiv) and cinnamylzinc chloride (123c, 2.86 mL, 0.35 M in THF, 1.0 mmol, 1.0 equiv). Purification 
of the crude product by flash chromatography (SiO2, isohexane/EtOAc = 100:1 + 2% TEA) afforded the 
racemic N-benzyl-2-bromo-N-(2-phenylbut-3-en-1-yl)aniline as a colorless oil (278 mg, 0.71 mmol, 
71%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.59 (dd, J = 7.9, 1.5 Hz, 1H), 7.35–7.15 (m, 9H), 7.07–6.97 
(m, 3H), 6.93 (td, J = 7.6, 1.5 Hz, 1H), 5.98 (ddd, J = 17.3, 10.3, 7.2 Hz, 1H), 5.05–5.00 (m, 1H), 4.90 
(d, J = 17.2 Hz, 1H), 4.14 (s, 2H), 3.44 (q, J = 7.5 Hz, 1H), 3.38–3.31 (m, 1H), 3.31–3.24 (m, 1H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 148.9, 142.6, 140.2, 138.2, 134.2, 128.9, 128.4, 128.2, 128.2, 
127.7, 127.2, 126.5, 124.9, 124.8, 122.0, 115.5, 59.5, 56.0, 47.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3061, 3027, 2921, 2824, 1637, 1601, 1584, 1494, 1473, 1452, 
1436, 1417, 1363, 1291, 1267, 1205, 1146, 1113, 1075, 1027, 992, 955, 914, 844, 753, 722, 696, 658. 
MS (ESI, 70 eV): m/z (%) = 391 (M +, 1), 274 (50), 194 (8), 178 (4), 154 (6), 115 (9), 91 (100). 
HRMS (EI): m/z calc. for [C23H23BrN+]: 392.1008; found: 392.10073 (M+H+). 
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1-Benzyl-4-methylene-3-phenyl-1,2,3,4-tetrahydroquinoline (140)147 
 
To N-benzyl-2-bromo-N-(2-phenylbut-3-en-1-yl)aniline (139g, 100 mg, 0.25 mmol) in dry toluene 
(0.5 mL) was added triethylamine (56 mg, 0.55 mmol) and tetrakis(triphenylphosphine)palladium(0) 
(29 mg, 25 µmol, 10 mol%) and the mixture was stirred 48 h at 70 °C. Then sat. aq. NH4Cl (0.5 mL) 
was added and the aqueous layer was extracted with EtOAc (3 × 5 mL). The combined organic phases 
were dried (MgSO4). Evaporation of the solvents in vacuo and purification by flash column 
chromatography (silica gel, ihexane / EtOAc = 80:1+ 2% TEA) afforded the title compound (140, 69 mg, 
0.22 mmol, 89%) as a colorless solid. 
Mp.: 114–116 °C. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.62 (dd, J = 7.8, 1.6 Hz, 1H), 7.41–7.02 (m, 11H), 6.75–6.54 
(m, 2H), 5.62–5.54 (m, 1H), 4.68–4.61 (m, 1H), 4.48 (s, 2H), 3.95–3.84 (m, 1H), 3.70–3.56 (m, 2H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 145.2, 143.9, 141.7, 138.5, 129.5, 128.7, 128.5, 128.4, 127.0, 
126.8, 126.8, 125.5, 121.5, 116.9, 112.4, 107.7, 55.9, 55.8, 46.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3085, 3060, 3028, 2923, 2860, 2360, 1624, 1598, 1584, 1563, 
1493, 1476, 1450, 1410, 1351, 1317, 1297, 1269, 1243, 1222, 1194, 1170, 1162, 1120, 1080, 1055, 
1030, 1006, 1001, 961, 940, 888, 836, 816, 750, 730, 711, 703, 694. 
MS (EI, 70 eV): m/z (%) = 311 (M+, 100), 296 (3), 282 (3), 234 (11), 220 (36), 204 (14), 115 (10), 91 
(44). 
HRMS (EI): m/z calc. for [C23H21N]: 311.1674; found: 311.1674 (M +). 
  
                                                     
147 U. Martínez-Estíbalez, O. García-Calvo, V. Ortiz-de-Elguea, N. Sotomayor, E. Lete, Eur. J. Org. Chem. 2013, 
15, 3013. 
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7 Synthesis of Novel Ephedrine Derivatives Containing a Tertiary 
Amine 
 
Compounds 136d-f were prepared according to literature procedures and titrated against iodine prior to 
use.148 
7.1 Preparation of (1S,2R)/(1R,2S)-O-(tert-Butyldimethylsilyl)ephedrine149 
 
To (+ or − )-ephedrine (hydrochloride salt, 1.01 g, 5.00 mmol) in dry DMF (15 mL) was added imidazole 
(0.68 g, 10.0 mmol) and tert-butylchlorodimethylsilane (1.06 g, 7 mmol) and the mixture was stirred for 
24 h at 70 °C. Then sat. aq. NaHCO3 (5 mL) was added and the aqueous layer was extracted with EtOAc 
(3 × 15 mL). The combined organic phases were dried (MgSO4). Evaporation of the solvents in vacuo 
and purification by flash column chromatography (silica gel, ihexane / EtOAc = 20:1 + 2% TEA) 
afforded the title compound (840 mg, 3.01 mmol, 60%) as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.37–7.17 (m, 5H), 4.60 (d, J = 5.0 Hz, 1H), 2.72–2.57 (m, 
1H), 2.37 (s, 3H), 1.28 (s, br, 1H), 1.01 (d, J = 6.4 Hz, 3H), 0.89 (s, 9H), -0.20 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 143.1, 128.1, 127.3, 127.0, 77.5, 61.8, 34.2, 26.0, 25.9, 18.3, 
14.8, -4.4, -4.9. 
IR (Diamond-ATR, neat):𝜈 / cm-1 = 2956, 2930, 2885, 2857, 2791, 1472, 1463, 1453, 1389, 1376, 
1361, 1253, 1202, 1189, 1158, 1134, 1098, 1060, 1006, 938, 910, 867, 833, 774, 733, 700, 671. 
MS (EI, 70 eV): m/z (%) = 222 (5), 191 (2), 163 (4), 149 (5), 133 (2), 117 (3), 88 (5), 73 (12), 58 (100). 
HRMS (EI): m/z calc. for [C16H30NOSi+]: 280.2091; found: 280.0276 (M+H). 
 
7.2 Typical Procedures 
Typical Procedure for the Preparation of the Benzylzinc Halides of Type 136 (TP1): 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with LiCl (466 mg, 11.0 mmol). The flask was heated to 450 °C for 10 min under high vacuum followed 
by the addition of zinc dust (1.31 g, 20.0 mmol). The vessel was evacuated and refilled with argon. THF 
(10 mL) and 1,2-dibromoethane (215 μL, 2.50 mmol) were added via syringe and the reaction mixture 
                                                     
148 F. M. Piller, A Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 7192. 
149 C. Fotsch, J. D. Sonnenberg, N. Chen, C. Hale, W. Karbon, M. H. Norman, J. Med. Chem. 2001, 44, 2344. 
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was heated to 50 °C until bubbling occurred. The benzylic halide (10.0 mmol) was added dropwise as a 
solution in THF (10 mL) over a period of 15 min. The mixture was stirred for the given time at room 
temperature before the zinc powder was allowed to settle down. The supernatant solution was carefully 
filtrated using a syringe filter and the yield of the resulting solution of the benzylzinc halide was 
determined by iodometric titration. 
Typical Procedure for the Preparation of Tertiary Ephedrine Derivatives (TP2): 
A dry and argon-flushed Schlenk flask, equipped with a magnetic stirring bar and a septum, was charged 
with N,N,N’,N’-tetramethylmethanediamine (1.0 equiv) and anhydrous CH2Cl2 to obtain a 1 M solution. 
After cooling to −20 °C, trifluoroacetic anhydride (1.0 equiv) was added dropwise and the solution was 
allowed to stir for 15 min at −20 °C. A second dry and argon-flushed Schlenk flask, equipped with a 
magnetic stirring bar and a septum, was charged with the TBS-protected ephedrine derivative (1.1 equiv) 
and THF to obtain a 0.2 M solution. After cooling to −20 °C, MeMgCl (1.1 equiv., 2.8 M in THF) was 
added dropwise and the solution was stirred for 30 min. Next, the magnesium amide was added over 
15 min to the previously prepared methylene(dimethyl)iminium trifluoroacetate at −20 °C and stirring 
was continued for another 30 min. Then, trifluoroacetic anhydride (1.0 equiv) was added, resulting in 
the formation of a white precipitate. The mixture was stirred for 15 min before the desired 
organomagnesium/organozinc reagent (1.1 equiv) was added at – 78 °C and the reaction mixture 
warmed to room temperature giving a clear solution. Sat. aq. NaHCO3 was added and the mixture was 
extracted with EtOAc (3 x 20 mL). The combined organic layers were dried with MgSO4, the solvent 
was removed in vacuo and purification by column chromatography afforded the expected products. 
Typical Procedure for the Deprotection of Tertiary Ephedrine Derivatives Prepared with TP4 
(TP3): 
A round bottom flask, equipped with a magnetic stirring bar and a septum, was charged with the tertiary 
ephedrine derivative (1.0 equiv), 5 mL dry CH2Cl2 and TBAF·3H2O (4.0 equiv). The progress of the 
reaction was monitored by GC-analysis of the consumption of the starting material. Upon complete 
deprotection after 12 h, 5 mL sat. aq. NaHCO3 solution was added and the product was extracted with 
EtOAc (3 x 20 mL). The combined organic layers were dried with MgSO4, the solvent was removed in 
vacuo and purification by column chromatography afforded the expected products. 
7.3 Preparation of Benzylic Organozinc Reagents 
(4-Methoxybenzyl)zinc Chloride (136b) 
 
According to TP2 1-(chloromethyl)-4-methoxybenzene (136b) (0.783 g, 5.00 mmol) in THF (3 mL) 
was added to a mixture of activated zinc powder (0.653 g, 10.0 mmol), LiCl (0.266 g, 7.50 mmol) and 
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THF (5 mL). After 12 h at 25 °C the reaction was finished and iodometric titration indicates a 
concentration of 0.56 M, which corresponds to a yield of 90%. 
 
(3-Ethoxycarbonylbenzyl)zinc Chloride (136c) 
 
According to TP2 ethyl 3-(chloromethyl)benzoate (136c) (0.396 g, 2.00 mmol) in THF (2.5 mL) was 
added to a mixture of activated zinc powder (0.261 g, 4.00 mmol), LiCl (0.106 g, 3.00 mmol) and THF 
(2.5 mL). After 12 h at 25 °C the reaction was finished and iodometric titration indicates a concentration 
of 0.32 M, which corresponds to a yield of 80%. 
 
((6-Chloropyridin-3-yl)methyl)zinc Chloride (136e) 
 
2-chloro-5-(chloromethyl)pyridine hydrochloride (0.492 g, 2.50 mmol) (136e) - was solved in water and 
the solution was basified with sat. aq. NaHCO3 solution. The aqueous layer was extracted with CH2Cl2 
(3 x 10 mL), the combined organic layers were dried with MgSO4 and the solvent was removed in vacuo. 
The dried product was added to a mixture of activated zinc powder (0.261 g, 4.00 mmol), LiCl (0.106 
g, 3.00 mmol) and THF (2.5 mL) as a solution in THF (2.5 mL) at 0 °C. The reaction mixture was 
warmed to 25 °C and after 12 h the reaction was finished. Iodometric titration indicates a concentration 
of 0.33 M, which corresponds to a yield of 66%. 
 
7.4 Preparation of Tertiary Ephedrine Derivatives of Type 145 
(1S, 2R)-1-((tert-Butyldimethylsilyl)oxy)-N-(4-methoxyphenethyl)-N-methyl-1-phenylpropan-2-
amine (145a) 
 
Prepared according to TP4 from (+)-141 (306 mg, 1.10 mmol, 1.1 equiv) and (4-methoxybenzyl)zinc 
chloride (136b, 1.96 mL, 0.560 M in THF, 1.10 mmol, 1.1 equiv). Purification of the crude product by 
flash chromatography (SiO2, ihexane/EtOAc = 20:1) afforded 145a as a colorless oil (350 mg, 85%). 
134   
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.26–7.17 (m, 5H), 6.94 (d, J = 8.7 Hz, 2H), 6.72 (d, J = 8.7 
Hz, 2H), 4.57 (d, J = 5.9 Hz, 1H), 3.72 (s, 3H), 2.79–2.70 (m, 1H), 2.59–2.36 (m, 4H), 2.23 (s, 3H), 1.00 
(d, J = 6.7 Hz, 3H), 0.81 (s, 9H), -0.03 (s, 3H), -0.36 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 157.9, 145.1, 133.1, 130.0, 129.7, 127.7, 126.9, 113.8, 77.4, 
65.4, 56.9, 55.4, 38.1, 34.2, 26.0, 18.3, 9.2, -4.2, -4.7. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2953 (m), 2929 (m), 2865 (m), 1690 (w), 1612 (w), 1511 (s), 
1462 (m), 1360 (w), 1300 (w), 1245 (vs), 1176 (m), 1110 (w), 1081 (s), 1060 (vs), 1039 (s), 1005 (m), 
863 (s), 832 (vs), 774 (vs), 737 (m), 698 (s), 668 (m). 
MS (EI, 70 eV): m/z (%) = 398.3 (1), 292.1 (5), 192.2 (100), 135.1 (30), 105.1 (6), 73.2 (10). 
HRMS (EI): m/z calc. for [C25H38NO2Si]+: 412.2666; found 412.2674. 
 
Ethyl 3-(2-(((1S, 2R)-1-((tert-Butyldimethylsilyl)oxy)-1-phenylpropan-2-
yl)(methyl)amino)ethyl)benzoate (145b) 
 
Prepared according to TP4 from (+)-141 (158 mg, 0.550 mmol, 1.1 equiv) and 
(3-Ethoxycarbonylbenzyl)zinc chloride (136c, 1.56 mL, 0.300 M in THF, 0.550 mmol, 1.1 equiv). 
Purification of the crude product by flash chromatography (SiO2, ihexane/EtOAc = 20:1) afforded 145b 
as a colorless oil (196 mg, 81%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.84 (d, J = 7.7), 7.80 (s, 1H), 7.30–7.16 (m, 7H), 4.60 (d, J = 
6.0, 1H), 4.38 (q, J = 7.1, 2H), 2.83–2.77 (m, 1H), 2.66–2.51 (m, 4H), 2.30 (s, 3H), 1.40 (t, J = 7.1 Hz, 
3H), 1.05 (d, J = 6.7, 3H), 0.86 (s, 9H), 0.02 (s, 3H), -0.31 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 167.0, 145.0, 141.3, 133.4, 130.5, 129.9, 128.3, 127.7, 127.2, 
126.9, 77.2, 65.4, 61.0, 56.4, 38.0, 34.9, 26.0, 18.3, 14.5, 9.4, -4.2, -4.8. 
IR (Diamond-ATR, neat): ν ̃/ cm-1 = 2955 (m), 2929 (m), 2856 (m), 1718 (vs), 1605 (w), 1587 (w), 
1462 (m), 1366 (m), 1274 (vs), 1257 (s), 1194 (s), 1104 (s), 1082 (s), 1060 (vs), 1026 (s), 1005 (m), 863 
(s), 834 (vs), 774 (vs), 749 (m), 697 (s), 669 (m). 
MS (EI, 70 eV): m/z (%) = 440.3 (1), 410.3 (1), 234.2 (100) 177.1 (4), 149.1 (6), 131.1 (6), 105.1 (5), 
73.1 (7) 
HRMS (EI): m/z calc. for [C26H38NO3Si]+: 440.2621; found 440.2616. 
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((1S, 2R)-1-((tert-Butyldimethylsilyl)oxy)-N-methyl-1-phenyl-N-(3-
(trifluoromethyl)phenethyl)propan-2-amine (145c) 
 
Prepared according to TP4 from (+)-141 (158 mg, 0.550 mmol, 1.1 equiv) and 
(3-(trifluoromethyl)benzyl)zinc chloride (136d, 0.350 mL, 1.43 M in THF, 0.550 mmol, 1.1 equiv). 
Purification of the crude product by flash chromatography (SiO2, ihexane/EtOAc = 30:1) afforded 145c 
as a colorless oil (187 mg, 83%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.41 (d, J = 7.9, 1H), 7.35 (s, 1H), 7.34–7.18 (m, 7H), 4.59 (d, 
J = 6.0 Hz, 1H), 2.80 (p, J = 6.5 Hz, 1H), 2.68–2.50 (m, 4H), 2.29 (s, 3H), 1.06 (d, J = 6.5 Hz, 3H), 0.86 
(s, 8H), 0.02 (s, 3H), –0.31 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 144.8, 141.8, 132.1, 130.3 (q, J = 31.8 Hz), 128.5, 127.6, 
126.7, 125.3, 124.2 (q, J = 273.3 Hz) 122.6, 77.1, 65.3, 56.2, 37.8, 34.7, 25.8, 18.1, 9.2, –4.4, –5.0. 
19F-NMR (376 MHz, CDCl3): δ / ppm = –62.48. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2955 (m), 2930 (m), 2857 (m), 1493 (w), 1471 (w), 1450 (m), 
1326 (s), 1320 (s), 1256 (m), 1198 (m), 1163 (s), 1123 (vs), 1071 (s), 1061 (s), 1027 (w), 1005 (w), 908 
(m), 863 (s), 833 (vs), 774 (vs), 737 (m), 699 (s), 669 (m). 
MS (EI, 70 eV): m/z (%) = 436.4 (1), 320.3 (2), 230.2 (100), 173.1 (7), 153.1 (6), 133.1 (5), 73.1 (5). 
HRMS (EI): m/z calc. for [C24H33F3N2OSi]+: 436.2284; found 436.2282. 
 
(1S, 2R)-1-((tert-Butyldimethylsilyl)oxy)-N-(2-(6-chloropyridin-3-yl)ethyl)-N-methyl-1-
phenylpropan-2-amine (145d) 
 
Prepared according to TP4 from (+)-141 (306 mg, 1.10 mmol, 1.1 equiv) and (3-((6-chloropyridin-3-
yl)methyl)zinc chloride (3.33 mL, 0.330 M in THF, 1.10 mmol, 1.1 equiv). Purification of the crude 
product by flash chromatography (SiO2, ihexane/EtOAc = 20:1) afforded the title compound as a 
colorless oil (313 mg, 75%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.03 (dd, J = 2.5, 0.7 Hz, 1H), 7.29–7.16 (m, 5H), 7.11 (dd, J 
= 8.2, 2.5 Hz, 1H), 7.04 (dd, J = 8.2, 0.7 Hz), 4.50 (d, J = 6.9 Hz), 2.77 (p, J = 6.7 Hz, 1H), 2.67–2.39 
(m, 4H), 2.23 (s, 3H), 1.05 (d, J = 6.6 Hz, 3H), 0.84 (s, 9H), 0.00 (s, 3H), -0.33 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.7, 148.8, 144.8, 139.2, 135.3, 127.8, 127.0, 126.9, 123.7, 
77.4, 65.5, 56.1, 37.1, 30.9, 26.0, 18.2, 9.5, -4.3, -4.8. 
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IR (Diamond-ATR, neat): ν̃ / cm-1 = 2954 (m), 2928 (m), 2855 (m), 1585 (w), 1564 (w), 1458 (s), 
1381 (m), 1360 (w), 1250 (s), 1209 (w), 1103 (s), 1082 (s), 1059 (vs), 1025 (s), 1005 (m), 863 (s), 833 
(vs), 774 (vs), 737 (m), 699 (s), 669 (m). 
MS (EI, 70 eV): m/z (%) = 403.2 (1), 287.1 (2), 197.1 (100), 140.1 (12), 104.1 (4), 73.1 (7), 56.1 (2). 
HRMS (EI): m/z calc. for [C23H34ClN2OSi]+: 417.2123; found 417.2129. 
 
(1S, 2R)-1-((tert-Butyldimethylsilyl)oxy)-N-(2-chlorophenethyl)-N-methyl-1-phenylpropan-2-
amine (145e) 
 
Prepared according to TP4 from (+)-141 (279 mg, 1.0 mmol, 1.0 equiv) and 2-chlorobenzylzinc chloride 
(136f, 0.69 mL, 1.60 M in THF, 1.1 mmol, 1.1 equiv). Purification of the crude product by flash 
chromatography (Al2O3, isohexane/EtOAc = 49:1) afforded 145e as a colorless oil (380 mg, 91%). 
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.34-7.23 (m, 6H), 7.15-7.08 (m, 3H), 4.63 (d, J = 5.9 Hz, 1H), 
2.81 (qi, J = 6.6 Hz, 1H), 2.71-2.61 (m, 4H), 2.32 (s, 3H), 1.06 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.02 
(s, 3H), –0.30 (s, 3H). 
13C-NMR (75 MHz, CDCl3) δ/ppm = 145.3, 138.7, 134.2, 131.2, 129.6, 127.9, 127.6, 127.1, 127.0, 
127.0, 65.8, 54.6, 38.4, 33.0, 26.2, 18.4, 9.7, –4.0, –4.6. 
IR (cm-1):  = 2956, 2929, 2886, 2856, 2796, 1472, 1360, 1251, 1082, 1053, 1028, 1006, 863, 834, 816, 
774, 747, 698, 680, 675. 
MS (70 eV, EI) m/z (%) = 417 (1) [M+], 402 (1), 198 (35), 197 (12), 196 (100), 139 (19), 103 (12), 73 
(17).  
HRMS for C24H3635ClNOSi (402.2025, [M–CH3]+): found: 402.2024. 
 
Ethyl 4-((((1S, 2R)-1-((tert-Butyldimethylsilyl)oxy)-1-phenylpropan-2-
yl)(methyl)amino)methyl)benzoate (145f) 
 
Prepared according to TP4 from (+)-141 (279 mg, 1.0 mmol, 1.0 equiv) and (4-
(ethoxycarbonyl)phenyl)zinc chloride (1.7 mL, 0.65 M in THF, 1.1 mmol, 1.1 equiv). Purification of the 
crude product by flash chromatography (Al2O3, isohexane/EtOAc = 99:1) afforded the title compound 
as a colorless oil (309 mg, 70%). 


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1H-NMR (300 MHz, CDCl3) δ/ppm = 7.80 (d, J = 8.4 Hz, 2H), 7.28-7.20 (m, 5H), 6.96 (d, J = 8.4 Hz, 
2H), 4.56 (d, J = 7.2 Hz, 1H), 4.32 (q, J = 7.0 Hz, 2H), 3.60-3.46 (m, 2H), 2.79 (qi, J = 6.6 Hz, 1H), 
2.12 (s, 3H), 1.35 (t, J = 7.0, 3H), 1.11 (d, J = 6.6 Hz, 3H), 0.83 (s, 9H), 0.00 (s, 3H). 
13C-NMR (75 MHz, CDCl3) δ/ppm = 166.7, 145.8, 144.8, 129.2, 128.7, 128.1, 127.6, 126.9, 126.9, 
64.9, 60.7, 58.7, 37.3, 25.8, 18.1, 14.4, 9.1, -4.4, -5.0. 
IR (cm-1):  = 2957, 2930, 2857, 2794, 1717, 1611, 1472, 1452, 1413, 1365, 1272, 1258, 1172, 1105, 
1098, 1084, 1060, 1020, 863, 834, 775, 756, 699. 
MS (70 eV, EI) m/z (%) = 441 (1) [M+], 221 (15), 220 (100), 163 (28), 73 (7). 
HRMS for C26H39NO3Si (440.2626, [M–H]+): found: 440.2616. 
 
(1R, 2S)-1-((tert-Butyldimethylsilyl)oxy)-N-(4-methoxyphenethyl)-N-methyl-1-phenylpropan-2-
amine (145g) 
 
Prepared according to TP4 from (+)-141 (306 mg, 1.10 mmol, 1.1 equiv) and (4-methoxybenzyl)zinc 
chloride (136b, 1.96 mL, 0.560 M in THF, 1.10 mmol, 1.1 equiv). Purification of the crude product by 
flash chromatography (SiO2, ihexane/EtOAc = 20:1) afforded 145g as a colorless oil (350 mg, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.26–7.17 (m, 5H), 6.94 (d, J = 8.7 Hz, 2H), 6.72 (d, J = 8.7 
Hz, 2H), 4.57 (d, J = 5.9 Hz, 1H), 3.72 (s, 3H), 2.79–2.70 (m, 1H), 2.59–2.36 (m, 4H), 2.23 (s, 3H), 1.00 
(d, J = 6.7 Hz, 3H), 0.81 (s, 9H), -0.03 (s, 3H), -0.36 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 157.9, 145.1, 133.1, 129.7, 127.7, 126.9, 126.4, 113.8, 77.4, 
65.4, 56.9, 55.4, 38.1, 34.2, 26.0, 18.3, 9.2, -4.2, -4.7. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2953 (m), 2929 (m), 2865 (m), 1690 (w), 1612 (w), 1511 (s), 
1462 (m), 1360 (w), 1300 (w), 1245 (vs), 1176 (m), 1110 (w), 1081 (s), 1060 (vs), 1039 (s), 1005 (m), 
863 (s), 832 (vs), 774 (vs), 737 (m), 698 (s), 668 (m). 
MS (EI, 70 eV): m/z (%) = 398.3 (1), 292.1 (5), 192.2 (100), 135.1 (30), 105.1 (6), 73.2 (10). 
HRMS (EI): m/z calc. for [C25H38NO2Si]+: 412.2666; found 412.2674. 
 
((1R, 2S)-1-((tert-Butyldimethylsilyl)oxy)-N-methyl-1-phenyl-N-(3-
(trifluoromethyl)phenethyl)propan-2-amine (145h) 
 
Prepared according to TP4 from (+)-141 (158 mg, 0.550 mmol, 1.1 equiv) and 
(3-(trifluoromethyl)benzyl)zinc chloride (136d, 0.350 mL, 1.43 M in THF, 0.550 mmol, 1.1 equiv). 


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Purification of the crude product by flash chromatography (SiO2, ihexane/EtOAc = 30:1) afforded 145h 
as a colorless oil (187 mg, 83%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.41 (d, J = 7.9, 1H), 7.35 (s, 1H), 7.34–7.18 (m, 7H), 4.59 (d, 
J = 6.0 Hz, 1H), 2.80 (p, J = 6.5 Hz, 1H), 2.68–2.50 (m, 4H), 2.29 (s, 3H), 1.06 (d, J = 6.5 Hz, 3H), 0.86 
(s, 8H), 0.02 (s, 3H), -0.31 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 144.8, 141.8, 132.1, 130.3 (q, J = 31.8 Hz), 128.5, 127.6, 
126.7, 125.3, 124.2 (q, J = 273.3 Hz) 122.6, 77.1, 65.3, 56.2, 37.8, 34.7, 25.8, 18.1, 9.2, -4.4, -5.0. 
19F-NMR (376 MHz, CDCl3): δ / ppm = -62.48. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2955 (m), 2930 (m), 2857 (m), 1493 (w), 1471 (w), 1450 (m), 
1326 (s), 1320 (s), 1256 (m), 1198 (m), 1163 (s), 1123 (vs), 1071 (s), 1061 (s), 1027 (w), 1005 (w), 908 
(m), 863 (s), 833 (vs), 774 (vs), 737 (m), 699 (s), 669 (m). 
MS (EI, 70 eV): m/z (%) = 436.4 (1), 320.3 (2), 230.2 (100), 173.1 (7), 153.1 (6), 133.1 (5), 73.1 (5). 
HRMS (EI): m/z calc. for [C24H33F3N2OSi]+: 436.2284; found 436.2282. 
 
7.5 Deprotection of the Alcohol Using TBAF 
(1S, 2R)-2-((4-Methoxyphenethyl)(methyl)amino)-1-phenylpropan-1-ol (146a) 
 
Prepared according to TP5 from 145a (290 mg, 0.700 mmol, 1.0 equiv). Purification of the crude 
product by flash chromatography (SiO2, ihexane/EtOAc = 5:1) afforded 146a as a white solid (208 mg, 
99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.35–7.21 (m, 5H), 7.08 (d, J = 8.6 Hz), 6.84 (d, J = 8.6 Hz, 
2H), 4.76 (d, J = 4.3 Hz, 1H), 3.79 (s, 3H), 2.92–2.80 (m, 1H), 2.75–2.62 (m, 4H), 2.34 (s, 3H), 0.87 (d, 
J = 6.9 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.1, 142.3, 132.4, 129.7, 128.2, 126.9, 126.2, 114.0, 73.1, 
63.7, 57.1, 55.4, 39.3, 33.3, 10.4. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2934 (m), 2834 (m), 2797 (m), 1611 (m), 1583 (w), 1511 (s), 
1462 (m), 1451 (m), 1300 (m), 1244 (vs), 1176 (m), 1035 (w), 996 (w), 960 (w), 909 (m), 849 (w), 821 
(s), 733 (s), 700 (s). 
MS (EI, 70 eV): m/z (%) = 292.1 (4), 192.2 (100), 135.2 (40), 105.1 (4), 73.1 (8).  
HRMS (EI): m/z calc. for [C17H20NO2]+: 254.1545; found 254.1586. 
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Ethyl 3-(2-(((1S, 2R)-1-Hydroxy-1-phenylpropan-2-yl)(methyl)amino)ethyl)benzoate (146b) 
 
Prepared according to TP5 from 145b (156 mg, 0.340 mmol, 1.0 equiv). Purification of the crude 
product by flash chromatography (SiO2, ihexane/EtOAc = 5:1) afforded 146b as a colorless oil (110 mg, 
94%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.90–7.79 (m, 2H), 7.37–7.14 (m, 7H), 4.74 (d, J = 4.3 Hz, 
1H), 4.36 (q, J = 7.1 Hz, 2H), 3.57 (br, 1H), 2.91–2.82 (m, 1H), 2.82–2.65 (m, 4H), 2.34 (s, 3H), 1.38 
(t, J = 7.1 Hz, 3H), 0.87 (d, J = 6.9 Hz, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 166.7, 142.2, 140.5, 133.2, 130.6, 129.8, 128.4, 127.9, 127.4, 
126.9, 126.1, 73.1, 63.6, 60.9, 56.5, 39.1, 33.8, 14.4, 10.0. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2990 (w), 2937 (w), 2797 (w), 1714 (vs), 1604 (w), 1587 (w), 
1449 (m), 1367 (m), 1273 (vs), 1195 (s), 1104 (s), 1083 (s), 1024 (m), 1000 (m), 909 (m), 864 (w), 817 
(w), 749 (s), 731, (s), 698 (vs), 673 (m). 
MS (EI, 70 eV): m/z (%) = 341.2 (1), 296.3 (6), 234.3 (100), 149.1 (10), 105.1 (10), 70.1 (8). 
HRMS (EI): m/z calc. for [C19H22NO2]+: 296.1651 ([M–OEt]+); found 296.1651. 
 
(1S, 2R)-2-(Methyl(3-(trifluoromethyl)phenethyl)amino)-1-phenylpropan-1-ol (146c) 
 
Prepared according to TP5 from 145c (157 mg, 0.350 mmol, 1.0 equiv). Purification of the crude 
product by flash chromatography (SiO2, ihexane/EtOAc = 5:1) afforded 146c as a colorless oil (94 mg, 
80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.46–7.42 (m, 1H), 7.39–7.19 (m, 8H), 4.72 (d, J = 4.5 Hz, 
1H), 3.22 (br, 1H), 2.85 (qd, J = 6.9, 4.5 Hz, 1H), 2.81–2.62 (m, 4H), 2.33 (s, 3H), 0.88 (d, J = 6.9 Hz, 
3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 142.1, 141.1, 132.0, 130.7 (q, J = 32.0 Hz), 128.8, 127.8, 
127.0, 126.1, 125.4 (q, J = 3.8 Hz), 124.2 (q, J = 271.5 Hz), 123.0 (q, J = 3.8 Hz), 73.3, 63.8, 56.3, 39.2, 
34.0, 10.0. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2963 (w), 2856 (w), 2800 (w), 1598 (w), 1493 (w), 1450 (m), 
1377 (w), 1369 (w), 1329 (vs), 1199 (m), 1161 (s), 1119 (vs), 1072 (s), 1026 (m), 1000 (m), 907 (m), 
883 (w), 798 (m), 761 (w), 734 (m), 699 (vs), 661 (m). 
MS (EI, 70 eV): m/z (%) = 318.3 (1), 230.3 (100), 173.2 (12), 153.1 (8), 77.1 (3), 58.9 (4). 
HRMS (EI): m/z calc. for [C19H22F3NO]+: 336.1572; found 336.1569. 
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(1S, 2R)-2-((2-(6-Chloropyridin-3-yl)ethyl)(methyl)amino)-1-phenylpropan-1-ol (146d) 
 
Prepared according to TP5 from 145d (253 mg, 0.600 mmol, 1.0 equiv). Purification of the crude 
product by flash chromatography (SiO2, ihexane/EtOAc = 5:1) afforded 146d as a colorless oil (183 mg, 
99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.16 (dd, J = 2.5, 0.7 Hz, 1H), 7.36 (dd, J = 8.2, 2.5 Hz, 1H), 
7.34–7.23 (m, 5H), 7.19 (dd, J = 8.2, 0.7 Hz, 1H), 4.73 (d, J = 4.8 Hz, 1H), 2.86 (qd, J = 6.8, 4.8 Hz), 
2.73–2.60 (m, 4H), 2.34 (s, 3H), 0.92 (d, J = 6.8 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.7, 149.2, 142.2, 138.9, 134.5, 128.0, 127.1, 126.0, 123.8, 
73.6, 63.8, 55.8, 38.8, 30.5, 9.9. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2963 (w), 2933 (w), 2897 (w), 1585 (m), 1565 (m), 1455 (vs), 
1382 (m), 1360 (w), 1285 (w), 1210 (w), 1135 (m), 1103 (s), 1051 (m), 1024 (s), 996 (m), 915 (w), 824 
(m), 798 (w), 761 (m), 736 (s), 700 (vs), 698 (w). 
MS (EI, 70 eV): m/z (%) = 197.2 (100), 140.1 (26). 
HRMS (EI): m/z calc. for [C17H19ClN2]+: 286.1236; found 286.1227. 
 
(1S,2R)-2-((2-Chlorophenethyl)(methyl)amino)-1-phenylpropan-1-ol (146e) 
 
Prepared according to TP5 from 145e (100 mg, 0.239 mmol). Purification of the crude product by flash 
chromatography (SiO2, ihexane/EtOAc = 20:1 + 2% NEt3) afforded 146e as a colorless oil (73 mg, 
99%). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.36–7.29 (m, 4H), 7.26–7.14 (m, 4H), 4.98 (s, 1H), 3.09–2.76 
(m, 5H), 1.33–1.19 (m, 1H), 0.93 (d, J = 6.8 Hz, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 141.9, 137.4, 134.1, 131.2, 129.7, 128.2, 128.1, 127.2, 127.1, 
126.1, 72.8, 64.2, 54.8, 39.1, 31.3, 29.9. 
IR (Diamond-ATR, neat): ν ̃ / cm-1 = 3352 (w), 3062 (w), 3027 (w), 2933 (m), 2853 (w), 2799 (w), 
1475 (m), 1450 (m), 1383 (w), 1248 (w), 1198 (w), 1156 (w), 1122 (m), 1052 (s), 1041 (m), 998 (m), 
750 (vs), 701 (vs). 
MS (EI, 70 eV): m/z (%) = 302 (M–H)+, 285 (31), 260 (30), 258 (100). 
HRMS (EI): m/z calc. for [C18H21ClNO]+: 302.1317; found 302.1317 [(M–H)+]. 
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Ethyl 4-((((1S,2R)-1-Hydroxy-1-phenylpropan-2-yl)(methyl)amino)methyl)benzoate (146f) 
 
Prepared according to TP5 from 145f (100 mg, 0.239 mmol). Purification of the crude product by flash 
chromatography (SiO2, ihexane/EtOAc = 20:1 + 2% NEt3) afforded 146f as a colorless oil (73 mg, 99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.92–7.86 (m, 2H), 7.35–7.26 (m, 3H), 7.26–7.16 (m, 4H), 
4.79 (d, J = 5.2 Hz, 1H), 4.31 (q, J = 7.1 Hz, 2H), 3.59 (s, 2H), 3.35–2.94 (m, 1H), 2.87 (qd, J = 6.8, 5.2 
Hz, 1H), 2.14 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.7, 145.1, 142.8, 129.7, 129.3, 128.5, 128.2, 127.2, 126.3, 
74.2, 63.8, 61.0, 58.8, 38.8, 14.5, 9.9. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2990, 2937, 2797, 1714, 1604, 1587, 1449, 1367, 1273, 1195, 
1104, 1083, 1024, 1000, 909, 864, 817, 749, 731, 698, 673. 
MS (EI, 70 eV): m/z (%) = 282 (4), 220 (100), 191 (3), 163 (59), 135 (11), 107 (12). 
HRMS (EI): m/z calc. for [C20H24NO3]+: 326.1762 ([M–H]+); found 326.1750. 
 
(1R, 2S)-2-((4-Methoxyphenethyl)(methyl)amino)-1-phenylpropan-1-ol (146g) 
 
Prepared according to TP5 from 145g (290 mg, 0.700 mmol, 1.0 equiv). Purification of the crude 
product by flash chromatography (SiO2, ihexane/EtOAc = 5:1) afforded 146g as a white solid (208 mg, 
99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.35–7.21 (m, 5H), 7.08 (d, J = 8.6 Hz), 6.84 (d, J = 8.6 Hz, 
2H), 4.76 (d, J = 4.3 Hz, 1H), 3.79 (s, 3H), 2.92–2.80 (m, 1H), 2.75–2.62 (m, 4H), 2.34 (s, 3H), 0.87 (d, 
J = 6.9 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.1, 142.3, 132.4, 129.7, 128.2, 126.9, 126.2, 114.0, 73.1, 
63.7, 57.1, 55.4, 39.3, 33.3, 10.4. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2934 (m), 2834 (m), 2797 (m), 1611 (m), 1583 (w), 1511 (s), 
1462 (m), 1451 (m), 1300 (m), 1244 (vs), 1176 (m), 1035 (w), 996 (w), 960 (w), 909 (m), 849 (w), 821 
(s), 733 (s), 700 (s). 
MS (EI, 70 eV): m/z (%) = 292.1 (4), 192.2 (100), 135.2 (40), 105.1 (4), 73.1 (8).  
HRMS (EI): m/z calc. for [C17H20NO2]+: 254.1545; found 254.1586. 
 
142   
(1R, 2S)-2-(Methyl(3-(trifluoromethyl)phenethyl)amino)-1-phenylpropan-1-ol (146h) 
 
Prepared according to TP5 from 145h (157 mg, 0.350 mmol, 1.0 equiv). Purification of the crude 
product by flash chromatography (SiO2, ihexane/EtOAc = 5:1) afforded 146h as a colorless oil (94 mg, 
80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.46–7.42 (m, 1H), 7.39–7.19 (m, 8H), 4.72 (d, J = 4.5 Hz, 
1H), 3.22 (br, 1H), 2.85 (qd, J = 6.9, 4.5 Hz, 1H), 2.81–2.62 (m, 4H), 2.33 (s, 3H), 0.88 (d, J = 6.9 Hz, 
3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 142.1, 141.1, 132.0, 130.7 (q, J = 32.0 Hz), 128.8, 127.8, 
127.0, 126.1, 125.4 (q, J = 3.8 Hz), 124.2 (q, J = 271.5 Hz), 123.0 (q, J = 3.8 Hz), 73.3, 63.8, 56.3, 39.2, 
34.0, 10.0. 
IR (Diamond-ATR, neat): ν̃ / cm-1 = 2963 (w), 2856 (w), 2800 (w), 1598 (w), 1493 (w), 1450 (m), 
1377 (w), 1369 (w), 1329 (vs), 1199 (m), 1161 (s), 1119 (vs), 1072 (s), 1026 (m), 1000 (m), 907 (m), 
883 (w), 798 (m), 761 (w), 734 (m), 699 (vs), 661 (m). 
MS (EI, 70 eV): m/z (%) = 318.3 (1), 230.3 (100), 173.2 (12), 153.1 (8), 77.1 (3), 58.9 (4). 
HRMS (EI): m/z calc. for [C19H22F3NO]+: 336.1572; found 336.1569. 
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